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Abstract 
Clostridium difficile is a common and potentially fatal cause of antibiotic-
associated diarrhoea and pseudomembranous colitis worldwide.  It has been 
isolated from patients and their surroundings, in healthcare facilities and from the 
community.  C. difficile is able to survive for many months on inanimate surfaces in 
the form of spores.  PCR ribotyping is used in the UK to characterise and identify 
strain diversity.  Investigating how the most problematic strains respond to 
cleaning regimes may influence the control of disease.  This work used the 
University Hospitals of Leicester Trust as a case study for this purpose of 
understanding the epidemiology of this pathogen within healthcare facilities.  Five 
individual agar media were compared based on their abilities to recover and 
resuscitate damaged ribotype 027 spores, a strain associated with disease 
outbreaks and increased severity.  Controlled laboratory experiments with a sub-
lethal dose of a germicide were conducted before C. difficile recovery from hospital 
wards.  An additional two sampling campaigns acquired environmental strains.  C. 
difficile isolation after routine cleaning demonstrated the inefficiency of the 
current recovery regime as C. difficile spores were recovered using direct contact 
plates, enrichment broths, and resuscitation media.  This study used layering of 
non-selective agar over selective agar, identifying a potential link in the 
proportions of media following the use of sponges in environmental sampling.  All 
strains were characterised by ribotyping; ribotype 027 was isolated from all 
sampling cohorts.  A four-month epidemiological study was conducted into the 
ribotype prevalence and distribution from C. difficile-positive faecal specimens.  A 
second survey investigated these effects with a modification of C. difficile detection 
from faecal samples.  Hydrogen peroxide vapour is currently being explored as a 
means of decontamination of healthcare-associated infections.  Inactivation 
kinetics of ribotype 027 spores were analysed in response to vapour and liquid 
exposure of hydrogen peroxide.  No reports thus far have explored such kinetics 
and controlled decontamination with both clinical and non-clinical strains.  
Evidence strongly suggests spores can be inactivated with its application.  
Furthermore, this study revealed there appears to be significant differences in 
susceptibility and inactivation of different C. difficile ribotypes. 
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1.1 Healthcare-associated infections 
Healthcare-associated infections (HCAI) can be distinguished as those not 
present or developing during admission, but occurring in a patient throughout the 
duration of stay and whilst in the care of a hospital or other healthcare facility 
(World Health Organization 2002).  This also accounts for infections acquired in 
the hospital but not manifesting prior to discharge, as well as occupational 
infections possessed by members of staff (Allegranzi et al. 2007).  HCAI have been 
reported to account for 300,000 infections in UK hospitals every year, with 1 in 10 
patients contracting an infection during their stay; the estimated annual cost of 
treating HCAI in the UK is £1 billion (HCAI Research Network & Department of 
Health).  In 70% of nosocomial infections where HCAI are the problem, the 
pathogen in question was resistant to at least one anti-microbial drug.  This is 
interesting as the now resistant drug was previously effective.  Those infections, 
caused by a range of microbial agents, included: Acinetobacter spp., Staphylococcus 
aureus, Enterococcus spp., and Clostridium difficile (Carmeli 2008).   
1.1.1 Transmission of HCAI 
Studies have been previously conducted on how HCAI establish infection 
and how they are spread in healthcare facilities, as well as into the external 
environment (White et al. 2008).  It is known that contamination of a pathogenic 
organism can occur from a patient to the hospital surroundings, and these are able 
to thrive and survive on surfaces in the environment for many months (Boyce et al. 
1997; Kramer et al. 2006).  From these locations, others are able to acquire these 
pathogens; these include members of staff in the healthcare facility in addition to 
visitors and potentially, other patients.  Verity et al. (2001) also alluded to the 
containment of bacteria through isolation areas, thereby reducing the possibility of 
transmission between affected and non-affected patients.  Reports have shown 
levels of contamination exist on the surrounding surfaces and sites around 
patients, indicating sources of infection (Cotterill et al. 1996).  This is not to 
suggest that the only means for transfer is through physical contact of 
contaminated surfaces; it has been shown that aerial dissemination of pathogens 
can also result in these infections (Beggs et al. 2008).  Further to this, increased 
numbers of bed occupancy have also been linked to increased numbers of 
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contamination of these bacteria, as there is subsequently a higher chance of 
prevalence and spread of infection (White et al. 2008). 
1.1.2 UK surveillance of HCAI 
Mandatory surveillance helps to ensure proficient and accurate systems are 
implemented to manage the spread of infections efficiently.  The Department of 
Health (DH) and Health Protection Agency (HPA) have enforced compulsory 
surveillance of a number of HCAI in order to focus on those that are currently 
posing the most problems in hospitals, such as Enterococcus spp., Staphylococcus 
aureus, and C. difficile.  These three infections are particularly important, as their 
prevalence is higher than most underlying pathogens due to antibiotic resistance.   
Monitoring was first enforced in the UK for Staphylococcus aureus, as well 
as methicillin-resistant Staphylococcus aureus (MRSA), after a bacteraemia out-
break in April 2001 (Johnson et al. 2005).  This allows the pooling of data from 
different locations and NHS Trusts, allowing a clearer overall geographical 
conclusion.  This was then followed by the surveillance of the vancomycin-
resistant enterococci (VRE) in October 2003 (Brown et al. 2006).  VRE infections 
and mortalities were recorded following outbreaks in the UK (Kuriyama 2003; 
Kawalec et al. 2007).  In January 2004, monitoring of C. difficile was introduced 
following the growing trend of associated infections and mortalities.  This is 
particularly problematic as C. difficile produces spores, increasing the ease with 
which the infection can be transmitted.  The HPA has since implemented an 
informative scheme investigating which strains of C. difficile are causing disease 
within the NHS (Health Protection Agency 2012).  This is explained further in 
Section 1.3.2.2. 
1.1.3 Preventing the spread of HCAI 
In 1999, a plan was devised where ‘visual cleanliness’ was the aim to 
effectively reduce the numbers of infections in hospitals and successfully monitor 
the hygiene procedures as stated in the guidelines of “Standards for 
Environmental Cleanliness in Hospitals” (NHS Estates 2000).  This was based on 
the surroundings being ‘visually’ clean.  However, Griffith et al. (2000) and Malik et 
al. (2003) proved that this ‘visual cleanliness’ is not a successful means of 
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eliminating contamination from the environment.  Both groups concluded that 
surfaces thought to be free from contamination were not, using adenosine 
triphosphate (ATP) bioluminescence techniques and microbiological sampling, 
detecting the presence of pathogens. 
Nevertheless, it has been shown that reducing the environmental 
contamination has the ability to reduce the transmission, and therefore infection 
of these bacteria in hospitalised patients (Cotterill et al. 1996).   Increasing the 
time spent cleaning, with reagents currently used, can lead to a decrease in the 
infection rate, as found by Rampling et al. (2001) when investigating an outbreak 
of MRSA.   
1.1.3.1 Enforcing hand washing and use of alcohol-based hand rubs 
Clearly, poor environmental hygiene can lead to the transmission of these 
healthcare infections (Wilcox 1996). Through the implementation of thorough 
hand washing with soap and water, or with alcohol-based hand rubs (ABHR), the 
spread of some nosocomial infections has been controlled (Curtis 2008).  This 
called for the need to minimise the spread and infection of HCAI through 
improvements to hand hygiene. 
ABHR are frequently utilised in hospitals due to the ease in which it can be 
used compared to hand washing with soap and water.  In addition, the application 
of ABHR reportedly irritates the hands less and has the benefit of accessibility in 
that it can be made available in multiple sites within a facility (Ellingson & 
McDonald 2010).  Despite its activity against the spread of MRSA and VRE, a 
number of studies have suggested that ABHR are less effective against C. difficile 
(Oughton et al. 2009; Ellingson & McDonald 2010; Jabbar et al. 2010).  
Furthermore, these studies also acknowledge that the application of ABHR does 
not produce statistically significant log10 reductions in C. difficile spore 
concentrations.  These authors all report that hand washing with soap and water is 
superior in effectiveness in reducing the concentration of C. difficile spores present 
on hands when compared with ABHR.  Interestingly, Jabbar et al. (2010) reported 
that C. difficile spores may be transferred from person to person via a handshake, 
with a transmission rate of 30% immediately after the use of an ABHR.  Therefore, 
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in spite of the increased use and availability of ABHR in healthcare facilities, it may 
well be counter-intuitive in the control of C. difficile infection. 
1.1.3.2 Use of cleaning agents and disinfectants 
Altering the procedures and materials which are used to clean wards and 
bays can also have an influence on the recovery of bacteria (Eckstein et al. 2007).  
This was shown in a study conducted by Fawley et al. (2007).  This group 
investigated different detergents and disinfectants on vegetative cells of C. difficile 
and their effects on inhibiting germination of the bacterial spores, including 
ChlorClean, a product standardly used in UK hospitals at 1000 ppm (mg/m3).  
Effectiveness was recorded when a chlorine-based product was added to the cells 
and significant reductions in the spore germination were found.  Numbers of 
recovered C. difficile spores also decreased when chlorine-cleaning agents were 
used in conjunction with a hydrogen peroxide pre-clean.  However, the study 
concluded that the use of hydrogen peroxide with a neutral detergent was unable 
to reduce the numbers of spores germinating as successfully.  Mayfield et al. (2000) 
recorded a mean decrease in incidence from 8.6 to 3.3 cases per 1000 patient-days 
in C. difficile rates following the application of hypochlorite solution in comparison 
to a quaternary ammonium disinfectant.  This ammonium-based agent also failed 
to be as effective as aldehydes and peroxides against Staphylococcus aureus (Exner 
et al. 2004). 
Irrespective of these findings, studies with C. difficile have found that 
cleaning agents can instead have an adverse effect.  Wilcox et al. (2000) found that 
the application of a disinfectant or cleaning products to specific clinical strains 
could lead to the increase in the numbers of spores germinated.  This was 
increased further with the use of particular chlorine-free cleaning agents.  A 
suggestion for this could be due to a response to the exerted environmental stress 
in the form of a virulence factor.  Other groups have also eluded to the routine use 
of disinfectants not being efficient enough to reduce the infection rates alone 
(Danforth et al. 1987; Dettenkofer et al. 2004).   
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1.2 Clostridium difficile 
First identified over seventy years ago from a collection of healthy neonatal 
faecal samples, C. difficile is an anaerobic, Gram-positive, spore-forming bacillus 
(Hall & O’Toole 1935).  Arguably, it is one of the most important causes of 
infectious diarrhoea, pseudomembranous colitis and toxic mega colon (Sorg & 
Sonenshein 2009).  There were 34,268 reports of Clostridium difficile-associated 
disease (CDAD) in people aged 65 years and over, in the UK from April 2008 to 
April 2009 (Health Protection Agency 2010).  A recent report into the financial 
burden of C. difficile infections identified an average of £7,000 is spent per case 
(Department of Health 2012).  Although often present in the gut, when patients are 
immunocompromised, disruption to the normal colonic flora can cause CDAD 
which manifests usually after administration of broad spectrum antibiotics 
(Eggertson & Sibbald 2004; Eckert & Barbut 2010).  The result of this is either an 
overgrowth of C. difficile or colonisation with environmental clostridia that are 
often present in healthcare environments (Dubberke et al. 2007). 
1.2.1 Bacteriology  
C. difficile infection has been linked to the administration of the drug 
clindamycin by Tedesco et al. (1974) and Cleary (1998).  Often occurring in the 
elderly or immunocompromised patients following the use of broad-spectrum 
antibiotics as well as antineoplastic drugs that possess antibiotic properties have 
led to an increase in the incidence of the toxigenic antibiotic-associated colitis 
(Saxton et al. 2009). 
There appears to be a general decrease in recorded C. difficile infections in 
those over the age of 65 over an annual period; there is a rise in the first quarter 
which falls over time, only to increase again over the winter months (Polgreen et al. 
2010).  This could be attributed to immune systems being less tolerant of the cold 
during this period and there being an increased probability of their admittance to 
a healthcare facility.  Further risk factors are: infections to the enteric system that 
result in alterations in the colonic microflora, being in intensive care and high-
dependence units, undergoing mechanical bowel cleansing, being over 60 years 
old, and conditions that affect the host-immune systems and defences such as 
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chemotherapy, human immunodeficiency virus (HIV) and malnutrition.  A 
combination, or indeed any of these factors alone, is able to lead to a rise in the 
incidence of the C. difficile-associated colitis (Cleary 1998). 
Through the production of spores that are passed out with faeces, C. difficile 
is able to persist in the environment.  These allow the persistence on a number of 
surfaces in healthcare facilities such as floors, tables, chairs, bedding, and clothes 
for up to five months, increasing the chance of further infection, and spreading to 
others (Kim et al. 1981; Mayfield et al. 2000).   
 
Figure 1.1: Number of death certificates reporting C. difficile infection (hatched) in comparison with infection as the 
underlying cause (dotted) in England and Wales between 1999 and 2010.   
Data was not provided for the year 2000.  Data was obtained from the Office of National Statistics 
(http://www.statistics.gov.uk).  ‘*’ - refers to C. difficile infection mentioned as a contributory factor on a death certificate. 
 
Figure 1.1 shows considerable rises in the numbers of incidence of CDAD in 
the early 2000s, and Figure 1.2 illustrates rates of C. difficile-positive faecal 
specimens, which had the effect of increasing the duration of stay in hospitals, in 
addition to mortality rates (Aslam et al. 2005).  There has been a decrease in the 
latter part of this decade due to the introduction of procedures and practices to 
limit the spread of infection.  Controlling the administration of broad-spectrum 
antibiotics, careful patient management and monitoring CDAD has also 
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contributed to this decline (Healthcare Commission 2005).  Mandatory 
surveillance of C. difficile allows the monitoring of whether the implemented 
control methods have an effect on the infection rates. 
 
Figure 1.2: Number of C. difficile-positive faecal specimens obtained through a voluntary surveillance in England and 
Wales between 1990 and 2009.   
From 2004, surveillance was made mandatory to monitor C. difficile infection in hospitals in the UK.  Data was obtained 
from the Health Protection Agency (http://www.hpa.org.uk). 
 
1.2.2 Pathogenesis 
C. difficile can exist endogenously unable to colonise in healthy individuals 
until the normal gut flora is altered.  This is inhibited through patients receiving 
antibiotics, thus resulting in over-growth of toxigenic strains in the gut and disease.  
Ingested C. difficile spores that colonise and proliferate in the human colonic flora 
produce toxins A and B; CDAD can only be caused by toxinogenic strains of C. 
difficile.  These toxins produced following spore germination result in fluid 
secretion, inflammation and mucosal damage (Berrington 2004).  This is what 
leads to the symptoms of diarrhoea and pseudomembranous colitis, although the 
process in which the intestinal microbiota is reduced is not fully understood.  The 
two afore-mentioned toxins are considered to be the major virulence factors in 
CDAD (Barbut & Petit 2001). 
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Toxin A is a potent enterotoxin, which causes necrosis, increases intestinal 
permeability, through the inhibition of protein synthesis that results in complete 
erosion of the colonic mucosa.  This then damages the intestinal villi and erodes 
the brush border membranes (Poxton et al. 2001).  Toxin B is thought to enhance 
the activity of toxin A as well as playing a role in virulence (Berrington 2004; 
Kuehne et al. 2010).  Most clinical strains of C. difficile are capable of producing 
both toxins A and B, while some only produce toxin B.  It is rare to identify strains 
which are positive for toxin A alone (Cohen et al. 1998; van den Berg et al. 2004). 
1.2.3 Methods of detection  
There are several methods for the detection of C. difficile from faecal 
specimens used in a microbiology laboratory.  Methods such as direct culturing 
and the glutamate dehydrogenase (GDH) antigen assay target C. difficile itself; 
whereas others detect the presence of the C. difficile toxins from the specimen, 
such as the enzyme-linked immunosorbent assay (ELISA).  A third group of tests 
detect the presence of the toxin genes via molecular methods, such as nucleic acid 
amplification tests (NAATs) (Kufelnicka & Kirn 2011). 
The most accurate method for C. difficile detection from faecal specimens 
remains laboratory culturing on agar plates.  Samples are shocked with either 
alcohol or industrial methylated spirits (IMS).  This eliminates contamination of 
cells which are not C. difficile; in addition, it encourages the sporulation of C. 
difficile (Clabots et al. 1989).  This faecal-alcohol mixture is then sub-cultured onto 
a cycloserine-cefoxitin egg yolk (CCEY) agar plate.  Within 48 hr, positive C. difficile 
colonies should appear.  These can then be used in sub-typing of strains, as 
described in Section 1.3.1.  However, this method has many inherent problems.  
Culturing individual samples of C. difficile is time-consuming, costly, and labour-
intensive.  In addition to this, it is dependent on the presence of spores or 
vegetative cells.  The turn-around time for identification is also slow, and therefore 
would not be ideal in outbreaks and for diagnostic purposes (Vaishnavi 2009). 
The most common technique is the use of commercial kits for ELISA that 
detect either toxin A or both toxins A and B, even when present in low levels (0.8 
ng/ml and 2.5 ng/ml, respectively) (Techlab Enteric Diagnostics n.d.).  The results 
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are obtained relatively quickly, boding well and aiding in the diagnosis of infection.  
The sensitivity of ELISA ranges from 50-90% and specificity from 70-95% 
(Vaishnavi 2009).  Recently, the detection of the bacterial antigen GDH has also 
been targeted.  These assays are most sensitive but less specific due to GDH being 
expressed by toxigenic and non-toxigenic C. difficile strains.  Positive samples are 
often further tested for the presence of toxins or their genes (Kufelnicka & Kirn 
2011). 
The use of polymerase chain reaction (PCR) primers and NAATs have also 
been utilised in the detection of C. difficile from faecal specimens, targeting the 
enterotoxin gene or toxin B (Vaishnavi 2009).  Following the use of PCR, analysis 
of the results can be time-consuming, requiring technical skills.  Commercial kits 
have become available including GeneOhm Cdiff [BD Diagnostics, USA], illumigene 
C. difficile [Meridian Biosciences, USA], and GeneXpert C. difficile [Cepheid, USA] 
(Kufelnicka & Kirn 2011).  The use of NAATs is often carried out following initial 
ELISA, for example with GDH-detection.  This entails the cheaper, quicker, and 
more sensitive test to be conducted first and subsequently the specific molecular 
method (Kawada et al. 2011).  Kufelnicka & Kirn (2011) suggest such 
combinations increase the sensitivity of tests to 75-100%, with high specificity. 
1.2.4 Transmission and patient susceptibility 
Patients, both asymptomatic carriers as well as those infected, are crucial in 
the spreading of the disease to those susceptible to infections (Clabots et al. 1989).  
The transmission and maintenance of spores, passed out with faeces, can occur 
unknowingly as C. difficile is capable of surviving in a dormant phase for a number 
of weeks or months, remaining on surfaces such as chairs, tables, floors, even 
linens despite washing (Kim et al. 1981).  These hardy spores can reside on 
inanimate objects which means there is a high chance of the organism transferring 
from patient to patient within bays and wards, in addition to infection spread via 
the hands, jewellery and stethoscopes of clinical staff (Bradbury & Barrett 1997; 
Alleyne et al. 2009).   
Cephalosporins, penicillins, and clindamycin are known to increase the 
incidence of hospital-acquired infections and are the three most common 
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antibiotics linked to C. difficile colitis.  Those less likely to cause colitis are 
trimethoprim, quinolones, ureidopenicillins and aminoglycosides (Cleary 1998).  A 
study was conducted where 17% of patients who received clindamycin were 
subsequently diagnosed with associated colitis over two months (Kabins & Spira 
1975).  Due to increased administration of cephalosporins, there appeared to be 
an increase in antibiotic-associated diarrhoea incidences, with Keighley & 
Matheson (1980) and Talbot et al. (1986) reporting 5-38% of patients under 
treatment with antibiotics as sufferers.  The duration and route of antibiotic 
administration has also been shown to affect the development of CDAD; oral 
treatment is thought to increase the risk greater than intravenous (Bignardi 1998; 
Barbut & Petit 2001).  Furthermore, McFarland et al. (1989) reported that of 428 
patients tested at admission, 7% were positive for antibiotic-associated diarrhoea; 
throughout the course of hospitalisation, this rose to 21% as culture-positive.  
Fekety (1997) stated that in 15-20% of antibiotic-associated diarrhoea cases, C. 
difficile is responsible, and of the remaining instances, symptoms are settled when 
the administration of antibiotics is terminated.  In addition to this, the chances of 
contracting CDAD have been shown to increase in relation to the length of the 
course of antibiotic use as well as the number of antibiotics prescribed (Hensgens 
et al. 2012). 
1.2.5 Current treatment 
This association to antibiotics means that the treatment plan for C. difficile 
can be quite problematic.  Two antibiotics have been routinely used over the past 
thirty years in treating C. difficile infection: vancomycin and metronidazole 
(Gerding 2000).  The use of these drugs is often sparing to avoid the development 
of antibiotic-resistant strains, as seen with VRE and MRSA.  Nevertheless, 
susceptibility to metronidazole has declined although the reasons why have yet to 
be determined (Kuijper & Wilcox 2008).  Additionally, there has been the recent 
introduction of fidaxomicin, the first in a new group of narrow spectrum 
macrocyclic antibiotics, as a replacement for the use of vancomycin (Louie et al. 
2011; Lancaster & Matthews 2012).  Reports have suggested fidaxomicin disrupts 
the microbiota less when treating C. difficile than vancomycin, as well as acting 
against many VRE (Nerandzic et al. 2012).  There have also been fewer cases of C. 
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difficile infection recurrence with the administration of fidaxomicin than 
vancomycin and a reduction in the number of cases of ribotype 027, a problematic 
C. difficile strain (Louie et al. 2011; Mullane et al. 2011). 
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1.3 Monitoring and characterisation of C. difficile strains 
Monitoring which strains of C. difficile are present in healthcare facilities is 
important because it allows the identification of the strains responsible for disease 
outbreaks.  Furthermore, it provides a discriminatory data set to be collected that 
can provide the framework required to understand the epidemiology of the 
disease.  Therefore, correct characterisation of strains is highly important to aid in 
the recognition of new emerging ribotypes. 
1.3.1 Strain differentiation with PCR ribotyping 
Some C. difficile strains are more problematic in causing disease or infection 
than others, with a continuous rise in CDAD reports worldwide.  Therefore, several 
typing methods have been used to study the epidemiology of C. difficile.  This 
allows the identification of which strains are responsible for outbreaks of disease, 
and which may be presently underlying.  Several methods have been developed to 
classify the sub-types of C. difficile including restriction endonuclease analysis, 
pulsed-field gel electrophoresis, multi-locus sequence typing, multi-locus variable-
number tandem-repeat analysis, amplified fragment length polymorphism, and 
surface layer protein A gene sequence typing (Killgore et al. 2008).   
However, the most widely used technique in the UK and throughout Europe, 
is polymerase chain reaction (PCR) ribotyping which targets the 16S and 23S rRNA 
interspacer regions of the bacterial gene with specific primers (Brazier 2001).  
Gurtler (1993) showed the C. difficile genome to be heterogeneous, as it possesses 
many copies of these rRNA genes.  These were found to differ in number between 
strains as well as the size between different copies on the same genome.  It was 
then demonstrated that these fragments can be amplified from 250 to 600 base 
pairs (bp); following separation using the techniques described and modified 
primers (O’Neill et al. 1996).  This is then used as a signature for the strains and 
referred to as a ribotype (Stubbs et al. 1999).  Different ribotypes of C. difficile are 
then subject to differentiation due to the number and the size of the spacer gene 
present within the bacterial genome (Brazier 2001).  This is why PCR ribotyping is 
thought to be extremely useful in determining the genetic variation of C. difficile 
(Terhes et al. 2006).  This methodology is also highly discriminative, reproducible 
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and as it is easier and quicker than other molecular typing methods (Stubbs et al. 
1999).  
As PCR ribotyping uses universal primers, the C. difficile strain has to be 
isolated from patient faecal samples and then cultured to ensure that only DNA 
from this species is present as a template for PCR.  Traditionally, the PCR products 
from ribotyping are separated on a high-resolution agarose gel, the sizes of the 
bands are then estimated using gel analysis software; size standards are used as 
markers.  There are inherent problems with this as DNA can separate differently 
within gels, and this creates issues regarding comparability; in addition to this 
analysis of the bands is notoriously subjective (Zaiss et al. 2009).   
An alternative approach to identifying the ribotyping profiles is to size the 
fragments on a capillary-based system, having first incorporated a fluorescent 
primer into the PCR mixture.  A fluorescent standard marker is also added to each 
sample before the fragments are analysed on a DNA sequencing machine.  The 
output is a series of peaks, which are constructed on a chromatogram, where each 
peak corresponds to a particular fragment size.  Several authors have suggested 
that using capillary electrophoresis to identify genotype profiles allows greater 
precision than gel-based systems as it can resolve the size of DNA fragments to 
within ±4 bp (Indra et al. 2008; Xiao et al. 2012).  This allows samples to be 
standardised both within and between laboratories as it is far less prone to 
individual bias that occurs using gel-based systems (Indra et al. 2008). 
The use of PCR ribotyping has been further developed since 2008 to 
produce a more reliable system of strain characterisation (Indra et al. 2008).  The 
capillary-based method makes use of the already successful PCR ribotyping 
technique, but overcomes the emerging problem hampering European reference 
laboratories: exchanging data between laboratories.  This results in differing 
nomenclatures between groups, resulting in confusion as to which strain has been 
identified and investigated (Kato et al. 2001; Spigaglia & Mastrantonio 2004; 
Aspevall et al. 2006).  The HPA also uses this method of identifying PCR ribotypes 
for its annual reports of ribotype dominance in the UK (Health Protection Agency 
2011).  
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1.3.1.1 C. difficile PCR ribotype 027 
The first recorded case of a C. difficile ribotype 027 outbreak occurred in 
Québec in 2003, where over 1,400 cases of infection were recorded in six Montreal 
hospitals, over an eighteen month period (Eggertson & Sibbald 2004).  In 2005, a 
subsequent outbreak of C. difficile occurred in the Netherlands, and therefore, in 
the following year, a surveillance programme was initiated to investigate the 
strain differences.  Fourteen Dutch hospitals took part in a three-year long 
surveillance project, which investigated the incidence and distribution of different 
strains of C. difficile based on their PCR ribotypes (Hensgens et al. 2009).   
Arguably, one of the worst series of C. difficile outbreaks was within the 
United Kingdom at Stoke Mandeville Hospital, Aylesbury.  According to the 
findings by the Healthcare Commission following two outbreaks in quick 
succession, there were 174 cases of C. difficile infection from 2003 to 2004, of 
which nineteen were fatal.  Furthermore, in the following year, a further 160 
patients were confirmed with C. difficile infection and another nineteen deaths 
were reported (Healthcare Commission 2006).  Interestingly, the strain that 
caused these large outbreaks was the same.   
Kuijper et al. (2006) reported that in 2003, ribotype 027 was one of the 
rarest strains in the UK; by 2004, it was recognised as the strain causing the most 
severe outbreaks in hospitals (McDonald et al. 2005; Arvand et al. 2009).  This 
strain has since been identified as prevalent in hospitals worldwide and is also 
known as North American pulsed-field gel electrophoresis type 1 (NAP1), 
restriction endonuclease analysis group BI and toxinotype III (O’Connor et al. 
2009).   
This strain is often referred to as a ‘hyper-virulent variant’, although this 
term is somewhat controversial (Stabler et al. 2006; Hubert et al. 2007; Morgan et 
al. 2008).  Investigations into the reasons for the prevalence of this strain have had 
conflicting results.  A frame-shift mutation and 18 bp deletion in the tcdC gene of 
ribotype 027 pathogenicity locus is thought to be responsible for a consequent 
increase in the production of toxin A and B, by 16 and 23 times, respectively 
(McDonald et al. 2005; McFarland et al. 2007).  Studies have suggested however 
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that this increase of toxins has no bearing on an increase in disease severity (Walk 
et al. 2012). 
Kuijper & Wilcox (2008) reported that these virulence factors are not 
exclusive to ribotype 027.  They have also been identified in other ribotypes, such 
as ribotype 078, which was initially isolated from bovine and porcine origins 
(Goorhuis et al. 2008).  The spread of this strain is still debated, with a European-
based survey by Barbut et al. (2007) reporting the presence of ribotype 078 in 
Greece only, whereas Bauer et al. (2011) identified it as the third most prevalent 
strain in their subsequent continent-based study.  Interestingly, recent reports of 
this strain were made from the Middle East, where reports on C. difficile infection 
are highly infrequent (Jalali et al. 2012).  Nevertheless, these virulence markers are 
not found within all problematic strains.  In 2008, one of the most frequently found 
strains in the UK was ribotype 106, and this strain does not possess any of the 
deletions identified in ribotype 027 and 078 (Kuijper & Wilcox 2008).  
Despite the increasing emergence of new ribotypes of C. difficile, PCR 
ribotype 027 is still one of the most prevalent strains of C. difficile in the UK, across 
Europe and North America.   
1.3.2 C. difficile surveillance  
1.3.2.1 Monitoring of C. difficile in Europe 
Since 2006, samples from any patient presenting with C. difficile in the 
Netherlands are submitted to Leiden University Medical Centre (LUMC), for 
culture isolation, propagation and PCR ribotyping (Hensgens et al. 2009).  
Therefore, the Netherlands has a significant and comprehensive set of data 
describing the emergence and predominance of different strains of C. difficile.  This 
shows that, although still currently dominant, the 027 strain is actually in decline 
and has revealed the emergence of ribotype 078 (Goorhuis et al. 2008; Hensgens 
et al. 2009).  However, this degree of surveillance is unique and the high costs 
associated with it have precluded its implementation in the UK.  
A survey was carried out in Hungary where 105 clinical isolates were 
investigated over two years from three geographical regions of Hungary, of which 
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65 were from inpatients and the remaining 40 from outpatients (Terhes et al. 
2006).  This study found five distinct PCR ribotypes which failed to map any which 
had been previously determined, identifying the prevalence of types 014 and 002 
(24.8% and 13.3%, respectively) (Terhes et al. 2006). 
There have been two European-wide studies conducted by the European 
Clostridium difficile infection study (ECDIS) that investigated the prevalence of 
ribotypes between different countries.  These surveys aim to identify the key 
strains causing infections and therefore potential geographical networks of strains 
(Barbut et al. 2007; Bauer et al. 2011).  Collaborations between fourteen European 
countries permitted the identification of sixty-six ribotypes from 411 isolates 
(Barbut et al. 2007).  This group reported the most commonly isolated strains at 
the time of the study were ribotypes 001 (13%), 014 (9%) and 027 (6.2%).  It was 
surprising to find that despite its predominance in particular regions, such as the 
Netherlands (40% of isolates) and Belgium (31.4%), ribotype 027 was not as 
prevalent across Europe.  It was not identified in the UK at all, although the 
authors concede this may be due to only one UK hospital participating in the study.  
Ribotype 001 accounted for 73% of the isolates from three Spanish hospitals; 
ribotype 017 was identified in 80% of the toxigenic samples from Irish and Polish 
hospitals (Barbut et al. 2007).   
Bauer et al. (2011) isolated 389 samples from thirty-four countries, 
comprising sixty-five PCR ribotypes.  Contrasting with the findings four years prior, 
the ribotype cluster 014/020, 001 and 078 were the most commonly identified, at 
16%, 10%, and 8%, respectively.  Barbut et al. (2007) interestingly attributed this 
strain to predominantly causing C. difficile infection in younger patients.  The 
overall proportion of ribotype 027 was 5%, demonstrating a further decline in 
European prevalence.  Nevertheless, it was still one of the most identified strains 
from UK and Ireland.  These data demonstrate the variation of ribotypes between 
countries, irrespective of geographical distance, indicating patterns of strain 
diversity exist.  Particular strains were isolated exclusively within countries, such 
as ribotype 017 in three Spanish hospitals within the study, suggesting the 
localisation of ribotypes may also exist (Barbut et al. 2007).  The comparison of 
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ribotypes between the two studies has also shown the conformation of which 
strains are dominant can change over time (Barbut et al. 2007; Bauer et al. 2011; 
Kachrimanidou & Malisiovas 2011). 
1.3.2.2 Monitoring of C. difficile in the UK  
The HPA in the UK has a programme where it conducts mandatory 
surveillance of C. difficile infection rates, and routinely releases documents within 
the NHS Trusts (both Acute Trusts and Primary Care Organisations).  Every three 
months, hospitals are required to report these rates, however, it is not mandatory 
to submit all samples for culturing.  This is largely due to cost and the labour 
intensive nature of the procedures. 
In the UK, the C. difficile Ribotyping Network (CDRN) has been operating 
under the HPA since 2007, conducting mandatory weekly surveillance of C. difficile 
infection rates from all NHS Trusts.  The CDRN ribotypes samples using the 
capillary-based system, analysing isolates where there are increases in incidence, 
mortality, and recurrence rates, severity of cases, or failure to meet C. difficile 
infection targets.  This provides an invaluable resource for understanding national 
C. difficile distribution, and consequently a framework in which to contextualise 
studies based on a smaller spatial scale (Health Protection Agency 2012). 
Although ribotyping in UK hospitals is confined to a subset of strains, it has 
allowed the recent emergence of new dominant ribotypes to be closely followed.  
For example, ribotypes 002, 015, and 078 have become more abundant over the 
periods 2007/8.  They then gained even greater prominence in 2008/9 (Health 
Protection Agency 2009).  This information is critical in order to monitor which 
strains of C. difficile are problematic, related to outbreaks and potentially to then 
investigate why they are so successful in the hospital environment.  Patterns have 
also been identified in terms of where strains are found; particular strains are 
found more commonly within communities rather than within healthcare facilities, 
in addition to the ability of different strains to produce different amounts of the C. 
difficile toxins (McDonald et al. 2005; Warny et al. 2005; Bauer et al. 2011).  This 
suggests there is variation within the virulence of strains.  These findings therefore 
demonstrate the need for constant monitoring and surveillance programmes for C. 
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difficile infection, within not only continents but also countries, to identify the 
epidemiological changes exhibited by strains which could in turn aid in the 
strategic therapeutic responses (Kuijper & Wilcox 2008).  
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1.4 Isolation of C. difficile from the environment 
In addition to identifying which strains exist within patient specimens, it is 
also important to determine the presence of C. difficile within the environment.  
Knowledge of which strains are capable of residing in healthcare facilities despite 
the cleaning regimes enforced by healthcare professionals and governing bodies 
provides an insight into the problematic types.  There have been many studies 
carried out whereby environmental sampling has been conducted and C. difficile is 
recovered from healthcare facilities.  Different techniques for recovering C. difficile 
spores and vegetative cells have been implemented.  
C. difficile has not only been isolated from healthcare facilities and patient 
specimens, but other sources (al Saif & Brazier 1996; Rodriguez-Palacios et al. 
2007; Bakri et al. 2009; Songer et al. 2009; Weese et al. 2009).  Its presence has 
been detected in pre-packaged salad bags as well as meat products.  Bakri et al. 
(2009) reported the detection of C. difficile from 7.5% of ready-to-eat salad bags 
tested.  Worryingly, as these salads are served uncooked, there is the concern that 
ingestion may result in the colonisation of C. difficile.  The authors suggested that 
this could increase the asymptomatic carriage and risk of transferring C. difficile 
among humans.  Rodriguez-Palacios et al. (2007) isolated C. difficile from 20% 
(n=60) of retail beef and veal as ground-meat samples from Canada.  Of these, 
eleven samples were toxigenic, and eight were ribotype 027.  A further Canadian 
study identified 12% of samples (n=115) of ground-beef and 12% (n=115) 
ground-pork as C. difficile-positive (Weese et al. 2009).  Ribotypes 078 (73%) and 
027 (27%) were identified from the 42% (n=88) C. difficile-positive samples 
isolated from cooked and raw beef, pork and turkey products, in North America 
(Songer et al. 2009).  
Contrastingly, studies conducted in Sweden found 2.4% (n=82) and the 
Netherlands only 0.8% (n=500) of meat product samples as C. difficile-positive, 
despite testing chickens, turkeys, sheep, calves and pigs (Von Abercron et al. 2009; 
Freeman et al. 2010).  Despite these findings, there has yet to be any evidence that 
definitively suggests C. difficile contamination in food can result in C. difficile 
infection in humans.  
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1.4.1 C. difficile agar media 
Many comparative C. difficile medium studies have been designed for the 
isolation of C. difficile from faecal specimens.  The composition of agar media and 
optimised conditions may not be ideal in environmental recovery, although this is 
seldom explored.  Media are often formulated as an ‘agar base’ requiring 
additional supplements, each with a specific objective, such as an antibiotic 
mixture hindering growth of any bacteria, except for C. difficile.  Other 
supplements can be added in order to enhance spore germination or to improve C. 
difficile colony growth. 
Fastidious anaerobe agar (FAA) and brain heart infusion (BHI) agar are 
used in selectivity for C. difficile in conjunction with different additional 
components.  However, alone they both have been found to enhance the colony 
fluorescence of C. difficile when performing one of the characteristics tests for 
identification: viewing under an ultra-violet (UV) light (Levett 1985; Tabaqchali & 
Jumaa 1995).  C. difficile is also thought to utilise fructose in base agars as a 
nutrient, and so there is a visible colour change in the medium upon acid 
production and metabolism (Buggy et al. 1983).  These two agar bases are often 
utilised in laboratory culturing of C. difficile.   
1.4.1.1 Use of supplements in C. difficile media 
There are antibiotics used in addition to the agar base when selecting for C. 
difficile.  The purpose of antibiotics in selective media is to inhibit most microbial 
flora growth, except that of C. difficile.   
Norfloxacin, a broad-spectrum antibiotic that interferes with bacterial DNA 
replication, is commonly used in addition to moxalactam, another broad-spectrum 
antibiotic that acts by interrupting synthesis of peptidoglycan.  This then inhibits 
the growth of various bacteria and other clostridia.  A study found the use of 
norfloxacin inhibited strains of Enterobacteriaceae and faecal streptococci when 
tested at a concentration of 16 mg/l (Aspinall & Hutchinson 1992).  When used in 
combination with moxalactam (32 mg/l), C. difficile moxalactam-norfloxacin 
(CDMN) also successfully inhibited the growth of all the clostridia, without 
affecting the growth of C. difficile.  Upon comparison with cycloserine-cefoxitin 
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fructose agar (CCFA), CDMN gave a 20% higher isolate rate and a 33% reduction in 
growth of contaminants.   
D-cycloserine (commonly known as cycloserine) is a third broad-spectrum 
antibiotic, which inhibits two enzymes of the murein production cycle.  This is 
frequently used in conjunction with cefoxitin, also a broad-range antibiotic that 
interacts with cell wall synthesis.  This antibiotic combination is a common 
mixture that inhibits a host of bacteria found in high proportions within faecal 
samples, when used at 250 mg/l and 8 mg/l.  These concentrations have been 
reported to be more successful at growing a diverse range of C. difficile strains 
than 500 mg/l and 16 mg/l, which were initially utilised in the production of 
selective media (Levett 1985).  It is also the most commonly utilised selective 
medium in the isolation of C. difficile from faecal specimens. 
An antifungal antibiotic administered in hospitals that has been associated 
with an increase of CDAD is amphotericin B.  Although not well documented in 
literature, because of its recorded effect on C. difficile-infected patients, is thought 
to aid in the germination of spores and maintain C. difficile growth.  Therefore, 
there is an instance of its use in the preparation of media prior to environmental 
sampling (Gerding et al. 1995).   
Egg yolk emulsion is used in the preparation of clostridial media for the 
detection of enzymatic activity of lecithinase and lipase.  C. difficile produces 
neither, and so the need for egg yolk in a selective medium has not been identified.  
Although, based on the dull, grey colony morphology produced, the addition of egg 
yolk proves useful with respect to confirmation and identification (Wilson et al. 
1982). 
George et al. (1979) found that with direct application of faecal samples to a 
medium containing horse blood, larger colonies were produced than with egg yolk 
emulsion.  It has also been shown that 7% (v/v) defibrinated horse blood with BHI 
agar (BHI blood) is beneficial in culturing C. difficile due to its nutrient composition, 
increasing sporulation rates and for identification purposes in the production of a 
greenish-yellow fluorescence of colonies when exposed to long-wave UV light.   
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Cysteine hydrochloride is another agent which speeds up the growth of C. 
difficile following application of the bacterium to the media (Aspinall & Hutchinson 
1992).  The addition of lysozyme into a medium has also been found to increase 
the recovery of C. difficile.  It acts through the stimulation of its spore germination 
where it often replaces the egg yolk emulsion in the cycloserine-cefoxitin 
supplemented agar (Verity et al. 2001; Wilcox & Fawley 2000; Dubberke et al. 
2007). 
Some cholate derivatives that are normal components of bile can act with 
glycine in inducing the germination of C. difficile spores.  Sorg & Sonenshein (2008) 
produced evidence to show that one of these, chenodeoxycholate, was responsible 
in inhibiting growth and germination of spores.  Sodium taurocholate, however, is 
the most common in C. difficile selective media, as it enhances spore recovery.  
Buggy et al. (1983) reported a six-fold increase in the recovery of C. difficile spores 
following the addition of taurocholate to cycloserine-cefoxitin fructose agar 
(TCCFA).  This group identified an increase in spore density, and subsequently an 
increase in the colonies formed following standard C. difficile anaerobic incubation 
for 48 hr at 37°C.  The success of this media was supported by Kaatz et al. (1988), 
who reported an increase in C. difficile spore recovery from the environment, with 
31.4% of cultures testing positive.  Upon administration of 0.1% sodium 
taurocholate in the place of 2.5% egg yolk in CCFA, the spore recovery increased 
twenty-fold (Buggy et al. 1983; Buggy et al. 1985).  The purity of the bile salt is also 
thought to be linked to the recovery, with a higher grade being more successful, as 
well as unrefined deoxycholate salts potentially inhibiting cell multiplication 
(Brazier 1998).  Using more than 0.1% sodium taurocholate appears to have no 
significant increase in recovery (Buggy et al. 1983; Wilson 1983).   
Despite the number of studies that have recovered C. difficile from the 
environments, and reported on hospital contamination rates, there has been little 
found in literature to suggest an overview into the most successful media, and/or 
its selective agents when conducting environmental sampling.  Research groups 
predominantly utilise a particular growth medium for the isolation and recovery 
of C. difficile with little to no justification as to its choice.  A comparative table into 
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the success of different C. difficile media and their incorporation in environmental 
sampling has been presented (Table 1.1). 
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Media Group Journal Success 
C. difficile brucella agar with 0.05% ST (Nerandzic & Donskey 2009) Journal of Clinical Microbiology 100% (direct application) 
C. difficile moxalactam-norfloxacin* 
(Alfa et al. 2008) BMC Infectious Diseases 33% 
(Bakri et al. 2009) Emerging Infectious Diseases 3/40 (7.5%) – from salad  enrichment broth 
Cycloserine-cefoxitin (Brazier’s) with egg yolk* 
(McCoubrey et al. 2003) Journal of Medical Microbiology 185/1348 (14%) 
(Shapey et al. 2008) Journal of Hospital Infection 48/203 (24%) 
Cycloserine-cefoxitin (Brazier’s) with 5 mg/l 
lysozyme 
(Roberts et al. 2008) BMC Infectious Diseases 23/32 (72%) – from air samples  recovery solution 
(Verity et al. 2001) Journal of Hospital Infection 16-35% - from swabs 
Cycloserine-cefoxitin (Brazier’s) without egg yolk 
with 5 mg/l lysozyme and 1% lysed blood 
(Wilcox et al. 2000) Journal of Hospital Infection 24% - from swabs (11% without lysozyme) 
Cycloserine-cefoxitin-amphotericin B  
with 0.1% ST* 
(Martirosian et al. 2005) Diagnostic Microbiology and Infectious Disease 22/180 (12.2%) 
(Martirosian et al. 2005) Anaerobe 5/14 (36%) 
Cycloserine-cefoxitin-fructose 
(Clabots et al. 1991) Journal of Clinical Microbiology 4-17% 
(Kim et al. 1981) Journal of Infectious Diseases 85/910 (9%) 
(Mundy et al. 1995) American Journal of Clinical Pathology 100% (direct application) 
Cycloserine-cefoxitin-fructose with 0.1% ST 
(Weese et al. 2000) Journal of Veterinary Diagnostic Investigation 24/381 (6%) 
(Buggy et al. 1983) Journal of Clinical Microbiology 14.5-45.8%  
(Cohen et al. 1997) Clinical Infectious Disease 9.1% 
(Niyogi & Pal 1992) Indian Journal of Medical Research 73% (direct application) 
Cycloserine-cefoxitin-fructose with 5 mg/l 
lysozyme and 0.1% ST 
(Sethi et al. 2010) Infection Control and Hospital Epidemiology 60% and 37%, 32% and 14%, 58% and 50% - from gauze pads and swabs 
Cycloserine-cefoxitin-fructose with 5 mg/l 
lysozyme 
(Dubberke et al. 2007) American Journal of Infection Control 13/48 (27%) – from sponges 
Cycloserine-cefoxitin-fructose with egg yolk (Fekety et al. 1981)  American Journal of Medicine 110/1086 (10%) in areas with known C. difficile 
Cycloserine-mannitol blood agar (Mundy et al. 1995) American Journal of Clinical Pathology 43/64 (67%) (direct application) 
Fastidious anaerobe agar with 0.1% ST* (Wheeldon et al. 2008) Journal of Applied Microbiology No data, reported as ‘success’ 
GS-BHI agar with 0.1% ST* (Kamiya et al. 1989) Journal of Medical Microbiology After heat-treatment: <1%; after alkali treatment: <6% 
GS-BHI agar with 10 mg/l lysozyme* (Kamiya et al. 1989) Journal of Medical Microbiology (Same as above): 10-47%; >90% 
Table 1.1: Comparison of environmental studies that utilise C. difficile selective media. 
Summary of different media used in the environmental recovery of C. difficile.  ST: sodium taurocholate.  ‘*’ - denotes media (or a variation) has been used in this thesis.  
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1.4.2 Direct contact plates in environmental sampling 
RODAC (Replicate Organism Detection And Counting), or direct contact 
plates have been used in the recovery of environmental samples of C. difficile 
(Buggy et al. 1983; Kaatz et al. 1988).  These plates have a raised agar surface that 
is exposed to environmental sites and through direct contact with these areas, are 
able to collect bacteria.  The presence of a grid outline on the base of the plate also 
facilitates the counting of bacterial colonies.  Preparing the RODAC plates with C. 
difficile-selective media acts to eliminate the requirement for a recovery medium 
or enrichment broth as growth of the bacteria occurs directly on the surface of the 
agar.  The use of RODAC plates can be used as a direct method in the investigation 
into media selectivity and recovery success. 
The aforementioned study by Buggy et al. (1983) utilised TCCFA in RODAC 
plates.  Kaatz et al. (1988) also used TCCFA to increase spore recovery of C. difficile 
from the environment, finding 31.4% of cultures testing positive after direct 
contact. 
Alfa et al. (2008) used RODAC plates prepared with CDMN agar in 
conjunction with UV markers to detect the presence of C. difficile contamination of 
toilets and commodes within a hospital ward, stating all the sites sampled should 
be routinely cleaned.  Their investigation identified 33% of samples were toxigenic 
C. difficile.  A follow-up study identified 86% recovery of C. difficile spores from 
contaminated toilet surfaces using the same techniques (Alfa et al. 2010).  The 
authors conclude that the use of RODAC plates allows direct comparisons as to the 
influence a disinfectant has on the inactivation of spores. 
However, a potential disadvantage in the use of RODAC plates, is the 
difficulties that arise in the process of environmental sampling are irregular areas, 
such as door handles and taps, both of which are considered ‘high’ contact sites.  
Recovery of C. difficile from these sites would prove difficult with the flat surface of 
the agar. 
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1.4.3 Pre-moistened sponge-sticks and swabs in environmental sampling 
A final method in the recovery of C. difficile from environmental sampling is 
with the use of sponges and swabs.  The pre-moistened swabs and sponge-sticks 
enable the recovery of microorganisms with ease when collecting samples at 
multiple sites.  The larger surface area, which can be covered with their use, also 
reduces the time taken to sample within healthcare facilities.  A further benefit of 
this method is the ability to sample ‘high’ contact sites that are not flat surfaces, for 
example, sink taps, and hand rails.  This suggests the use of this technique may 
provide a detection method that is more sensitive for C. difficile environmental 
contamination. 
Dubberke et al. (2007) showed recovery of C. difficile using pre-moistened 
cellulose sponges with neutralising broth following spreading over an area of 1 m2.  
The presence of the broth encourages the microbes to attach to the surface of the 
sponge, increasing the potential recovery.  This group found 27% samples (n=48) 
collected from these sponges were positive for C. difficile from the six healthcare 
facilities they investigated.  They concluded an increase in contamination was 
observed in those rooms with a C. difficile-infected patient present, in addition to 
the prevalence of ribotype 027. 
Otter et al. (2009) compared the use of these sponges against swabs with 
broth enrichment following the wards in question being exposed to hydrogen 
peroxide vapour decontamination; they found the percentage recovery for each 
was 28 and 1.5, respectively.  This study also showed there was a greater recovery 
in terms of C. difficile being able to be cultured with the sponges.  There was no 
information as to the strains identified from this sampling campaign. 
A disadvantage to using the pre-moistened sponges is despite the ability to 
sample multiple sites, it is not possible to identify the exact location of the source 
of contamination.  Therefore, it is also difficult to determine the significance of the 
contamination, which would be possible with direct contact sampling (Otter et al. 
2009). 
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1.4.4 Recovery of damaged cells from the environment 
Subsequent to environmental sampling, samples from sponges and swabs 
are often immersed into enrichment broths or plated onto the surface of agar 
media.  Enrichment broths frequently contain supplements, such as sodium 
taurocholate or antibiotics, to enable damaged spores to recover from the stresses 
induced and encourage spore germination (Arroyo et al. 2005; Bakri et al. 2009; 
Rodriguez-Palacios 2009; Jalali et al. 2012).  These can then be cultured further, 
for example for strain typing.  The second methodology used is the application of 
the sample onto a C. difficile-selective agar medium to encourage proliferation 
(Clabots et al. 1992; Dubberke et al. 2007; Roberts et al. 2008).  These two 
techniques can be used in conjunction to initially enrich the sample and then 
isolate C. difficile following growth on a selective medium (Rodriguez-Palacios 
2009). 
Kang & Fung (2000) have investigated how the preparation of media can 
have an effect on its ability to resuscitate bacteria following environmental 
sampling.  This group have examined the recovery of Escherichia coli O157:H7, 
Staphylococcus aureus, Yersinia enterocolitica, Listeria monocytogenes, and 
Salmonella typhimurium, employing a method of layering a thin non-selective 
media onto antibiotic-containing media.  This practice allows the development and 
nurturing of the damaged spores and cells onto the non-selective media.  
Following the initial growth period, the role of the antibiotics is to inhibit the 
formation of other species and microorganisms, selecting primarily for the desired 
bacteria.  The results produced by this group with the application of heat-treated 
and damaged cells onto the double-layered agar media demonstrate a higher 
success rate than the bacterial resuscitation of single-layered agar media.  No 
studies have utilised this method to-date for the recovery of environmentally 
collected and damaged C. difficile spores. 
 
  
Chapter 1. Introduction and Literature Review 
 
29 
 
1.5 Hydrogen peroxide vapour decontamination 
A common method for the deep cleaning of hospitals that is currently 
becoming incorporated into cleaning regimes is the use of hydrogen peroxide 
vapour decontamination.  Based on the number of HCAI in hospitals, it is clear that 
a means to control the spread of contamination needs to be developed.  There are 
surfaces and medical equipment in the healthcare facilities that can act as 
reservoirs for C. difficile.  The resistance of C. difficile to cleaning methods has been 
established, and this is attributed to its presence in the environment in spore form 
(Sorg & Sonenshein 2008).  This increases the chances of cross-contamination 
through contact by healthcare staff, contributing to the spread of infection rather 
than reducing it.  Few studies have optimised the hydrogen peroxide exposure 
with respect to time and concentration.  Therefore, there is a need for data on the 
effects hydrogen peroxide can have on the inactivation kinetics of C. difficile spores.   
Of the many decontamination methods that could be implemented in the 
cleaning of hospitals, hydrogen peroxide could potentially be the most 
advantageous.  Originally designed for the decontamination of rooms in the 
pharmaceutical industry, it has been developed for use in healthcare facilities.  Any 
variability in manually cleaning would also be reduced with its use, although it is 
often recommended that a pre-clean be conducted prior to exposure of hydrogen 
peroxide to remove any organic material (Pottage et al. 2010).  
Catalase is an enzyme some bacteria naturally produce which breaks down 
hydrogen peroxide into its constituent components: water and oxygen.  Hydrogen 
peroxide is an oxidising agent, and it is known that bacterial catalase-peroxidase 
systems exist to combat against such oxidative stress (Otter & French 2009).  
Problematic pathogens responsible for many HCAI are highly catalase-positive and 
therefore this catalase presence could account for difficulties arising in the 
inactivation of these bacteria.  Interestingly, C. difficile does not produce catalase 
(Fu et al. 2012). 
Contrasting reports have also been found that demonstrate that re-
colonisation of certain nosocomial pathogens can occur within a week in some 
cases, as well as within a day after hydrogen peroxide decontamination (Hardy et 
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al. 2007; Otter et al. 2007).  This is not to suggest the use of hydrogen peroxide 
would bear no effects if implemented in healthcare facilities as a means for 
cleaning.  Dependent on the surface exposed to the vapour, there are data to 
suggest varying efficacy in decontamination.  Rogers et al. (2005) have shown 
significant differences on porous and non-porous surfaces with Bacillus subtilis 
spores.  A 1.2-log10 CFU reduction was reported with exposure on carpet and 2.2-
log10 CFU reduction on bare pine wood (J. V Rogers et al. 2005).  However, when 
recovering the spores from paper wallboard, formica laminate and glass, this 
group reported a log10 CFU reduction of greater than 7.5 (J. V Rogers et al. 2005).  
Application of hydrogen peroxide also has repercussions in healthcare 
facilities if this is to be used as a viable option for cleaning.  Inevitable drawbacks 
of this technique are the requirement of removing patients from rooms, the 
relatively high costs associated in comparison to the traditional method of manual 
cleaning, and the requirement for specialised equipment and personnel to operate 
the decontamination systems.  Although for safety reasons these cannot be 
changed, a disadvantage can be investigated: the times and concentrations 
required for decontamination.  Operating the decontamination systems at 
concentrations such as these would prolong the re-admission of patients.  An 
average of 4.5 hr is required following a hydrogen peroxide vapour 
decontamination session, whereas it is only 67 min after a manual bleach clean 
(Davies et al. 2011).  This longer wait time subsequently has an impact on the 
turnaround time for hospitals, limiting the number of patients that the hospital can 
be newly admitted into vacant rooms (Boyce et al. 2008; Otter et al. 2009; Davies 
et al. 2011).   
Nevertheless, hydrogen peroxide vapour has also been shown to reduce the 
proportion of Staphylococcus aureus, Acinetobacter baumannii, and VRE in hospital 
environments within other studies (French et al. 2004; Otter et al. 2007; Ray et al. 
2010; Chan et al. 2011).  The application in its vaporised form does not appear to 
cause any damage to, or affect the functionality of, medical equipment that 
suggests it could be used as an alternate tool for cleaning.  It is also a substitute to 
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the potentially hazardous sterilisation of heat-labile materials (Andersen et al. 
2006). 
1.5.1 Deep Clean Project 
In order to combat HCAI, a key component is introducing and maintaining 
cleanliness in and around hospitals.  In September 2007, the British government 
declared a change in the cleaning procedures and an increased level of hygiene 
was set.  This announcement forced NHS Trusts to assess the existing states of the 
hospital environments, as well as encouraging them to recognise which particular 
areas would require refurbishment or a comprehensive deep clean, allowing a 
baseline of cleanliness to be established.  With a budget set of £57 million by the 
Government, the Deep Clean Project aimed to target different NHS Trusts on an 
individual basis, dependent on where they deem the most action is required 
(Department of Health 2008).  
There was some success reported soon after the instigation and initiation of 
the Deep Clean Project.  The Weston Area Health NHS Trust implemented a pilot 
scheme whereby bed areas were steam cleaned via aerosols by staff, following the 
discharge of a patient.  This technique was used in addition to the Trust 
purchasing new commodes and bedpan washers, increasing the number of hand-
wash basins within wards and replacing one hundred bedside lockers.  There was 
also the introduction of a ‘bare below the elbows’ initiative enforced by all clinical 
members of staff to eliminate bacterial contamination from contact with clothing 
(Department of Health 2008).  A 25% reduction in the numbers of C. difficile 
infection was recorded.   
In order to ensure certain levels of cleanliness were maintained, wards 
were potentially subject to being fined and, if problems persisted, closed down.  
The DH stated specific attention was to be paid to Patient Environment Action 
Team (PEAT) scores that focus on the cleanliness in and around hospitals, national 
specification scores, and any complaints and incidents relating to the environment 
(Department of Health 2008).  Other criteria were in-patient surveys as well as 
local patient and staff satisfaction surveys, and trends in infection rates, in 
particular, with regards to C. difficile and MRSA (Department of Health 2008). 
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1.5.2 Hydrogen peroxide decontamination systems 
There are two different hydrogen peroxide systems predominantly used in 
cleaning: vapour decontamination and in the form of a dry-mist.   
The vapour decontamination system uses 30-35% (w/w) hydrogen 
peroxide solution, with an air stream to maximise the coverage of exposure 
throughout a room (Otter et al. 2007; Boyce et al. 2008).  In order to operate the 
system, rooms must be entirely enclosed, including sealing of air-conditioning 
ducts and any sources of ventilation.  A uniform layer of 2-6 µm of hydrogen 
peroxide is applied onto the surfaces following air saturation, before the catalysis 
to water vapour and oxygen is conducted with an active aeration system.  The use 
of activated charcoal has also been shown to reduce the concentration of hydrogen 
peroxide (Aguinaco et al. 2011).  Utilising this subsequent to hydrogen peroxide 
exposure would decrease the waiting time for a safe level prior to the re-admission 
of patients. 
Otter & French (2009) investigated the resistance of a range of 
microorganisms to hydrogen peroxide.  This group successfully inactivated all 
tested organisms within 90 min: Acinetobacter baumannii was the most resistant 
to the hydrogen peroxide vapour, followed by MRSA and Klebsiella pneumoniae, C. 
difficile and finally, VRE.  The reports suggest only 10 min was required to 
inactivate more than 6-log10 CFU of VRE, a catalase-negative organism, and 30 min 
for C. difficile.  The authors contribute the presence of catalase in the other 
microorganisms tested to their comparative resistance to hydrogen peroxide. 
The hydrogen peroxide dry-mist systems aerosolise a solution of 3-10% 
(w/w) hydrogen peroxide, (<50 ppm) silver ions, and (<50 ppm) orthophosphoric 
acid (Shapey et al. 2008; Barbut et al. 2009; Boyce 2009).  The dry-mist produces 
droplets between 8-12 µm in diameter, which can then be directed onto surfaces 
with nozzles.  The mist naturally decomposes into water vapour and oxygen 
following its application.  Some of these systems reportedly do not measure the 
concentration of hydrogen peroxide in the air at the time of exposure, which could 
be potentially dangerous. 
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Andersen et al. (2006) observed complete inactivation of Bacillus 
atrophaeus spores (6-log10 CFU reduction) with the use of a dry-mist hydrogen 
peroxide system (Sterinis) [Gloster Sante Europe, France].  This group tested the 
decontamination of spore strips in hospital rooms and ambulances.  In closed test 
rooms, 87% (n=146), and in a surgical department, 100% (n=48), of samples were 
decontaminated.  The authors also report 100% (n=60) success in ambulances, 
with the dry-mist fumigating glove compartments, under mattresses, equipment 
and the drivers’ cabins.  They concluded these findings were subsequent to three 
cycles of the system, with each taking about 3 hr; one or two cycles were not 
deemed as successful.   
1.5.3 Hydrogen peroxide inactivation of C. difficile strains 
Boyce et al. (2008) investigated the effects of hydrogen peroxide 
decontamination with a vaporised system [Bioquell Ltd., UK], in a university-
affiliated hospital known to be affected with C. difficile, in particular the infection 
of ribotype 027.  There were control measures implemented prior to the study: 
increasing C. difficile toxin testing and isolation of infected patients, encouraging 
hand hygiene with washing using soap and water, and reducing the administration 
of broad-spectrum antibiotics.  These changes were reported to have little impact 
on the proportion of patients with CDAD.  This group sampled wards pre-
intervention as well as during the intervention, for two ten month periods to allow 
for any seasonal fluctuations in infection.  Each patient room was reported to have 
taken 3-4 hr, and 12 hr per ward for complete decontamination.  The use of 
hydrogen peroxide vapour significantly reduced C. difficile infection in all five of 
the tested wards, with a 53% reduction in those months when ribotype 027 was 
identified. 
Shapey et al. (2008) investigated C. difficile contamination in three wards 
inhabited by elderly patients with the Sterinis system.  The wards were sampled 
both before and after the usage of the hydrogen peroxide exposure.  Prior to its 
application, 24% samples were C. difficile-positive.  With only one cycle of its 
application, 3% (P<0.001) of samples recovered were C. difficile-positive.  These 
were also characterised by ribotyping, identifying the strains as ribotypes 001, 
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027, and 106.  The counts recorded were similar to those from isolation rooms 
which were deemed low risk (elective orthopaedic, obstetrics and paediatric 
wards) (Shapey et al. 2008).  This group reports that the effects of hydrogen 
peroxide exposure to these sites could have been bactericidal and/or sporicidal.  
Sampling was conducted again three to six weeks following the intervention and 
there was no increase in the number of C. difficile-positive samples. 
Another report of the application of hydrogen peroxide and different 
strains of C. difficile was conducted by Barbut et al. (2009).  An in vitro study was 
conducted with hydrogen peroxide dry-mist exposure, with application to three 
different C. difficile strains (toxinotype 0, and a historical ribotype 027 and an 
epidemic ribotype 027), using the aforementioned Sterinis system (Barbut et al. 
2009).  Following a single cycle, this group identified a mean 4.18-log10 CFU 
reduction on coupons infected with spores.   
1.5.4 Kinetic inactivation of C. difficile 
Currently, groups often utilise the aforementioned hydrogen peroxide 
decontamination equipment for large-scale operations in healthcare facilities, 
employing vapour concentrations within the range of 500-2000 ppm (Hall et al. 
2007; Hardy et al. 2007; Otter et al. 2007).  It has been suggested that hydrogen 
peroxide vapour concentrations exceeding 75 ppm are hazardous to human health 
(Krishnan et al. 2006).  There has been little investigation into the kinetic 
inactivation of C. difficile, focusing on the combination of time of exposure against 
the active concentration of hydrogen peroxide. 
Lawley et al. (2010) investigated the effects of adding 1 and 10% hydrogen 
peroxide solutions to pure C. difficile ribotype 017 spores, a non-clinically relevant 
strain.  This group identified with the lower concentration that 75% of spores are 
inactivated after 1 min of exposure; there is no change in the subsequent 19 min of 
exposure.  With 10% hydrogen peroxide, >99% inactivation was observed within 
1 min, and complete kill of all spores occurred by the end of the 20 min experiment.  
Ribotype 017 spore strips prepared on sterile filter paper, concentration of 6-log10, 
were exposed to 400 ppm hydrogen peroxide vapour for 1, 5, 20 and 60 min.  The 
group studied the efficiency of the hydrogen peroxide decontamination, 
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identifying over 75% inactivation after 5 min with C. difficile and 100% after 20 
min.  These findings contrast with the data from the Geobacillus 
stearothermophilus, which identified 60 min was required for complete 
inactivation, demonstrating the sensitivity of C. difficile spores to hydrogen 
peroxide in comparison. 
Many studies utilise a peak exposure concentration to induce inactivation 
of spores, as reported by Fu et al. (2012).  This methodology may not be successful 
in targeting all major problematic strains.  There have been no reports thus far 
conducted which investigate whether the treatment times and their corresponding 
times of exposure are sufficient to eradicate multiple clinical C. difficile strains.  It 
is therefore possible that exposure to a peak concentration of a limited time may 
result in the persistence of a few resistant spores.  The effects of decontamination 
could therefore be rendered useless, permitting re-colonisation. 
Labas et al. (2008) reviewed the effects of hydrogen peroxide in the 
disinfection of Escherichia coli.  This group utilised a modified Series-Event model, 
which assumes a unit of microbial damage equates to an individual event.  An 
accumulation of these ‘damage-causing’ events results in the inactivation, with a 
kinetic constant throughout.  The surviving organisms are then calculated.  This 
group found a 3-log10 CFU increase in the inactivation of Escherichia coli from 15 
ppm to 300 ppm after 2.5 hr exposure of hydrogen peroxide.  The experimental 
data matched their Series-Event model well.  The authors concluded the 
inactivation was dependent on the concentration of hydrogen peroxide utilised, as 
well as increasing the concentration results in the reduction of an initial lag phase.  
The literature is sparse with regards to investigations of C. difficile 
inactivation kinetics.  Studies rarely compare more than one concentration of 
hydrogen peroxide against time, and infrequently research a range of isolated 
strains.  This makes comparisons between findings increasingly difficult, as the 
concentrations of vaporised hydrogen peroxide used are often peak, rather than 
applied at a steady state.  Therefore, there is a call for the collection and 
presentation of these data to allow for the identification of the parameters 
required to induce C. difficile spore inactivation.    
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1.6 Research aims and objectives 
This introduction has thus far discussed some of the problems encountered 
by the healthcare industry.  Surprisingly, despite the reports of C. difficile 
contamination in the hospital environment, few studies have been designed to 
optimise its isolation, recovery, and resuscitation.  There are a number of 
techniques that could be employed and these are infrequently compared.  It is 
important to monitor and identify C. difficile strains that are dominant and 
prevalent in healthcare facilities, and PCR ribotyping is a method used in the UK to 
characterise C. difficile strains.  Epidemiological studies identifying strain 
predominance within a geographical region are also infrequently conducted.  This 
information could be crucial in identifying the migration of strains around a 
country.  With respect to cleaning regimes and eradication of C. difficile 
contamination, hydrogen peroxide vapour is currently being explored as a method 
for decontamination of healthcare facilities.  However, there is a lack of kinetic 
inactivation data pertaining to C. difficile strains.  The work conducted into the 
application of these liquid and vaporised hydrogen peroxide exposure approaches 
in a controlled environment is scarce.   
Therefore, the main aims and objectives of the work conducted in this 
thesis are as follows: 
i. To evaluate five different agar media prepared in RODAC plates in a 
novel method, based on their recovery of chemically damaged C. 
difficile spores from stainless steel tiles. 
ii. To identify the differences in recovery of C. difficile with 
combinations of these five media with selective and germination 
agents based on their application in laboratory experiments and 
within hospital environments.   
iii. To establish and optimise C. difficile environmental sampling 
techniques. 
iv. To explore techniques in the resuscitation of C. difficile spores 
following recovery from environmental sampling. 
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v. To optimise and utilise PCR ribotyping as a method of characterising 
C. difficile strains present in the environment of healthcare facilities 
and compare these with those isolated directly from patient faecal 
specimens.   
vi. To establish the prevalence of strains isolated from an NHS Trust 
with respect to spatial and temporal distribution in an 
epidemiological context. 
vii. To identify the effects in C. difficile ribotype distribution within an 
NHS Trust following a change in the method of detection from faecal 
specimens. 
viii. To investigate the use of controlled concentrations of hydrogen 
peroxide vapour as a means of C. difficile spore inactivation.  
ix. To assess the times and concentrations of hydrogen peroxide 
exposure to elicit C. difficile spore inactivation.   
x. To compare the inactivation kinetics of different ribotypes of C. 
difficile with both vaporised and liquid-form hydrogen peroxide. 
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1.7 Structure of the thesis 
The thesis comprises of six chapters, which have been summarised: 
 Chapter 1 introduces the thesis with a brief overview, highlighting 
potential areas of research development.  It also reviews the relevant 
literature, with a summary of the major contributions of work to the 
field.   
 Chapter 2 describes the model system developed to establish which 
media would be the most successful in the recovery and 
resuscitation of C. difficile spores following damage after chemical 
stress with a germicide, ChlorClean. 
 Chapter 3 explains the importance of environmental sampling, with 
three separate studies to recover C. difficile from hospital sites.  This 
chapter also explores different sampling tools, including the 
culturing of samples onto various agar media. 
 Chapter 4 reviews C. difficile ribotype distributions in an NHS Trust 
from two distinct cohorts, exploring spatial and temporal prevalence 
of strains.  This chapter also explores changes in ribotype diversity 
following the replacement of the traditional diagnostic technique 
with an accurate novel method. 
 Chapter 5 demonstrates how controlled application of hydrogen 
peroxide can elicit a significant reduction in the viability of C. difficile 
spores.  This chapter investigates the inactivation kinetics of spores 
through varying the concentration used.  Hydrogen peroxide is 
exposed in liquid and vapour-form to ribotype 027 and three 
additional C. difficile strains. 
 Chapter 6 concludes the work presented throughout the thesis and 
recommends future work. 
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2.1 Introduction 
There is significant information in literature pertaining to the best solid 
agar medium for the initial isolation and growth of C. difficile from faecal 
specimens or for the subsequent confirmation of the bacterium’s presence (Wilcox 
2006).  There are also a number of studies which have utilised different methods 
for the recovery of C. difficile from various environments, for example to report on 
hospital contamination rates (Clabots et al. 1991; Wilcox et al. 2000; Guerrero et al. 
2011).  However, there are no reported studies of the most successful or ideal 
medium, and/or its selective agents, when conducting direct contact plate 
environmental sampling.  It is well documented that C. difficile spores are able to 
persist on surfaces in the environment for long periods of time (Fekety et al. 1981; 
Kim et al. 1981; Gerding et al. 2008).  These surfaces include those found in 
hospitals and other healthcare facilities.  Resistant spores are able to survive for 
many months (Wilcox 1996).  Therefore, it is necessary to identify a suitable 
medium that supports the growth of stressed C. difficile, facilitating the recovery, 
resuscitation and allowing the germination of its spores which may be damaged 
after experiencing these stresses. 
The benefits of the different supplements used in C. difficile selective media 
have been outlined in Chapter 1, and therefore when deciding upon the five media 
to be used in this study, it was important to consider a range of selectivity agents.  
The purpose of germinants in media preparation is to aid the bacterial spores in 
progressing through germination and form colonies on the surface of an agar plate, 
which can then be enumerated.  The media used here are listed in Section 2.2.3.1.  
In order to ensure that not all five media selected contained antibiotics for C. 
difficile selectivity, two were chosen that were considered non-selective but 
prepared with germination enhancers (sodium taurocholate and lysozyme).   
In the UK, chlorine-releasing agents are used for routine disinfection of 
hospital wards and the neighbouring toilet and bathroom areas.  The most 
common is a product called ChlorClean, its active ingredient is sodium 
dichloroisocyanurate (NaDCC); it is used at a concentration of 1000 ppm.  Other 
studies have shown this cleaning product to be successful at decreasing the 
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abundance of C. difficile spores on surfaces at concentrations of either 1000 ppm 
or above (Ungurs et al. 2011).  The series of experiments in this chapter will utilise 
sub-lethal concentrations of ChlorClean and observe changes in spore viability. 
2.1.1 Aim of this study 
This study aimed to identify the most effective media for the recovery and 
growth of C. difficile from healthcare sites.  This chapter outlines how five media 
were used to recover C. difficile spores in the laboratory using a model system to 
mimic the hospital environment with the use of a germicide product, ChlorClean, 
and pick-up efficiency from the surface of a stainless steel tile.  It was important to 
identify whether a particular combination of selective or germination agents was 
preferential in the recovery of spores.  The work devised within this chapter 
describes how stressing the spores to different concentrations of ChlorClean in 
liquid suspension affect spore viability. 
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2.2 Materials and Methods 
2.2.1 Anaerobic chamber 
The anaerobic chamber used to culture C. difficile throughout this study 
was the Anaerobic Workstation – mini MACS [Don Whitley Scientific Ltd., UK]; 
anaerobic gas and oxygen-free nitrogen [BOC Ltd., UK]. 
2.2.2 Preparation of C. difficile spores on solid media 
Stocks of C. difficile spores were prepared from a modified protocol based 
on that described by Shetty et al. (1999) and Wheeldon et al. (2011).  Ribotype 027 
was isolated from a faecal specimen of an infected C. difficile patient.  
Cryogenically-preserved stocks were sub-cultured onto BHI blood agar and 
anaerobically incubated for six days at 37°C encouraged the sporulation of C. 
difficile.  Plates were removed and left in aerobic conditions over-night.  The spore-
vegetative cell mixture was collected and washed in 50% (v/v) IMS/PBS solution.  
Samples were then centrifuged at room temperature for 20 min at 4200 rpm 
[Beckman-Coulter, Allegra-X-22R] to separate the spores from cell debris.  The 
pellet was re-suspended in PBS and heat-shocked for 20 min at 60°C to ensure 
only C. difficile spores were viable.  Samples were serially diluted in PBS and plated 
onto BHI agar supplemented with 0.1% sodium taurocholate prior to incubation 
for 24 hr before being enumerated using the method of Miles et al. (1938).  Spores 
were stored in PBS at 4°C until use; storage was never longer than two months.  
The spores were visualised under a scanning electron microscope (SEM), as 
described in Chapter 5. 
2.2.3 RODAC plates for C. difficile recovery 
One method is common for environmental sampling and recovery of C. 
difficile: the use of RODAC plates [Becton, Dickinson and Company Diagnostics, 
USA].  This requires the use of different media for direct surface contact.  The 
media were prepared with an ‘agar base’ and the addition of supplements, such as 
an antibiotic mixture which prohibits growth of all bacteria except that of C. 
difficile.  The use of supplements can be to enhance C. difficile spore germination or 
to inhibit the growth of the other competing bacterial species. 
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2.2.3.1 Composition of solid media  
CCAB: Cycloserine-cefoxitin-amphotericin B with 0.1% sodium 
taurocholate.  Prepared from Columbia agar [Oxoid Ltd., UK] supplemented with 
0.1% (w/v) sodium taurocholate.  Wilson et al. (1982) demonstrated the 
importance of high-grade sodium taurocholate to aid in the germination of C. 
difficile spores and subsequent colony formation.  Following sterilisation by 
autoclaving, an antibiotic mixture of cycloserine (250 mg/l) and cefoxitin (16 mg/l) 
was added [BioConnections, UK].  Amphotericin B (0.5 mg/l) and 5% (v/v) sheep 
blood [both Oxoid Ltd., UK] were also added as described by Martirosian et al. 
(2005).   
CCEY: Cycloserine-cefoxitin agar with egg yolk, also known as Brazier’s 
Medium.  Solid agar was prepared as directed and autoclaved at 121°C for 15 min.  
Once cooled, 5% (v/v) egg yolk emulsion and an antibiotic mixture of cycloserine 
(250 mg/l) and cefoxitin (8 mg/l) were added [all BioConnections, UK].  This is the 
most commonly used agar medium in laboratories for the isolation of C. difficile 
from faecal samples.  The selectivity is provided by the antibiotics in the same 
concentrations as above.   
CDMN: Clostridium difficile moxalactam-norfloxacin agar.  Prepared from 
the C. difficile Oxoid base and autoclaved at 121°C for 15 min before 
supplementing with 7% (v/v) defibrinated horse blood, and an antibiotic mixture 
comprising moxalactam (64 mg/l) and norfloxacin (24 mg/l) [all Oxoid Ltd., UK].   
FAA: Fastidious anaerobe agar [BioConnections, UK].  Medium was 
prepared according to the manufacturer’s directions, with the addition of 1% Agar 
Bacteriological (Agar No. 1) [Oxoid Ltd., UK] and 0.1% sodium taurocholate.   
GS-BHI: Glucose-supplemented Brain-Heart Infusion agar with 10 mg/l 
lysozyme and 0.1% sodium taurocholate.  The composition of the medium was 
modified from Kamiya et al. (1989).  BHI agar was prepared as directed with the 
addition of 1.5% Agar Bacteriological (Agar No. 1).  Supplements of 0.8% (w/v) 
glucose, 0.05% (w/v) L-cysteine-HCl, 1% (w/v) soluble starch, 10 mg/l lysozyme 
and 0.1% sodium taurocholate were also added prior to autoclaving.   
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2.2.3.2 Preparation and application of RODAC plates 
Agar was poured aseptically into RODAC direct contact plates.  Each plate 
was filled with 12 ml of media.  Each RODAC plate was gently pressed to a 
horizontal surface, applying constant uniform pressure using a 200 g weight to 
ensure contact of the whole agar surface with the sample area.  The plates were 
pressed to a surface for a period of 30 sec, and then transferred to a 37°C 
anaerobic incubator for 48 hr. 
2.2.4 RODAC plates on stainless steel tiles 
To mimic the recovery of C. difficile from a surface, following sub-lethal 
damage induced by exposure to a disinfectant, a known concentration of spores 
was applied onto a stainless steel tile.  This was then coated with ChlorClean 
[Guest Medical Ltd., UK] before recovery by tamping using different solid media in 
RODAC plates.  This action imitated the sampling of bacteria from healthcare 
facilities’ surfaces. 
2.2.4.1 Preparation of the stainless steel tiles 
Stainless steel tiles (30 cm x 20 cm, Grade 2B, 2 mm thick) were sterilised 
by autoclaving and washed with pure Teepol [Teepol, UK] and water before drying 
in a Class II Laminar Flow Cabinet.  Tiles were soaked for 15 min in 1% (v/v) 
Teepol solution, a further 15 min in general purpose grade acetone [Fisher 
Scientific Ltd., UK] and finally thoroughly washed with 1500 ml distilled water.  
Tiles were left to dry thoroughly for 15 min in the laminar flow cabinet. 
2.2.4.2 Application of C. difficile spores and ChlorClean 
The chlorine-releasing agent used here was ChlorClean.  ChlorClean tablets 
were dissolved in 1000 ml ultra-pure water for 1000 ppm; this was diluted 
accordingly for the desired concentration of germicide.  A 0.1% (v/v) Tween 80-
spore suspension (6-log10 CFU) was prepared and thoroughly mixed by vortex.  
The purpose of the surfactant Tween 80 was to aid the spreading of spores over a 
surface.  Of this mixture, 200 µl was applied to a 14 cm x 14 cm area on the 
stainless steel tile and spread in a uniform pattern until dry.  An equal volume of 
ChlorClean (either 100 or 1000 ppm) was added, and evenly dispersed in the same 
manner. 
Chapter 2. Media for the Isolation of C. difficile from the Hospital Environment 
 
45 
 
2.2.4.3  C. difficile spore recovery onto RODAC plates 
The media listed in Section 2.2.3.1 were prepared in RODAC plates.  Four 
plates were placed in quadrants within the 14 cm x 14 cm area on the stainless 
steel tiles for 30 sec, with 200 g weight to ensure even surface contact.  The same 
area was sampled again a further three times using fresh plates of the same media.  
This was to investigate how many spores were still recoverable and viable after 
the initial pick-up.  Plates were incubated anaerobically for 48 hr at 37°C before 
enumerating. 
2.2.5 Effects of ChlorClean concentration and exposure time on C. difficile 
spores 
Having studied the recovery of C. difficile spores with high concentrations of 
the germicide, the next series of experiments conducted were to investigate how a 
range of ChlorClean concentrations (10, 50, and 100 ppm) can affect the number of 
viable spores over time, stressing them to different extents.  In order to examine 
the impact of ChlorClean interacting with C. difficile spores over a defined time, 
this was carried out over 60 min. 
2.2.5.1 Preparation of liquid suspension of C. difficile spores and ChlorClean 
A 0.1% (v/v) Tween 80-C. difficile spore mixture was prepared.  This 
mixture was individually added to the ChlorClean concentrations and aliquots 
taken at times (min) t = [0, 1, 5, 10, 15, 30, and 60].  The samples were then 
centrifuged at 21,000 x g for 5 min before removing the supernatant and re-
suspending the pellet in an equal volume of PBS.   
2.2.5.2 C. difficile spore recovery 
Spores were recovered from the suspension by applying and spreading 50 
µl of sample onto 55 mm Petri dishes prepared with BHI agar and 0.1% sodium 
taurocholate plates until dry.  These were placed in the anaerobic workstation 
overnight at 37°C, before enumeration and calculating CFU. 
2.2.6 Statistical analyses 
Minitab 16 [Minitab Inc., USA] was utilised to perform statistical analyses 
on the data obtained from these experiments.  Both Minitab 16 and Microsoft Excel 
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were used to create graphical representations of these data.  Significance was set 
to P<0.05.  The F-test was used with a one-way analysis of variance.  A two-sample 
t-test compared differences of mean CFU. 
2.2.7 Ethical issues 
Ethical approval was obtained for the use of the strain in this chapter.  All 
information regarding patient data was made anonymous prior to use. 
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2.3 Results 
2.3.1 Comparison of media for the recovery of C. difficile spores 
To date, only a few reports have compared different C. difficile media and 
their selectivity and ability in recovering spores from environmental sites (Buggy 
et al. 1983; Wilcox et al. 2000; Sorg & Sonenshein 2008; Rousseau et al. 2010).  
These groups used a limited number of media, with research groups often using 
the same medium, with little to no guidance as to why they were chosen, nor were 
they compared to other media in the experiments conducted.  Therefore, the aim 
of this work was to determine how the different supplements in selective media 
alter the recovery of C. difficile from physical environmental surfaces.  This is in 
contrast to the extensively studied C. difficile isolation from faecal samples 
(Borriello & Honour 1981; Levett 1985; Health Protection Agency 2008). 
C. difficile spores require sodium taurocholate to complete germination and 
develop into colonies (Wilson et al. 1982).  It was therefore decided to incorporate 
this as a germination agent in three of the five media tested.  Antibiotics are 
standardly used in media as C. difficile is naturally resistant and therefore their 
incorporation would increase selectivity.  Over the past twenty years, only a few 
groups have studied C. difficile spore survival from stainless steel surfaces in an 
endeavour to mimic the processes observed within a healthcare facility (Pinto et al. 
2009; Ungurs et al. 2011).  Based on the lack of literature at the time of these 
studies being conducted, it was therefore decided to attempt to apply C. difficile 
spores onto stainless steel tiles and subsequently recover them. 
In order to investigate both the spore survival and media selectivity with 
regards to recovering the damaged spores, an experiment was designed where 
spores were aseptically evenly dispersed onto stainless steel tiles and 
subsequently recovered using direct contact plates which were prepared with 
different media and selective agents.  To optimise the media in the least 
complicated manner, the tiles were exposed to only the spore stock of C. difficile, 
and not a soil culture or mixed preparation consisting of other organisms.  This 
could have been conducted by emulating biological soiling with 0.3% bovine 
serum albumin, as demonstrated (Otter & French 2009).  This would eliminate the 
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possibility of competition from other bacteria on the solid agar surface.  This 
would serve to give a clear indication of how well the media could recover C. 
difficile from a surface with no other selection pressures.  It was also important to 
use a spore stock prepared of PCR ribotype 027 due to the severity, relapse rate, 
and mortality associated with this particular strain (Kuijper et al. 2008). 
The application of 200 µl of a 6-log10 CFU spore stock onto the stainless 
steel tiles can theoretically produce a maximum possible recovery on a given 
RODAC plate of 4.41-log10 CFU.  This recovery demonstrates the limitations of this 
methodology, as it is impossible for 100% of the spores applied to the surface to be 
recovered with a simple tamping of a RODAC plate.  This was calculated using the 
concentration of the spore stock with the areas of the exposed tiles and the contact 
plates themselves. 
 
Figure 2.1: Recovery of C. difficile PCR ribotype 027 spores on various agar media following tamping from stainless 
steel tiles with RODAC plates.  
The bars indicate averages from eight replicates in one independent experiment and the error bars indicate the 
standard errors of the means.  CFU: colony-forming units. 
 
GS-BHI agar was the most successful medium in this study (Figure 2.1), 
picking up 57.2% of the expected recoverable spores.  The lack of antibiotics in 
this medium does not appear to inhibit its selectivity in the pick-up of spores from 
the stainless steel tiles, providing nutrients and necessary supplements for the 
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germination into countable colonies.  FAA recovered 8.1% of the surface spore 
concentration, and despite additionally comprising of only sodium taurocholate, it 
recovered more spores than the selective media.  The selectivity of the antibiotic-
containing media was expected to result in a higher pick-up rate than found due to 
their use by many research groups; the recovery ranged from 1.17% to 3.38% of 
the expected.  The combination of cycloserine and cefoxitin, accompanied with egg 
yolk in the CCEY agar was more successful than that of CCAB, containing the 
relatively uncommon antibiotic, amphotericin B.  Surprisingly, despite its success 
rates in previous studies conducted in healthcare facilities, recovering spores from 
the surfaces in the environment, CDMN recovered substantially fewer spores than 
the other media (Alfa et al. 2008).  In addition to this, statistical analysis has shown 
only CDMN and CCAB were similar (P=0.106) in their ability to recover C. difficile 
spores; all other media are significantly different from one another (P<0.05). 
Having established the maximum numbers of recovery for each solid agar 
with application of spores onto the tiles, the next step was the exposure of the C. 
difficile ribotype 027 spores to ChlorClean by spreading both solutions onto 
stainless steel tiles.  This was to investigate the effects of a common chlorine-based 
cleaning agent used in hospitals to eradicate problematic bacteria, such as MRSA 
and C. difficile.  A sub-lethal concentration was used to ensure the spores were in a 
moribund state, rather than inactivating them completely.  It also served to 
identify differences in media selectivity following imposing stress onto the spores, 
not only in pick up efficiency, but also for the subsequent germination of spores. 
This experiment was carried out using the methodology described 
previously (Section 2.2.4), and the spreading of ChlorClean, prepared at 100 ppm, 
onto autoclaved stainless steel tiles.  Figure 2.2 shows the counts of C. difficile 
spores recovered from an initial tamping of the agar onto the stainless steel tiles 
and the five media following exposure to this concentration of the germicide. 
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Figure 2.2: Distribution of the five agar media and the ability to recover C. difficile spores from stainless steel tiles 
following exposure to 100 ppm ChlorClean.   
The bars indicate averages from a minimum of sixteen replicates in one independent experiment the averages from one 
independent experiment.  ‘*’ - denotes outliers.  CFU: colony-forming units. 
 
There is a difference between the counts, however, overall CCEY appears to 
be the most successful medium at recovering damaged C. difficile from one 
tamping using RODAC plates from stainless steel tiles.  Despite the mean CFU 
recovered from FAA being slightly higher, the data show no significant difference 
between CCEY and the non-selective FAA (P=0.615).   
Of the C. difficile selective media, CCEY agar clearly yields the highest spore 
recoveries; CDMN and CCAB recovered only 0.82% and 0.77% respectively of the 
number of C. difficile spores present on the surface.  In the previous experiment 
with no exposure to a germicide, these two media picked up 1.17% of the spores 
applied onto the tiles.  Although a decrease was expected with the addition of 
ChlorClean, the efficiency of spore recovery using the maximum possible CFU and 
the initial control data show CCAB led to the recovery of 65.8% and CDMN 69.6% 
(Table 2.1).   
With the non-selective media, following exposure to ChlorClean, FAA 
appears to be better at resuscitating damaged C. difficile spores, however the pick-
up efficiency of these media was much lower than that of the selective media: 
GS-BHIFAACDMNCCEYCCAB
1000
900
800
700
600
500
400
300
200
100
Agar Media
C
FU
Chapter 2. Media for the Isolation of C. difficile from the Hospital Environment 
 
51 
 
32.7% (FAA) and 4.1% (GS-BHI).  Despite its initial 57.17% recovery of spores 
from a single tamping with no germicide exposure, GS-BHI agar was only able to 
pick up 2.32% upon inducing spore stress.  Nevertheless, the non-selective media 
were once again found to be more capable of recovering spores than CDMN and 
CCAB.  
Statistical analysis has identified significant similarities between different 
media from this experiment.  CCAB and CDMN counts (P=0.360) differed from 
those obtained from any of the other media tested.  CCEY agar was found to be 
similar to FAA (P=0.615) and GS-BHI (P=0.099), although the counts obtained from 
FAA and GS-BHI showed these two media to be statistically different. 
Agar Media No ChlorClean 100 ppm ChlorClean Success Rate (%) 
CCAB 298 ± 1 196 ± 11 65.8 
CCEY 863 ± 54 655 ± 35 75.9 
CDMN 299 ± 1 208 ± 6 69.6 
FAA 2061 ± 147 673 ± 9 32.7 
GS-BHI 14583 ± 281 591 ± 13 4.1 
Table 2.1: Colony counts of C. difficile recovered from stainless steel tiles with RODAC plates prepared with different 
agar media.  
Spores were recovered with and without exposure to 100 ppm ChlorClean.  Data represent mean ± standard errors of 
the mean.  Recoveries was calculated using means of 100 ppm ChlorClean and means of controls as total possible 
counts recoverable for given medium. 
 
Following the initial tamping of the agar media onto the stainless steel tiles 
to recover the C. difficile spores, freshly prepared RODAC plates corresponding 
with the same media, were subsequently tamped onto the same area three more 
times (Figure 2.3).  The method for using and incubating the RODAC plates was the 
same as previously described.   
For all media, repeated tamping of a given area resulted in the number of 
spores recovered decreasing suggesting that fewer spores were remaining on the 
face of the tile, but also the ability of the media to actually make contact and have 
the spores adhere to its surface was declining (Figure 2.3).  CCAB and CDMN agar 
recovered the least spores, and with repeated tamping, demonstrated somewhat 
of a steady decline in pick-up. 
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Figure 2.3: C. difficile spores recovered as colonies by five different agar media from stainless steel tiles following 
exposure to 100 ppm ChlorClean.   
Areas of recovery were blotted three further times.  Data points indicate averages from a minimum of sixteen replicates 
in one independent experiment.  CCAB (black), CCEY (red) and CDMN (green) are selective media; FAA (blue) and 
GS-BHI (orange) are non-selective media.  CFU: colony-forming units. 
 
Regression analysis for all of the media was calculated based on the average 
counts produced for each agar medium.  The data produced suggested that 
following a further tamping of the tiles with either CCAB or CDMN, the recovery of 
C. difficile spores would no longer be expected.  Interestingly, the regression 
analysis also showed CDMN and CCAB possess similar trend lines and appear to 
recover at least three times fewer spores with each tamping than the other media.  
These two media also produced similar rates of recovery with no germicide 
applied onto the tiles.  It has also been estimated that a sixth blot would be 
required in order to recover the maximum capable of CCEY and GS-BHI, and seven 
for FAA.  These figures are the theoretical number of tamping required to recover 
the entire population.  This does not mean the media in question would have been 
able to recover all of the spores applied onto the surface of the tile by the 
corresponding tamping.  However, merely judging by the decline in the number of 
spores recovered with each subsequent RODAC plate, it could be inferred that that 
particular medium would be unlikely to be able to resuscitate and germinate any 
more C. difficile spores.    
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When comparing all of the data generated in Section 2.3.1, statistical 
analyses show that for each of the five media, there is a statistical difference 
between the counts obtained from exposing the C. difficile spores to the germicide 
and those from the initial recovery test (P<0.05).  Therefore, these data show the 
application of a NaDCC has either had an impact on the ability for the media to pick 
up and recover the spores or reduced the number of spores viable and possible to 
adhere to the surface of the agar plate to germinate; most importantly, it has an 
overall impact in that it is killing spores.   
2.3.2 Recovery of C. difficile spores with an increased germicide 
concentration 
The experiment described above allowed the testing of the different media 
to be compared based on their recovery of C. difficile spores after exposure to 100 
ppm ChlorClean disinfectant.  The aim of this study was to identify a medium 
which would possibly be able to recover the maximum number of viable C. difficile 
spores from a hospital environment.  Therefore, to attempt to mimic cleaning 
routines in hospitals, which utilise ChlorClean at 1000 ppm, two of these five 
media (CCEY and GS-BHI) were tested for recovery efficiency at this concentration.  
The choice of media was based on the high levels of recovery exhibited by CCEY 
agar in the previous experiment with the exposure of ChlorClean at a sub-lethal 
level, and the less studied non-selective medium (GS-BHI), containing two 
different C. difficile spore germinating agents.   
The methodology described in Section 2.2.4 was utilised as before, altering 
only the concentration of the germicide.  The CFU counts observed for CCEY agar 
at the two different concentrations of ChlorClean are compared in Figure 2.4.  
There was no significant difference in spore recovery (P=0.090); the variances 
were similar (24052.6 for 100 ppm and 22572.9 for 1000 ppm).  The data 
obtained in the previous experiment comparing CCEY agar with the other media in 
this study showed there was no statistical difference between CCEY and the two 
non-selective C. difficile media.  Taken together, these data demonstrate that this 
medium is likely to be able to recover damaged C. difficile spores from a hospital 
environment and allow them to fully germinate, regardless of disinfectant strength.   
Chapter 2. Media for the Isolation of C. difficile from the Hospital Environment 
 
54 
 
 
Figure 2.4: C. difficile spores recovery from stainless steel tiles following exposure to different ChlorClean 
concentrations (100 ppm and 1000 ppm) using CCEY agar in RODAC plates.  
Concentrations: 100 ppm (blue) and 1000 ppm (green).  Bars indicate averages from a minimum of sixteen replicates in 
three independent experiments and the error bars indicate the standard errors of the means.  CFU: colony-forming 
units. 
 
C. difficile spore recovery with GS-BHI agar was recorded in the same 
manner (Figure 2.5).  Despite a relatively small variation in the mean number of 
colonies recovered, there was a significant difference between the two different 
germicide concentrations investigated (P=0.023).  Therefore, despite its pick-up 
efficiency following 100 ppm ChlorClean in the initial stainless steel tiling 
experiment, it appears application of ChlorClean at an increased concentration 
reduces spore recovery; the variances between these two experiments (3570.7 for 
100 ppm and 26022.8 for 1000 ppm) differed almost ten-fold.  Application of an 
increased concentration could therefore act to increase the inconsistency of spore 
recovery.  Analysis of C. difficile spore recovery subsequent to stress exerted from 
the increased concentration of NaDCC for CCEY and GS-BHI agar suggest the 
relative pick-up abilities to be similar (P=0.305). 
These studies show that C. difficile spores are able to survive the application 
of 1000 ppm ChlorClean when applied onto a solid surface.  These data also 
demonstrate that CCEY and GS-BHI media are able to yield high recovery of spores, 
allow efficient germination and proliferation for calculations using CFU. 
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Figure 2.5: C. difficile spores recovery from stainless steel tiles following exposure to different ChlorClean 
concentrations (100 ppm and 1000 ppm) using GS-BHI agar in RODAC plates.  
Concentrations: 100 ppm (purple) and 1000 ppm (red).  Bars indicate averages from a minimum of sixteen replicates in 
three independent experiments and the error bars indicate the standard errors of the means.  CFU: colony-forming 
units. 
 
2.3.3 Investigating exposure of ChlorClean to C. difficile spores over time 
Thus far, the experiments outlined in this chapter have been based on 
studies investigating the effect of exposing spores to ChlorClean and then 
subsequently recovering by means of applying a RODAC plate containing agar 
media.  This study has demonstrated the effects ChlorClean has on C. difficile 
spores over time, even at sub-lethal concentrations.  The advised working 
concentration for this product is 1000 ppm, as previously stated.  For the purpose 
of this experiment, doses of 10, 50, and 100 ppm were employed again for 
investigating the effects of sub-lethal concentrations; these experiments were 
conducted in liquid suspension.  This would also provide an insight into how 
changes in lower concentrations of ChlorClean can affect the proportion of viable 
spores. 
C. difficile spores were prepared as previously described (6-log10 CFU) and 
exposure to an equal volume of 10, 50, or 100 ppm ChlorClean.  At specific time 
intervals, these samples were centrifuged, the pellet washed before re-suspending 
in an equal volume of PBS and then plated and spread onto BHI agar with 0.1% 
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sodium taurocholate and incubated anaerobically overnight; colonies were 
enumerated and expressed as CFU (Figure 2.6). 
 
Figure 2.6: Semi-logarithmic scale representation of ribotype 027 spore recovery following exposure to different 
ChlorClean concentrations over 60 min.   
Concentrations: 10 ppm (blue), 50 ppm (red) and 100 ppm (green).  The data points indicate the averages of a single 
experiment carried out with a minimum of three repeats.  CFU: colony-forming units. 
 
The application of 10 ppm ChlorClean does not appear to have a great effect 
in reducing the number of C. difficile spores.  However, the CFU was lower than the 
initial inoculum and greater than with 1 ppm ChlorClean (data not shown).  Over 
time, the addition of 10 ppm had little effect; the counts remained similar.  
Increasing the germicide concentration to 50 ppm elicited a reduction of the spore 
population, despite being twenty times more diluted than the recommended 
working concentration.  Almost a 2-log10 CFU reduction was seen over the initial 
30 min, with a further 2-log10 CFU reduction after 60 min ChlorClean exposure 
from the recovery at t=0.  Despite the preparation being ten times diluted than 
with cleaning, 100 ppm ChlorClean resulted in a steep decline in the number of 
spores recovered over time.  A 3-log10 CFU reduction was seen after 10 min 
exposure and after 30 min, the recovery is negligible, with one colony recorded 
over three repeats.  There was a marked difference of 4-log10 CFU between the 
counts following exposure to 10 and 100 ppm ChlorClean after 60 min. 
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2.4 Discussion 
Despite the diversity of solid media used for culturing and propagation of C. 
difficile from faecal samples, to date, there is no definitive selective media 
recommended for the recovery of the bacterium from environmental sites.  
Different research groups tend to use either one or two media in their work, each 
with its own merits with respect to supplementary agents.  Thus far, there is little 
guidance provided in the literature on media for environmental sampling, and no 
reports which compare different media for C. difficile isolation from potentially 
contaminated surfaces.  
Within this chapter, the importance of investigating selective media for the 
recovery of C. difficile spores has been highlighted.  Five different media were 
tamped onto stainless steel tiles contaminated with C. difficile ribotype 027 spores, 
both with and without the use of a sub-lethal concentration of a chlorine-
containing germicide, ChlorClean.  All the media chosen had been identified in 
literature as being successful in C. difficile spore recovery and germination, either 
from surfaces in healthcare facilities or in the laboratory.  The effect of directly 
adding sub-lethal concentrations of ChlorClean to the C. difficile spores has also 
been investigated in this chapter.  This was to identify how contact time with sub-
lethal levels of the germicide can affect the number of C. difficile spores which can 
be recovered. 
The results from this study show that whether in the presence of the 
germicide or not, the success rates of agar media differ in their abilities to recover 
C. difficile spores.  However, a difference is clearly observed in the recovery 
following the killing of spores with ChlorClean.  Stressing the spores as such would 
then allow for the identification of the medium most successful at resuscitation.  
When investigating recovery success, Pinto et al. (2009) suggested that a 
maximum of 56% of the spores applied onto a surface can subsequently recovered 
from stainless steel discs.  This would imply that of the 6-log10 CFU of C. difficile 
spores initially applied to the stainless steel tile, 4.41-log10 CFU would be expected 
to be the maximum recoverable with the use of direct agar media contact.  Based 
on this estimation, when investigating the different media, GS-BHI was the most 
Chapter 2. Media for the Isolation of C. difficile from the Hospital Environment 
 
58 
 
successful agar at recovering C. difficile spores from the stainless steel tiles with 
57.17% of the applied spores recovered by the medium.  Upon applying 100 ppm 
ChlorClean, the medium recovered fewer spores; only 2.32% of the original 
inoculum could be recovered with single tamping of media.  Using GS-BHI agar to 
recover C. difficile spores following the exposure to 1000 ppm ChlorClean resulted 
in recovery of 2.02% of the initial inoculum.  Therefore, although GS-BHI agar 
appeared to be the most successful medium tested for C. difficile spores recovery 
from contaminated stainless steel tiles, there was a significant effect on the CFU 
recovered following ChlorClean application.  The spore germinants that were 
present in GS-BHI agar could therefore enable the spores recovered to complete 
germination into colonies.  It is also possible that the lack of antibiotics could 
result in a lack of C. difficile selectivity when used in a setting with other competing 
spores. 
Despite the recovery of spores being notably lower with FAA than GS-BHI 
agar in the control study, FAA still recovered significantly more counts than the 
selective C. difficile media investigated (2061 ± 147).  The number of spores 
recovered when tamping the contaminated surface with FAA medium showed that 
not only was it similar to that of CCEY agar with the exposure of 100 ppm 
ChlorClean, but it was the medium recovering the highest mean number of 
colonies (673 ± 9) under conditions of germicide exposure. 
When testing CCEY agar for spore recovery from the contaminated surface, 
the exposure of spores to 100 ppm ChlorClean again resulted in a 25% reduction 
in CFU, and when increasing the chlorine agent to 1000 ppm, there is a further 
reduction of 14%.  These results suggest that despite the significantly low recovery 
of spores from the initial inoculum (3.38%), upon stressing the spores CCEY agar 
is still able to recover a similar proportion (2.57%); with the application of 1000 
ppm ChlorClean, recovery remained at 2.22%.  The maintenance of spore recovery 
at increasing ChlorClean concentrations was unique among the media compared 
here.  
Martirosian et al. (2005) reported 12.2% and 36% recovery of C. difficile 
samples with CCAB after environmental sampling.  CCEY agar was used by Shapey 
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et al. (2008), who reported following hospital sampling, 24% of isolates were 
positively identified as C. difficile.  The combination of moxalactam and norfloxacin 
in CDMN was shown to improve selectivity and the recoverability of C. difficile over 
cycloserine-cefoxitin fructose agar with a 20% higher isolation rate (Aspinall & 
Hutchinson 1992).  Alfa et al. (2008) also reported a rate of 33% positive cultures 
(n=102) recovered from toilets of CDAD patients, despite the introduction of an 
optimal cleaning technique devised by this group, with UV markers.  Wheeldon et 
al. (2008) tested five different bile salts in a series of experiments to investigate 
the recovery of C. difficile spores, identifying the most successful combination to be 
FAA with 0.1% sodium taurocholate.  Kamiya et al. (1989) used two compositions 
of GS-BHI agar to recover C. difficile spores following a series of heat and alkali 
treatments: either 10 mg/l lysozyme (success rate: 10-47% and >90%) or 0.1% 
sodium taurocholate (<1% and <6%).  Despite the low success rate with the bile 
salt, for the purpose of this work it was thought a combination of the supplements 
might aid in the germination of spores.   
A decline in bacterial spore recovery with the addition of a chlorine-based 
cleaning agent is expected, as this is the purpose of the product.  However, the 
level of which the media were unable to recover C. difficile was surprising.  CCAB 
and CDMN were able to recover 65.8% and 69.6% of the original recovered CFU 
with the addition of ChlorClean, however for the non-selective C. difficile media, 
FAA and GS-BHI, the efficiency was much lower: 32.7% and 4.1%, respectively.  
This is despite the success rates reported in literature.   
The use of antibiotics in the media preparation has not necessarily 
increased the proportion of C. difficile spore recovery and despite being integral to 
their composition, CCAB and CDMN agar were unable to recover as many spores as 
the other tested media.  Amphotericin B, a little known antibiotic with respect to 
media, but often administered and linked to C. difficile infection has not been as 
capable in the selection of C. difficile spores as expected (Gerding et al. 1995).  This 
is interesting as the other two antibiotics within CCAB, cycloserine and cefoxitin, 
were able to elicit higher levels of recovery in CCEY agar.  A low recovery of spores 
was also observed with the use of the moxalactam and norfloxacin in CDMN agar; 
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the antibiotics were presumed to aid in selectivity of C. difficile spore recovery, 
however this did not appear to hold true when comparing these media to CCEY, or 
even the non-selective agars. 
These data suggest that the incorporation of antibiotics could have elicited 
somewhat of an inhibitory effect on the ability of C. difficile recovery.  Perhaps, it 
could also be inferred that the use of antibiotics may select for completely viable 
spores, permitting these to germinate, as opposed to spores which have endured 
physical damage for example and are less lusty but are not inactivated.  The effect 
of this is that it would result in the number of CFU being lower as spores that are 
not entirely viable would not be selected.  This could therefore be problematic if 
attempting to recover C. difficile spores from surfaces in a healthcare environment. 
The ability of GS-BHI agar to recover C. difficile as successfully as it had 
could be attributed to the addition of lysozyme and sodium taurocholate.  
Lysozyme use in a media has been well-documented within research groups and 
found to subsequently increase the recovery of C. difficile through spore 
germination stimulation (Wilcox et al. 2000; Verity et al. 2001).  The addition of 
sodium taurocholate into agar bases also increases spore recovery.  Buggy et al. 
(1983) identified up to six times more viable C. difficile spores were recoverable 
with the incorporation of sodium taurocholate into media.  The use of this bile salt 
could also be the reason why the second non-selective media in this study, FAA, 
was able to recover C. difficile spores and complete germination as successfully. 
The addition of a chlorine-based cleaning product is vital in the overall 
reduction of C. difficile spore contamination on a hard surface; the data obtained in 
this chapter emulated previous results.  Ungurs et al. (2011) investigated 
concentrations of a NaDCC-based germicide of a minimum of 1000 ppm, with an 
upper value of 6000 ppm.  For the purpose of this study, ChlorClean was selected 
as it is commonly used in the routine clean of a healthcare facility, and its 
incorporation of NaDCC has been shown to be more effective against the survival 
of C. difficile spores than a standard hypochlorite solution (Fawley et al. 2007).  
The work here also used lower concentrations to subject the spores to stresses, 
which would not result in a complete ablation of the number of viable spores.  In 
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order to compare the different media investigated, it was therefore important to 
demonstrate a low level of stress, but not too great an amount.   
A study conducted by Wheeldon et al. (2008) reported that with 1000 ppm 
of available chlorine, there was a significant 2.76 to 2.96-log10 CFU reduction of 
spores recovered on FAA with 0.1% (w/v) sodium taurocholate and 5% (v/v) 
defibrinated horse blood, with a contact time on the surface for 15 to 30 min.  
Another group, Perez et al. (2005), identified more than a 6-log10 CFU reduction in 
spore viability with a sodium hypochlorite solution of 1000 ppm chlorine with a 
contact time of only 15 to 20 min.  Comparing the data from these two studies, 
suggests variations may well exist between studies and experiments.  Much like 
other decontamination studies of this nature, this work has demonstrated the use 
of chlorine-based cleaning products, such as ChlorClean, is vital in the cleaning 
process for the reduction of viable spores.  The results here have shown there to 
be statistically significant differences with CFU recovered when comparing even a 
sub-lethal concentration to that of a control. 
Another aspect of C. difficile spore recovery investigated in this study was 
that of repeated tamping of agar media prepared in RODAC plates onto the 
contaminated surface of the stainless steel tile.  The results demonstrate that the 
total number of spores, which are exposed to the surface of the agar following the 
exposure to ChlorClean, to form colonies, declines with each additional further 
tamping.  This could be due to the number of viable spores capable of adhering to 
the agar decreasing with each subsequent contact of the agar.  Data from Ungurs et 
al. (2011) suggests that with the spreading of C. difficile spores onto a stainless 
steel tile and attempting to remove them with a chlorine-releasing agent akin to 
ChlorClean, there was a decrease in the viability of spores.  This group reported as 
little spore reduction with 1000 ppm NaDCC.  When the concentration was 
increased to 3000 ppm, they reported a reduction of 1.51 to 2.59-log10 CFU 
reduction between 20 and 120 min exposure.  This was higher still with 6000 ppm: 
2.39-log10 CFU reduction at 2 min with total kill of all spores by 20 min.  These 
data suggest a much higher concentration is required with direct contact onto a 
surface in order to elicit a response or substantial reduction in spores.  The results 
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from this group confirm the result from this body of work: longer exposure time of 
chlorine results in more inactivation of C. difficile spores. 
The effect of ChlorClean over time has also been studied in this chapter, and 
these data support that a longer exposure time to the germicide proves to be more 
lethal.  This study also aimed to identify the effects of employing sub-lethal 
concentrations of ChlorClean to C. difficile spores over a time course of 1 hr in 
liquid culture, as opposed to dried onto a surface.  These data demonstrate there is 
a clear difference in the inactivation of C. difficile spores and the subsequent 
proportion which can be recovered using the chosen sub-lethal concentrations of 
ChlorClean.  The higher the concentration of ChlorClean applied to the spores, the 
more significant the reduction in viability observed. There was no log10 CFU 
reduction observed over the 1 hr time period for 10 ppm, but with 50 ppm, a 1-
log10 CFU reduction was recorded after only 10 min exposure.  By the end of the 
time course, 50 ppm ChlorClean had resulted in a 3-log10 CFU reduction of C. 
difficile spores.  This was also observed with 100 ppm, however, the initial 
recovery of spores at t=0 for 50 ppm was 5.57-log10 CFU, with 100 ppm as 4.62-
log10 CFU.  This suggests that the effect of adding ChlorClean impacts the viability 
of spores instantly; there is no delay in impact. 
It can therefore be assumed that the spores are placed under stress with the 
addition of ChlorClean, either when deposited onto stainless steel tiles as above, or 
upon contacting with the disinfectant liquid form.  These results also suggest that 
with more contact time with the germicide, there is an overall reduction in the 
number of viable spores present in solution and therefore able to successfully 
complete germination.   
Numerous studies have shown that using NaDCC concentrations of 1000 
ppm, as well as above this, are able to successfully elicit reductions in the spore 
titre recovered subsequent to exposure (Jeanes et al. 2005; Perez et al. 2005; 
Dawson et al. 2011; Ungurs et al. 2011).  The results from this study differ in that 
they have shown that even with lower levels and doses of the cleaning agent, 
statistically significant reductions in spore viability can be observed.  Despite this 
being seemingly obvious, the 3-log10 CFU reduction of spore recovery with 100 
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ppm from t=0-60 min was faster than expected.  This would suggest the level of 
chlorine activity in the product is still sufficiently high enough to reduce the 
viability of the C. difficile spores and in turn inactivate them.  This is not to suggest 
such low concentrations in healthcare facilities should be employed, but it 
confirms that, even at lower levels, there is some reduction of spore viability.  
Nevertheless, it is important to note that too high a concentration of ChlorClean 
could compromise safety.  As it is used in routine cleaning, the patients, healthcare 
workers, and cleaning staff could be put into damage with exposure to high 
concentrations of ChlorClean. 
The experimental work presented in this chapter is based on spore 
recovery data obtained from the use of one strain of C. difficile, ribotype 027.  This 
particular strain was selected for use in this project due to its and persistence 
within healthcare facilities and in the community (Bauer et al. 2011; Health 
Protection Agency 2011).  It is important to bear in mind that the case may well be 
that differences exist between strains in susceptibility to a range of disinfectants 
and cleaning treatments, or perhaps more specifically to the NaDCC-based product 
used, ChlorClean (Dawson et al. 2011).  Recent studies investigating C. difficile 
spore recovery following various cleaning treatments have used different strains: 
Ungurs et al. (2011) used C. difficile strain NCTC 11209, while Wheeldon et al. 
(2008) used ribotype 027 as did Horejsh & Kampf (2011) and Siani et al. (2011). 
Identification of the most successful medium in recovering damaged and 
stressed spores would therefore provide information into the components 
required to recover the spores from the hospital or healthcare environment, and 
its surfaces.  The results found in this chapter illustrate the importance of 
identifying a means of recovering C. difficile from the environment using agar 
media.  As discussed above, CCEY agar appears to be the most successful; in terms 
of statistical analysis, this agar was capable of recoveries the same as the non-
selective media GS-BHI and FAA.  CCEY agar also possessed the additional factor of 
antibiotics incorporated within the medium, which appeared to aid in selectivity 
when stress was applied onto the C. difficile spores.  Despite the findings of FAA 
and GS-BHI agar successfully recovering C. difficile spores in this study, it must be 
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born in mind that when utilising these in the healthcare environment for detection 
of C. difficile contamination, there would be an absence of antibiotics.  This could 
result in a lack of selectivity for C. difficile and may allow the thriving and 
proliferation of other organisms.  Therefore, although it has been documented as 
the most successful medium when attempting to isolate and culture C. difficile 
from faecal samples, this work suggests that CCEY agar would also be the most 
suitable when conducting environmental sampling.   
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2.5 Conclusions 
 A model system was developed to compare the spore recoveries 
between five different agar media, with and without a germicide.  
GS-BHI agar recovered over 57% of the C. difficile spores applied 
to the tile surface, but only 2% with ChlorClean usage.  FAA was 
also successful in spore recovery, despite the lack of antibiotics 
for means of selectivity (8%).   
 CCEY agar significantly recovered C. difficile spores (655 ± 35 CFU) 
more efficiently and consistently than the other two selective 
media, CCAB (196 ± 11 CFU) and CDMN (208 ± 6 CFU) with 100 
ppm ChlorClean.  This was the most successful selective media.   
 Despite the addition of 1000 ppm ChlorClean, CCEY and GS-BHI 
agars were able to recover C. difficile spores, 565.6 and 516.1 CFU, 
respectively. 
 Exposing ribotype 027 spores directly to liquid ChlorClean (10, 
50, and 100 ppm) resulted in inactivation of spores as the 
concentration increased.  Fewer spores germinated and form 
colonies over time.  With a twenty-fold dilution of the 
recommended concentration, a 3-log10 CFU reduction of spores 
can occur within 60 min, demonstrating a significant reduction 
can be elicited with a smaller dose of ChlorClean. 
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3.1 Introduction 
The role of environmental contamination has been implicated in the spread 
of HCAI, however there is still considerable controversy surrounding this, in 
addition to a number of complicating factors.  Reports in literature suggest rooms 
of C. difficile infected patients are frequently contaminated with the infecting 
organism and that the proportion of environmental samples from such rooms that 
test positive for C. difficile ranges between 9% to 59% (Barbut et al. 2009).  A 
report has also suggested that in rooms inhabited by patients who are neither 
infected nor colonised with C. difficile, up to 8% of environmental samples could be 
positive for the bacterium (Kim et al. 1981).  Roberts et al. (2008) sampled the air 
in a bay inhabited with elderly patients, identifying C. difficile spores counts of 53–
426 CFU/m3 contaminating the air.  These spores would then fall through the air 
and settle on surfaces in wards and isolation rooms, capable of persisting on 
surfaces for up to five months; it is important to identify methods that result in 
their eradication (Kim et al. 1981).   
Different techniques are utilised for the recovery and isolation of bacterial 
contamination.  Three techniques were employed in the work described here for 
the recovery of both C. difficile spores and vegetative cells.  Direct contact or 
RODAC plates have been used in other studies as a means for recovering bacteria 
from environmental sources (Buggy et al. 1983; Lemmen et al. 2001; Alfa et al. 
2008).  Preparing these plates with different media and also the incorporation of 
antibiotics and other selective agents allows for the recovery of specific bacteria.  
These have been explored in the previous chapters of this thesis.  IMS washing or 
alcohol shocking with ethanol to isolate C. difficile is a practice commonly used 
with both clinically and environmentally obtained samples, selecting for spores 
only.  C. difficile faecal samples are routinely exposed to a mix (1:1) of either IMS or 
ethanol for this purpose before isolation of the bacterium.  The mixed culture is 
then plated out onto selective medium comprising antibiotics and incubated to 
allow for the bacterial growth.  This is usually CCEY agar, if not a variation (Wilcox 
2006).  Samples have also been transferred into selective or enrichment broths to 
aid in the isolation of C. difficile following environmental pick-up (Arroyo et al. 
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2005).  Sponges or swabs are inoculated into these solutions, usually consisting of 
antibiotics to aid bacterial selectivity.   
Layering two different media in a single Petri dish is a practice utilised 
within the food industry, but less so within the hospital environmental sampling 
field (Wu et al. 2001).  The top, non-selective agar layer, acts to supply 
microorganisms with an environment for any injured or damaged cells to thrive 
following application to the surface and subsequent incubation (Wu et al. 2001).  
The antibiotic and selective agents present within the bottom layer would then 
eliminate all microbial growth except the selected bacterium.  This would allow 
their growth as well as the simultaneous inhibition of other microorganisms (Kang 
& Fung 2000; Wu et al. 2001).  It was also suggested in literature that the non-
selective medium poured on top would not hinder the characteristic pigmentation 
and morphology of the colonies which would be produced by microorganisms, and 
therefore this was also inferred its use in this thesis (Wu 2008).  Creating an agar 
consisting of layering two different media, both with distinguishing characteristics, 
would allow the slow diffusion of antibiotics up through the non-selective media, 
without selection pressure on those spores not affected by cleaning routines.   
3.1.1 Aim of this study 
The main purpose of the work described in this chapter was to identify 
which C. difficile strains are present in the environment in healthcare facilities, 
particularly ‘high’ contact sites.  Patients, staff, and visitors frequently physically 
contact these areas.  Based on the different media investigated in the previous 
chapter, two sampling campaigns were conducted to investigate the differences 
exhibited between the laboratory-based recovery from surfaces and that of the 
hospital.  This intended to distinguish which of these media were best for the 
recovery of C. difficile spores in a controlled study, as well as with a higher level of 
germicide present.  In the final section of this chapter, these media were used to 
resuscitate C. difficile spores recovered from the environment with pre-moistened 
sponges.  This used the above described layering media technique.   
This study aimed to determine which medium is the most effective for the 
recovery of C. difficile spores from healthcare facilities.  RODAC plates were used 
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for this purpose along with the use of environmental sponges.  Identifying the 
strain distribution in wards of two healthcare facilities within the UHL Trust was a 
further aspect of study within this chapter.  This was carried out through 
determining the ribotypes of the isolates obtained from these sampling studies. 
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3.2 Materials and Methods 
Three distinct environmental sampling campaigns were carried out for this 
study for C. difficile contamination.  They have been differentiated here by the 
methods used to recover bacteria from wards.  The first two campaigns utilised 
RODAC plates.  In the first campaign, CDMN agar alone was used for the recovery 
of C. difficile; the second was conducted with the five different media used in the 
previous chapter of this thesis (Chapter 2).  The third environmental sampling 
campaign made use of sponge-sticks pre-moistened with neutralising buffer [3M 
Healthcare, UK] to recover bacteria from sites prior to enrichment and 
resuscitation on different preparations of the five aforementioned agar media.  
3.2.1 Sampling with RODAC plates: Campaign 1 
Sampling was carried out at two hospitals in the UHL Trust: the LRI and 
LGH, with Pawel Wolyniec [Loughborough University].  In both hospitals, the 
sampling was conducted in a single bay around beds (Figure 3.11).  These were 
selected as they were closed prior to being cleaned by using steam followed by 
hydrogen peroxide release.  Treatment was carried out with a device that emitted 
a vapour from an aqueous solution of 5% hydrogen peroxide, (<50 ppm) silver 
ions and (<50 ppm) orthophosphoric acid (Department of Health 2008). 
Following the re-opening of these wards, sampling was conducted.  The bay 
selected in the LRI was a part of an Ophthalmic Surgery Ward (Ward 37, Bay 3), 
and the bay in the LGH was a part of an Acute Medicine Ward (Ward 6, Bay 3).  
Weekly sampling was conducted in both hospitals before the morning routine 
clean for a 15-week period.  RODAC plates containing the medium CDMN were 
pressed down onto a range of surfaces with a 200 g weight for 30 sec. 
3.2.1.1 Sampling locations 
Sampling was carried out in 71 locations in both wards (Figure 3.12 and 
Figure 3.13, pages 116 and 117).  These locations were: floors, floor spaces under 
beds, tops of lockers, tops of bedside tables, bottoms of bedside tables, arms of 
chairs, wall rails, toilet floors, underneath the toilet lids, a toilet support bar, and 
windowsills. 
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3.2.1.2 Incubation of plates and C. difficile recovery  
Following sampling, the plates were transferred into a 37°C anaerobic 
incubator for 48 hr.  Colonies were counted and recorded; any possessing the 
characteristic grey pigmentation and irregular-shaped C. difficile morphology were 
sub-cultured onto BHI blood agar and incubated for a further 48 hr. Diagnostic 
tests were then performed to confirm the identity of the bacterium.  These tests 
are based on colony morphology, odour produced and yellow-green fluorescence 
under UV light.  RODAC plates were placed back into the anaerobic workstation for 
a further 72 hr to allow for additional growth, with checks performed every 24 hr.  
Distinctive colonies recovered from further incubation were also propagated. 
3.2.1.3 Bacterial identification kit 
The API 20A (rapid ID32 A) strips kit [bioMérieux, France] is a standard 
diagnostic method used widely to identify and determine the identity of common 
anaerobic bacteria.  Groups have reported use of this kit to determine the 
anaerobic species detected following environmental sampling (Kaatz et al. 1988; 
Lindstrom et al. 1999).  Through a series of twenty-nine different biochemical 
tests using a range of enzymes present in individual cupules, colour changes 
indicate a positive or negative result for each reaction.  These outcomes are then 
scored using an identification table provided with the kit.  Eighty different 
anaerobic organisms have been investigated by the manufacturers, and their 
results for each biochemical test recorded.  Samples were prepared as described in 
the guidelines provided with this kit. 
3.2.1.4 Bacterial 16S sequencing 
Another method used to distinguish the species of the bacteria present on 
the RODAC plates was using universal 16S primers.  These target the conserved 
region of the 16S rRNA gene, providing an accurate substitute to bacterial 
identification by phenotypic methods as well as re-classification of bacteria 
(Clarridge 2004). 
Universal 16S primers, Bact-8F {5'-AGA GTT TGA TCC TGG CTC AG-3'} and 
Bact-1492R {5'-CGG CTA CCT TGT TAC GAC TT-3'}, were used as described by 
Baker et al. (2003).  DNA was extracted using the phenol/chloroform technique 
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described later in this thesis (Section 4.2.4).  The samples were quantified as 
before, and then treated as described in the guidelines provided with the QIAquick 
Gel Extraction Kit Protocol: using a micro-centrifuge [Qiagen, UK].  Below are the 
conditions for the PCR employed: 
Process Temperature (°C) Time (sec) Cycles 
Initialisation 95 300 1 
Denaturing 95 30 30 
Annealing 55 60 30 
Extension 72 60 30 
Further extension 72 300 1 
Table 3.1: PCR protocol for bacterial 16S sequencing. 
3.2.1.5 Analysis of PCR products 
Samples were diluted to 30 pMol prior to sequencing by The Sequencing 
Centre [University of Dundee].   
3.2.1.6 Statistical analyses  
Data gathered from the environmental sampling were analysed using 
Microsoft Excel’s statistical functions and Data Analysis Tool Pack.  The results 
obtained from the bacterial 16S sequencing were converted with Chromas v2.33 
[Technelysium Pty Ltd., Australia] into FASTA sequences and the species identified  
by comparing with published sequences with the online database GenBank 
[National Center for Biotechnology Information, USA]. 
3.2.2 Sampling with RODAC plates: Campaign 2 
Sampling was carried out once in the LRI, within the C. difficile isolation 
ward.  A map and legend of the beds are shown in Figure 3.11.  The following solid 
media were used: CDMN, CCEY, CCAB, FAA, and GS-BHI. 
3.2.2.1 Sampling locations 
Patients testing positive with C. difficile infection based on diagnostic tests 
from faecal specimens were transferred into the C. difficile isolation ward in 
individual rooms.  For this study, two of these occupied rooms were sampled. 
Five RODAC plates, one of each solid medium, were placed and pressed 
down with a 200 g weight for 30 sec in a given location.  The sites sampled were: 
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floor entrance, floor under bed, bed rail, back of bed frame, sink, table top, table 
base, top of contaminated materials bin, floor behind door and bed controls.  
Following a daily routine clean of the rooms and an additional 30 min wait, to 
allow the detergent and germicides used to dry efficiently, sampling of these areas 
was repeated.  The ward toilet (inside and outside of the rim, floor near toilet, 
toilet rails and sink) used by other patients, as well as the sluice (inside and 
outside rim, floor near sink, sink and draining board) for disposing of bedpan 
waste, were sampled once with the five media. 
3.2.2.2 Incubation of RODAC plates 
The same method as outlined in Section 3.2.1.2 was utilised. 
3.2.2.3 C. difficile recovery 
After sampling, the RODAC plates were subjected to an alcohol wash.  The 
surface of each plate was washed individually with 1 ml IMS repeatedly, collecting 
all colonies into an Eppendorf tube.  This suspension was mixed via vortex and left 
at room temperature for 45 min.  Of this mixture, 0.5 ml was centrifuged at 15,000 
x g for 5 min and the pellet washed and re-suspended in FA broth containing 
cycloserine and cefoxitin (250 mg/l and 8 mg/l), with 0.1% sodium taurocholate 
(CCFA broth), as an enrichment step.  Following anaerobic incubation for 10 days 
at 37°C, these were cultured onto CCEY agar plates.  Any colonies resembling the C. 
difficile morphology as previously described were sub-cultured further onto BHI 
blood agar to confirm presence of the bacterium. 
Of the 1 ml IMS-culture suspension, 50-75 µl was plated onto four different 
agar media in an attempt to resuscitate the bacterium (CCEY, BHI blood agar, FAA 
with 0.1% sodium taurocholate, and GS-BHI agar with 10 mg/l lysozyme and 0.1% 
sodium taurocholate).  These were then anaerobically incubated at 37°C for 48 hr.  
These media were chosen based on differences in antibiotic mixtures, additional 
supplements as well as their agar bases.  Any C. difficile-like colonies were sub-
cultured as above. 
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Positive C. difficile samples obtained from both methods of recovery were 
cultured in liquid media prior to chromosomal DNA extraction and strain 
identification by PCR ribotyping as described in Section 4.2.4. 
3.2.3 Sampling with pre-moistened sponge-sticks: Campaign 3 
Investigations into other sampling tools were carried out, and pre-
moistened sponges, containing neutralising buffer to aid  bacterial recovery, were 
decided upon due to the larger surface area that could be covered, and the ability 
to make contact with non-flat surfaces.  Sampling was carried out on one occasion 
in the same C. difficile isolation ward in the LRI as with the second sampling 
campaign.  
The resuscitation of viable C. difficile spores was identified as a problem 
from the previous sampling campaigns (Sections 3.3.1 and 3.3.2), and therefore 
different media for recovering the bacterium were utilised.  Based on the five 
media which had been previously used (CCEY, CDMN, CCAB, FAA, and GS-BHI), 
combinations were created whereby a non-selective medium was poured on top of 
a selective, or antibiotic-containing medium (Table 3.2).  Different volume ratios 
(ml) of the agar mixes were prepared, as well as each medium poured individually. 
 FAA GS-BHI 
CCAB 5:15 10:10 15:5 5:15 10:10 15:5 
CCEY 5:15 10:10 15:5 5:15 10:10 15:5 
CDMN 5:15 10:10 15:5 5:15 10:10 15:5 
Table 3.2: Volume ratios of layered media utilised in the resuscitation of C. difficile isolates.   
Layering was carried out by the pouring and setting of CCAB, CCEY, or CDMN, and over-laying FAA or GS-BHI to a 
total of 20 ml.  Each medium was also prepared alone (20 ml). 
 
3.2.3.1 Sampling locations 
In this sampling study, pre-moistened sponges were used to wipe three 
surfaces within five occupied patient rooms: sink area and taps, floor near patient 
bed and the bed rails used by patients.   
3.2.3.2 Treatment of pre-moistened sponge-sticks 
Following contact with surfaces in the patients’ rooms, the sponges were 
immediately immersed and sealed in individual bags to retain moisture.  To each 
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individual sponge, 10 ml PBS with 0.01% (v/v) Tween 80 solution was added 
before homogenising at 260 rpm for 5 min using the Stomacher 400 Laboratory 
blender [Seward, UK], as previously conducted (Dubberke et al. 2007).  The 
solution was transferred into a fresh vial before use. 
3.2.3.3 C. difficile recovery 
Samples were thoroughly mixed via vortex for 1 min before adding 1.5 ml 
pure ethanol (1:1) and mixing for a further 1 min.  The remaining solution was 
then stored at 4°C.  The samples were left for 45 min for sufficient alcohol shock, 
100 µl of this solution was aseptically applied and spread onto each of the 23 
different agar combinations.  Plates were incubated at 37°C anaerobically for 48 hr 
to allow sufficient growth.  Checks were made daily for 72 hr and potential C. 
difficile-positive colonies were sub-cultured onto BHI blood agar and confirmed as 
described above. 
3.2.4 Ethical issues 
Ethical approval was obtained for all sampling campaigns conducted in this 
chapter.  All information regarding patient data was made anonymous prior to use.  
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3.3 Results 
3.3.1 Recovery from sampling with RODAC plates: Campaign 1  
Bacterial counts were recorded from the CDMN plates following 
environmental sampling in both the LRI and LGH wards.  The average counts 
calculated for each location have been shown (Figures 3.1 and 3.2). 
3.3.1.1 Leicester General Hospital 
Results from the LGH ward (Figure 3.1) show increases in the counts of 
bacterial contamination obtained from 8 of 11 locations sampled during week 6 of 
15, with counts from the toilet support bars reaching 220 colonies.  This location 
returned the highest number of colonies for 5 of the 15 weeks that sampling was 
carried out.  The toilet floor also yielded high numbers of colonies, with a global 
average of 42.69 colonies per round of sampling, and median of 40.88.  This 
median value is over four times greater than the colonies counted from the toilet 
seats, 9.35.  
 
Figure 3.1: Average colony counts observed from a selection of sites using CDMN RODAC plates following sampling 
from an LGH ward over a 15-week period. 
 
Very low recoveries of anaerobic organisms were recorded for certain 
areas.  These were the windowsills, with an average of 5.56, and the top of the 
bedside table, with an average of 5.22 colonies per week.  These locations 
consistently produced very low counts, except for weeks 5 and 6 of this sampling 
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period.  The top of the bedside table had its highest count in week 5, with 30 
colonies recovered.  In week 6, the counts for these locations increased to 21 and 
11.5 colonies, respectively.  Following this, both returned to averages of 0-3 
colonies recovered the following week. 
The bedside table base averages do not appear to reveal a trend or pattern 
of any kind; colony counts from this location were recorded as low as 0.6 during 
week 2 and as high as 50.5 colonies during week 6.  There is a fluctuation in 
recovery for this site, but no correlation can be determined. 
However, a general pattern can be seen overall when analysing the data 
collected from the LGH in the second week of sampling.  There was a decrease in 
recovered colonies for all locations so much so that the highest average was 1.33 
colonies on the sampled wall rails, although no explanation can be given for this.  
The following week, all locations reported increases in recovered colonies on the 
CDMN plates ranging from a 10-fold rise for the wall rail to a 55-fold elevation on 
the arms of the chairs.  The latter decreased in the following week, as the 
remainder of sites had increased colonies recovered through week 6. 
Overall, weeks 7-8 showed a decrease in bacterial recovery.  Despite the 
highest value of this fortnight period being 133.3 colonies recovered from the 
toilet support bars, the general trend was a fall in the numbers recovered.  The 
following five-week span (weeks 9-13) showed no consistent pattern in terms of 
increases and decreases of bacterial recovery.  During this period, no significantly 
high counts were observed other than 60.83 colonies being recovered in week 12 
for the toilet floor.  All other counts through these weeks ranged from 0.0 to 42.45.  
The final two weeks of the time period (weeks 14-15) show a respective increase 
in total recovered colonies for week 14 and decrease for the final week, with the 
highest number recovered from the latter at 11.83 colonies. 
3.3.1.2 Leicester Royal Infirmary 
The results of sampling over a 15-week period in the LRI ward are 
presented in Figure 3.2.  Key areas of high recovery of bacteria using the CDMN 
plates are shown to be the bedside table base, which had an average of 9.2 colonies 
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per week recorded, the toilet support bar (13.22) and the floor of the toilet (7.51).  
In contrast to this, it was found that areas of low recovery were the top of the 
bedside table (0.76) and the top of the lockers (1.34) colonies per week. 
 
Figure 3.2: Average colony counts observed from a selection of sites using CDMN RODAC plates following sampling 
from an LRI ward over a 15-week period. 
 
The two highest numbers of colonies recovered from all sites were both 
found in week 5.  Counts of 66.5 and 60 were observed for the bedside table base 
and toilet support bar, respectively.  The third highest was 46.2 colonies, also from 
the toilet support bar.  There were many instances in which no colonies were 
recovered from specific sites; the arm of the chair adjacent to the patients’ bed 
failed to recover bacteria for 8 of the 15 weeks. 
There was a general increase in the overall recovery of anaerobic growth in 
week 2, which subsequently fell in week 3.  This steady increase of an average of 
0.3 additionally recovered colonies continued through the following week.  Week 5 
of the period, however, recovered the highest counts for 4 of the 11 chosen sites.  
This resulted in 13 colonies collected from the floor, 22.83 from the toilet floor, 
66.5 from the base of the bedside table and the 60 from the toilet support bar, as 
referred to previously.  The total counts fell from week 5 to week 6; the weekly 
average total of 219 recovered from all sites in week 5 decreased to 46.9 colonies, 
a significant decrease of 78.5%.  Weeks 8 and 9 were recorded as identical in 
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terms of recovering colonies, both recovering total highs of 1.17 for the base of 
bedside table, and no growth recorded for the respective tops, arms of chairs, 
toilet seats, and windowsills. 
A rise in counts similar to that observed for weeks 2-3, also occurred 
almost two months later in weeks 10-11.  Following this, no general patterns were 
recorded until week 15 where rises in numbers of colony growth were recorded at 
all sites.  There were no known reasons as to why this would have occurred.  In the 
final week of the study, 3 of the 11 chosen locations recovered levels of bacterial 
growth that were within the highest three numbers for their given site. 
3.3.1.3 Identifying bacterial growth on RODAC plates 
After the RODAC plates were used for environmental sampling, they were 
incubated for 48 hr at 37°C in the anaerobic chamber, and then were removed and 
the colonies counted. 
Initially, those colonies suspected to be C. difficile based on their 
morphology (about 1 mm in diameter) were selected from the CDMN plates and 
re-plated onto fresh blood plates.  As single colonies had been selected from these 
plates and sub-cultured further, it was assumed that pure cultures of C. difficile 
were isolated.  These samples were allowed a further 48 hr in anaerobic 
conditions and these cultures were subject to the characteristic C. difficile tests 
described earlier in this report (Section 3.2.1.2).  Through the diagnostic tests, it 
was found that not all of the colonies selected from the CDMN agar plates were C. 
difficile, failing the determining tests.  This was despite the media being a specific 
agar-based product combined with particular antibiotic supplements, moxalactam 
and norfloxacin, which are recommended for C. difficile isolation.  Based on the 
differentiation observed with colony morphologies, identification of the 
microorganisms was conducted. 
3.3.1.4 API 20A strips kit 
The API 20A (rapid ID32 A) strips kit is a standard diagnostic method 
commonly used to identify anaerobic bacteria, as described in Section 3.2.1.3.  
Colonies were chosen from four isolated locations, sampled with CDMN plates 
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from the LRI.  The colonies chosen were selected because they closely resembled 
the previously described colony morphology expected for samples of C. difficile, 
but failed the characteristic identification tests.  In addition to this, to ensure 
reproducibility, a known strain of C. difficile, ribotype 027, was used in this 
procedure as a positive control (Figure 3.3).  The colour changes observed were 
identical to those recorded by the manufacturers for C. difficile. 
 
Figure 3.3: API 20A (rapid ID 32 A) strip for ribotype 027.   
The colours represent a positive or negative result for a biochemical test.  This was used as a positive control and was 
a known strain of C. difficile. 
 
Sample G9 was collected from the top of a locker.  However, the kit was not 
able to produce a conclusive result in terms of identifying the bacterium based on 
the list of eighty tested anaerobes, due to conflicting potential species requiring 
specific colour changes.  Samples 10 and 11 obtained from the top and bottom of 
one bedside table, respectively, were also tested.  These both produced 
inconclusive results too, as the colour changes observed did not map any specific 
species listed.  Based on the inconclusive results of the biochemical reactions for 
these three samples, the kit was unable to aid in the classification of the anaerobes 
isolated from the RODAC plates.  
Sample 22 was collected from the base of a different bedside table within 
Ward 37.  The colour changes due to biochemical reactions for this organism 
indicate the bacterium was Clostridium clostridioforme.  However, despite this one 
positive result, as well as the positive control simultaneously carried out, there 
was an overall lack of irrefutable results with this method of identifying and 
confirming anaerobic organisms.   
This test was largely ambiguous and variations of colours often made it 
hard to distinguish whether a given result could be construed as positive or 
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negative for a given organism.  No further samples were prepared for this method 
of classification. 
3.3.1.5 Bacterial 16S sequencing 
Based on the lack of conclusive results from the API 20A strip kits, another 
technique was investigated.  The second method chosen to classify the colonies 
obtained from the CDMN plates using in the first environmental sampling 
campaign was bacterial 16S sequencing.  There were twelve colonies selected from 
the RODAC plates prepared with CDMN used in environmental sampling; chosen 
for their differences in colony morphology, and obtained from both hospital sites, 
as described in Table 3.3.  This was to identify the bacteria that were capable of 
growing on CDMN agar. 
The sequencing procedure was able to identify facultative anaerobes that 
would not have been detected with the use of the API strips, as these are limited to 
known anaerobes alone.  This study has aided in the identification of facultative 
anaerobes present in the hospital environment, as well as the potential inability of 
the CDMN plates to recover these whilst lacking the desired selectivity.  
 
C. difficile colony is highlighted within the yellow circle.  Other colonies were deemed as contaminants. 
 
Subsequent to discovering the different morphology of C. difficile colonies 
when growing on the CDMN plates following recovery from the environment, the 
identities of a further three positive C. difficile isolates were confirmed.  These 
possessed the characteristic dull, grey morphology seen with sample 56* (Figure 
3.4).  These were samples 22 and 23 from the LRI ward from the top and bottom of 
 
Figure 3.4: C. difficile colony formation on a CDMN RODAC agar plate. 
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the same bedside table, in addition to sample G52 from the LGH, isolated from a 
toilet support bar (Section 3.6).  Conducting PCR ribotyping for these four samples 
identified all isolates as ribotype 027. 
 
Chapter 3. Environmental Sampling of C. difficile 
 
83 
 
 
Sample Location Appearance of colony Species 
6 Arm of chair Medium, with haemolysis (4 mm) Staphylococcus epidermidis 
7 Floor Medium, with haemolysis (4 mm) Staphylococcus epidermidis 
28a Base of bedside table Small, pale grey (2 mm) Staphylococcus haemolyticus 
31 Floor Large, yellow (5 mm) Staphylococcus saprophyticus 
56* Underside of toilet seat Dull grey † (3 mm) Clostridium difficile 
G2 Floor under bed Small, pale grey (3 mm) Staphylococcus saprophyticus 
G8 Floor under bed Large, yellow (6 mm) Enterococcus faecium 
G9 Top of locker Large, with haemolysis (6 mm) Staphylococcus epidermidis 
G22 Base of bedside table Medium, yellow (4 mm) Staphylococcus epidermidis 
G23 Top of bedside table Medium, grey (4 mm) Lactobacillus fermentum 
G31 Floor Large, with haemolysis (6 mm) Staphylococcus epidermidis 
G32 Floor under bed Small, yellow (2 mm) Staphylococcus epidermidis 
Table 3.3: Descriptions of colonies selected for bacterial 16S sequencing.   
† - indicates the colony selected had serrated edges.  All others were smooth-edged.  All samples possessed a maximum identity of >95%. 
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3.3.2 Recovery from sampling with RODAC plates: Campaign 2 
The previous environmental sampling study identified difficulties with the 
use of just one medium in the RODAC plates.  It was also thought the locations 
chosen for sampling were not ideal for recovering C. difficile.  Therefore, the five 
media investigated for C. difficile recovery in the laboratory subsequent to 
exposure to ChlorClean were prepared and used in a second hospital sampling 
campaign.  The ward chosen for this study was the C. difficile isolation ward in the 
LRI as it was expected that C. difficile contamination would be abundant.  Sampling 
was carried out in two private isolation rooms as well as a shared toilet area and 
the sluice for waste disposal.  The isolation rooms were sampled before, and thirty 
minutes after, a daily routine cleaning procedure.  This was to investigate the 
effects of the standard routine cleaning technique carried out. 
After conducting the sampling, any positive C. difficile-like colonies were 
sub-cultured onto BHI blood agar plates for the diagnostic tests to confirm 
presence of the organism.  The positive isolates are represented by blue bars in 
Figure 3.5.   
The low recovery of putative C. difficile colonies, and overall high bacterial 
counts on the plates made it difficult to visually assess the number of C. difficile 
colonies that had formed following the tamping.  Therefore, all of the plates were 
subjected to an IMS wash and treated as previously described plating onto four 
freshly prepared agar plates (BHI blood, CCEY, FAA, and GS-BHI) as shown (Figure 
3.6).  BHI blood agar was chosen for its use in diagnostic tests for confirming 
presence of C. difficile; CCEY agar for its ability to isolate C. difficile within a sample 
when found amongst a range of other faecal bacteria due to its antibiotic 
selectivity.  Conversely, FAA and GS-BHI agar were chosen specifically because 
they did not contain antibiotics but had aids to spore germination.  These media 
were also successful in C. difficile recovery in Chapter 2.  The numbers of positive C. 
difficile isolates identified after this enrichment step increased the totals, as shown 
by purple bars in Figure 3.5. 
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Figure 3.5: Recovery of C. difficile isolates with and without IMS washing of RODAC plates.  
‘Pre-IMS’ refers to the number of plates with positive C. difficile colonies observed upon visual inspection.  ‘Total’ is the 
final number of C. difficile positive samples obtained following IMS washing. 
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Resuscitation media after IMS washing 
Location 
RODAC 
plate 
PCR 
Ribotype 
Positive 
before IMS 
FAA BHI blood GS-BHI CCEY 
Side room 1 (pre-clean)  
Table base GS-BHI 103 
 
+ + + 
 
Top of yellow bin FAA 103 
 
+ 
   
Top of yellow bin CDMN 010 
  
+ 
  
Floor behind door FAA a 
 
+ + + 
 
Side room 1 (post-clean)  
Floor entrance GS-BHI 103 
 
+ + 
  
Table top GS-BHI 103 * 
   
+ 
Side room 2 (pre-clean)  
Floor entrance GS-BHI 103 
 
+ + + + 
Floor under bed CCEY 103 * 
   
+ 
Floor under bed CDMN a 
  
+ 
  
Bed rail CCEY 103 * 
   
+ 
Back of bed frame CDMN 103 * 
   
+ 
Back of bed frame GS-BHI 103 * 
   
+ 
Back of bed frame FAA 010 
 
+ + + + 
Sink CDMN 103 * 
   
+ 
Sink FAA 103 * 
   
+ 
Table top GS-BHI a 
 
+ + 
 
+ 
Floor behind door FAA 103 
   
+ 
 
Bed controls CCAB 103 * 
   
+ 
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 Resuscitation media after IMS washing 
Location 
RODAC 
plate 
PCR 
Ribotype 
Positive 
before IMS 
FAA BHI Blood GS-BHI CCEY 
Side room 2 (post-clean) 
Floor entrance CCEY 103 * 
   
+ 
Sluice 
Draining board CDMN 103 
 
+ 
   
Sink FAA 027 
 
+ 
   
Sink GS-BHI 027 
 
+ 
   
Floor near sink CCAB 027 * 
   
+ 
Floor near sink FAA 081 
 
+ + + 
 
Toilet 
Toilet rim (outside) FAA b 
 
+ + + 
 
Toilet rails GS-BHI 103 
   
+ 
 
Sink FAA 103 
  
+ 
  
Sink GS-BHI 103 * 
   
+ 
Table 3.4: Distribution of samples and corresponding ribotypes with RODAC plates.  
‘*’ – Individual colony was identified as C. difficile from visual selection before IMS washing.  ‘+’ – Isolation via IMS washing step and resuscitation on the specified agar.  ‘a’/’b’ – unknown ribotypes.
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The data from this resuscitation procedure show the additional IMS 
washing step has a profound effect on the number of isolates classified as positive 
for C. difficile, with the RODAC plates prepared with the media CDMN, GS-BHI and 
FAA.  Only three isolates were confirmed as C. difficile-positive with the use of the 
liquid enrichment technique, CCFA broth with 0.1% sodium taurocholate.  In total, 
of the 202 RODAC plates used, 25 recovered C. difficile (12.4%).  Furthermore, 20 
of the 42 sites were C. difficile-positive (47.6%). 
The most striking improvements in recovery are with the two non-selective 
media: GS-BHI agar and FAA.  An additional six isolates were obtained from the 
original GS-BHI agar plates and eight more from the initial FAA plates used in the 
hospital.  The medium CDMN recovered C. difficile on two RODAC plates prior to 
the IMS washing stage, and subsequently a further three when the enrichment 
technique had been used.  CCEY and CCAB did not exhibit any differences in the 
numbers of RODAC plates successfully germinating C. difficile spores following the 
IMS wash and recovery. 
 
Figure 3.6: Recovery of C. difficile isolates after IMS washing and resuscitation onto agar media.  
 
The use of CCEY agar led to the recovery of only two isolates of C. difficile 
directly from the RODAC plates tamped onto surfaces within the ward, and the 
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additional IMS wash step failed to germinate any additional spores.  Despite this, 
the data from this study show that CCEY agar appears to be highly successful when 
used as a resuscitation medium, recovering fourteen additional isolates of C. 
difficile.  BHI blood agar and FAA led to the recovery of eleven and twelve positive 
C. difficile isolates respectively after samples were IMS washed and plated out, and 
on GS-BHI, there were eight.  There were isolates that were positive on more than 
one resuscitation medium (Figure 3.6). 
Following the confirmation of C. difficile, from either the initial visual 
checks of the RODAC plates used in the sampling or the additional resuscitation 
technique, the putative C. difficile isolates were cultured and the chromosomal 
DNA extracted.  The isolates were contextualised by strain using PCR ribotyping 
identified from this round of sampling (Figure 3.7).   
 
Figure 3.7: Ribotypes of isolates and the initial recovery agar media from RODAC plates. 
 
These data suggest the clear prominence of ribotype 103 within the side 
rooms and additional sites sampled, as it was recovered on all five prepared 
media.  Before the routine cleaning, eight out of the ten sites sampled recovered C. 
difficile.  Only three of the five media recovered the expected dominant ribotype 
027, however these were all localised in the sluice area sampled (Figure 3.8).  It 
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was expected that ribotype 027 would be present throughout all tested sites due 
to the reports of its ubiquity (Morgan et al. 2008).  The sluice was also found to 
possess ribotype 081, as only identified solely with FAA, and 103, with one sample 
recovering each of these strains.   
With respect to the tested media, the overall recoveries were somewhat 
lower than anticipated based on the results reported in literature.  However, FAA 
and GS-BHI agar each recovered nine positive samples.  Between these two media, 
at least one of each ribotype was found.  Both media detected the presence of the 
unknown ribotype ‘a’.  This strain was identified in both side rooms sampled, but 
only before the routine clean (Figure 3.8).  Following the cleaning process, repeat 
sampling was unable to recover this particular type again.  Unknown strain ‘b’ was 
only found once with FAA prepared in the RODAC plates and in the toilet.  The 
toilet area was a site with only this strain and ribotype 103 present.  Of the five 
sites sampled within the sluice, three were C. difficile-positive; the same 
proportion was identified within the toilet. 
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Figure 3.8: Distribution of ribotypes recovered in the C. difficile isolation ward, according to site.   
‘SR’: identification assigned to C. difficile isolation side room number.  ‘Pre’ and ‘post’ refer to whether the sampling was 
conducted before or after routine cleaning. 
 
The clearest result from this body of data is the difference in recovery from 
the second side room selected for sampling (Figure 3.8).  The data strongly imply 
that the number of C. difficile spores present on surfaces in that room have been 
reduced by the cleaning method employed.  In addition to this, the findings suggest 
that certain ribotypes react differently to cleaning, ribotype 103 may be resist to 
cleaning, whereas ribotype 010 may be sensitive to the cleaning agents.  Ribotype 
010 was isolated from both sided rooms before cleaning; it was recovered from 
neither afterwards.   
The data also suggest that the strain types do not differ between rooms 
(ribotypes 010, 103 and ‘a’).  Patients in these isolation rooms are often bed-bound 
and immobile; therefore, they cannot be responsible for the transfer of these 
strains.  It could be inferred that the movement between rooms by either the 
cleaning or the hospital staff could result in the transfer of the C. difficile ribotypes. 
3.3.3 Recovery from sampling with pre-moistened sponge-sticks: Campaign 3 
The paucity of C. difficile isolated from the previous two environmental 
sampling studies gave rise to the idea of adopting another technique for bacterial 
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recovery.  The use of RODAC plates in environmental sampling limits the sampling 
area.  This restriction therefore could be a reason as to why such low levels of 
recovery were found.  Using a pre-moistened sponge would give the benefit of 
allowing a larger surface area to be covered as well as the flexibility of sites that 
were not flat.  ‘High’ contact sites chosen were the sink area and taps, the floor 
near the patients’ beds and the bed rails used by patients.   
For the purpose of this study, pre-moistened sponges were used to sample 
one of these three surfaces in five occupied C. difficile-positive patient rooms in the 
isolation ward, at the LRI.  The sponges were used before adding 10 ml PBS with 
0.01% (v/v) Tween 80 solution and homogenising as described by Dubberke et al. 
(2007).  The samples were thoroughly mixed both before and after the addition of 
1.5 ml pure ethanol (1:1).  After 45 minutes at room temperature, 100 µl was 
spread aseptically onto each of the 23 selected agar combinations.  Putative C. 
difficile colonies were subjected to the standard characteristic confirmation tests. 
The preparation of the double-layered agar media was to maximise the 
recovery of spores from the environment that may have been subjected to stresses, 
such as desiccation or exposure to cleaning products.  The top agar contained no 
selective agents or antibiotics, as the presence would stimulate further stress onto 
the spores; this non-selective media also encourages the spore resuscitation.  The 
antibiotics in the lower layer then diffuse up to the surface of the top layer to 
induce selectivity.  This interval of time between the resuscitation and antibiotic 
reaching inhibitory concentration potentially permits the maximum C. difficile 
recovery.  To compare the effects of different proportions of each combination, the 
volume ratios of the agar mixes were varied as shown (Table 3.2). 
The data show no single media combination utilised in this work was the 
most effective for recovery of C. difficile.  Additionally, not all media were able to 
recover C. difficile when the samples were applied directly onto them; only CCAB 
and the two non-selective media (FAA and GS-BHI agar) were successful (Figure 
3.9).  Analysis of the total bacterial counts for the RODAC plates used show FAA 
and GS-BHI agar to be the least selective with C. difficile growth, culturing a variety 
of other microbial species.  It was therefore expected that these two would be able 
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to produce high numbers of success; however only five of the total fifteen samples 
prepared grew on GS-BHI and only one on FAA. 
 
Figure 3.9: C. difficile isolates obtained after recovery from double-layered C. difficile agar media. 
 
Generally, there appears to be little difference between the abilities of the 
layered media to recover C. difficile.  All three of base media in conjunction with 
the various layered combinations successfully grew C. difficile from the samples 
obtained.  Minor distinctions were noted, for example, CCAB only recovered one 
sample when used in the ratio of 5 ml to 15 ml with GS-BHI agar; five fewer than 
CDMN.  Comparing this one positive with the five obtained with GS-BHI agar alone 
(20 ml) could suggest that the combination of the two media is not optimal for 
bacterial growth.  Furthermore, with the ratio reversed and triple the quantity of 
antibiotic-containing media used, only two samples were recovered.  However, 
when used in equal ratio, the combination of CCAB and GS-BHI resulted in six 
positive samples.  Therefore, the results from this novel methodology of C. difficile 
recovery demonstrate there may well be a link between the volumes of agar media 
used and the recovery success.   
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Figure 3.10: C. difficile isolates obtained after recovery with layered agar media by site. 
‘SR’: identification assigned to C. difficile isolation side room number. 
 
Figure 3.10 depicts an overview of all the sites sampled in the third 
sampling campaign for which C. difficile colonies were confirmed on the media 
after spreading.  Of the 15 sites selected for sampling, 10 were C. difficile-positive 
(66.7%).  Side room 1 was the only room from which C. difficile was recovered 
from all three sites.  This could be attributed to the fact that this patient was the 
most mobile, standing to use the sink area with little assistance from the ward staff, 
for example.  Side rooms 2, 3 and 4 were C. difficile-positive at two of the three 
sampling sites, and only one of the three sites in side room 5.  The bed rails and 
floor were the two C. difficile-positive locations in side room 4, and similarly were 
the sites with the higher recovery of C. difficile within side room 1. 
The floor was the one site to be C. difficile-positive from all five sampled 
rooms.  This again could be due to the movement of cleaning and hospital staff and 
transmission through the air.  Sampling of the bed rails led to the recovery of the 
second and third highest counts overall (from side rooms 4 and 1, respectively).  C. 
difficile growth was also recovered in side room 2, which corroborates the 
expectation that ‘high’ contact areas are reservoirs for C. difficile.  Patients in side 
rooms 3 and 5 were immobile, and therefore the lack of movement could have 
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resulted in reduced contact with the bed rail for help in moving compared with the 
other patients.  This could explain why there was less C. difficile recovered from 
the sink areas as the risk of spread is subsequently reduced if these areas are not 
touched by the contaminated patients. 
This study also involved identifying the ribotypes of the faecal samples 
from the patients occupying the five isolation rooms, and comparing these with the 
strains obtained from the three surrounding sites.  Table 3.5 demonstrates a clear 
presence of ribotype 027 in the isolation side rooms sampled as well as directly 
from the patients themselves.  This comparative study has shown the strain 
identified from a patient is the same as those strains isolated from sites around 
them. 
Patient Faeces Bed rail  Sink  Floor  
1 027 027 027 027 
2 Unavailable 027 --- 027 
3 027 --- 027 027 
4 027 027 --- 027 
5 Unavailable --- --- 027 
Table 3.5: Comparison of ribotypes from patients' faecal samples with those identified from the surrounding sites.   
Patient numbers also refer to side room number.  ‘---‘ refers to no positive C. difficile isolate was obtained from site. 
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3.4 Discussion 
C. difficile presence has been reportedly widespread, nosocomially as well 
as outside the hospital environment (al Saif & Brazier 1996; Beggs et al. 2008; 
Weaver et al. 2008; Sethi et al. 2010).  Detection of this contamination in 
combination with characterisation typing methods, enforces knowledge in 
outbreaks as well as underlying prevalence of strains.  With respect to hospital 
settings, sampling of C. difficile permits investigation into how the landscape of 
infection changes, in addition to detecting where potential ‘hot spots’ may lie.  
Identification of which sites in a hospital ward are more likely to be infected with C. 
difficile also helps ascertain where cleaning may need to be targeted and therefore 
assists in shaping cleaning regimes.   
There are many methods discussed in literature for isolating C. difficile from 
the environment.  Sampling with direct contact plates prepared with selective 
media has been shown to recover C. difficile (Fekety et al. 1981; Buggy et al. 1983; 
Danforth et al. 1987; Clabots et al. 1991; Lemmen et al. 2001; Martirosian et al. 
2005; Alfa et al. 2008).  Previous work within this thesis has demonstrated the 
importance of germination agents present within an agar medium in its ability to 
recover C. difficile (Chapter 2).  Within this chapter, emphasis has been placed on C. 
difficile selective media and its role in resuscitation, building on the findings 
initially found in this thesis, demonstrating the optimisation required in order to 
germinate damaged spores before strain characterisation.  Furthermore, the work 
presented here investigates whether a novel technique in C. difficile resuscitation 
could be used in its isolation from environmental sampling. 
Prior to the environmental sampling studies carried out in this chapter, 
preliminary work was conducted.  All five agar media were prepared in RODAC 
plates and used to recover microorganisms in a hospital ward.  The results 
indicated higher counts were obtained with the use of CDMN agar (data not 
shown).  Therefore, as this agar was able to recover the most bacterial counts, it 
was assumed the probability of picking up C. difficile would also be increased and 
it was subsequently utilised as the lone medium in RODAC plates for the first 
sampling campaign conducted at the LRI and LGH. 
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In-depth studies similar to the first sampling campaign described in this 
chapter are infrequently conducted.  Conducting sampling in such a manner in 
addition to the processing, culturing and analysis of isolates can be time-
consuming and deemed as not cost-effective.  However, the work carried out here 
has shown that routine cleaning of wards may be ineffective in eradicating 
bacterial contamination.  Sampling was conducted prior to routine manual 
cleaning, and recovery of microorganisms was nevertheless detected. 
With respect to the sites sampled in the LGH, locations with high numbers 
of bacterial growth were the floors and support bars in the toilets, and the wall rail 
in the bay area.  Areas with the lowest recovery at this ward were the bedside 
table tops and the windowsills.  The high levels of recovery may be attributed to 
increased use of the toilet facilities in the ward, as these communal sites would be 
utilised by all patients throughout the day.  This would result in an increased 
probability of transmission within this area and a high transfer efficiency of 
microorganisms.  The wall rails are classified as a ‘hard to reach’ area, in the sense 
that the cleaning staff may not necessarily be able to clean these areas easily due 
to the height at which they are placed, in addition to the fact that patients may stay 
in this ward for long periods of time (Barbut & Petit 2001).  Therefore, in an 
attempt to minimise the disturbance to patients, sites may not be cleaned as 
thoroughly, increasing the rates of bacterial accumulation.  The top of the bedside 
table is an area that would be cleaned more often than any other site as this is used 
by patients throughout the day and is subject to spillages of food and drink.  These 
would be cleaned up more efficiently, resulting in a reduction in the numbers of 
bacteria, as observed.  As an area which would not have many people making 
contact with it, and thus when cleaned would theoretically be free from bacterial 
transmission through touching, the windowsills were another site with little 
recovery of colonies. 
For the samples collected at the LRI, the toilet support bars, base of the 
bedside table and toilet floors led to the recovery of C. difficile.  This could be due 
to the high usage of the support bars, and toilet areas in general in comparison to 
the rate of cleaning.  Therefore, with more patients using these areas, there is an 
Chapter 3. Environmental Sampling of C. difficile 
 
98 
 
increased chance for bacterial colonisation and subsequent pick up during 
sampling (Davies et al. 2011).  The base of the bedside table would be wiped down 
and cleaned less frequently, as spillages of food and drink on the surfaces would be 
removed, but there would be fewer circumstances where the base would be 
cleaned.  The results from these data suggest that in ‘hard to reach’ areas such as 
the wall rails and floor spaces under beds, there were fewer bacterial colonies 
recovered.  These locations would be expected to have lower counts of bacteria as 
cleaning staff, patients and healthcare workers are unlikely to frequently come 
into contact with these sites (Davies et al. 2011).  
A potential explanation for the numbers of bacterial contamination on the 
sites identified within this sampling campaign is that in the UK, cleaners of wards 
are provided with a specific list of areas to clean.  An emphasis is placed on the 
cleaning of visual contamination on floors and within toilets (Dancer 2008).  It has 
also been reported that the responsibility of cleaning certain frequently touched 
sites such as bed rails, door handles and switches, including the nurse call button, 
falls onto the ward nurses (Dancer 2004).  However, whether this was true for the 
hospital wards used in the sampling studies within this thesis is unknown.  Kramer 
et al. (2006) also discussed the importance of bacterial contamination on sites 
within hospitals and the effect of its persistence.  This report demonstrated how 
the transmission of most HCAI is through contact with the patient and/or 
healthcare workers and inanimate sites.  Therefore, poor cleaning of these sites 
may be a latent source for harbouring and transmission of pathogens. 
Based on the counts from the samples recovered in the LGH, concerning 
changes and differences in recovery numbers over the course of the sampling 
period, there appeared to be some periodic changes occurring.  General increases 
in counts were observed roughly every four weeks, for example, weeks 5 and 6 
saw high counts, which then fell.  The counts rose again through the later weeks in 
the study, particularly in weeks 10 and 14 (excluding a brief increase in week 12 
for the toilet floor).  This four-week cycle indicates that general rises in bacterial 
contamination are seen on a monthly basis.  There was an anomaly observed 
during weeks 7 and 8 of the sampling, recovering fewer colonies consistently.  It 
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could be speculated that fewer patients were present in the bay during this time, 
and thus the chance of bacterial transmission was reduced, but these data were 
not available at the time of conducting this study and so conclusive findings cannot 
be reported. 
Considering the data collected from sampling within the LRI, there were 
three notable instances in the fifteen weeks investigated in this current study 
whereby there was an increase in counts observed.  These all occurred 
periodically, every five weeks, with rises in weeks 5, 10, and 15.  Similarly, to the 
LGH, this is indicative of a cyclical pattern.  There are distinct patterns observed 
for changes; there appears to be more fluctuation in recovery from the earlier 
periods of sampling, with counts settling during the latter season.  However, the 
lack of information regarding the ward occupancy over time hinders the 
derivation of conclusions from these findings.   
Overall, there appear to be fewer colonies recovered in total from the LRI 
than LGH, with averages ranging from 0.76 to 13.22 and 5.22 to 42.69 colonies, 
respectively.  This has been consistently viewed when analysing the data.  
However, the ophthalmic ward in the LRI did have a greater patient turnover.  This 
ward housed patients prior to surgery that waited no more than one day, and so 
cleaning staff accessed this site more often; bed areas were cleaned thoroughly 
following the discharge of a patient.  In comparison, the LGH ward where sampling 
took place is one whereby a patients’ stay can exceed weeks, and therefore, bed 
areas may not be cleaned as thoroughly trying to minimise disruption to the 
patient.  The increase in periodic cleaning and times spent within the LRI ward 
could potentially be attributed to the low values of recovery, as reported by Wilcox 
& Fawley (2000).  This group identified how frequent cleaning of a site may play a 
role in reducing the bacterial colonisation.  In conjunction with the data collected 
throughout this chapter, it could therefore be concluded that regular cleaning of 
sites in and around patients could reduce the transmission and persistence of 
bacterial contamination. 
This study also showed that the presence of antibiotics within a medium 
when used for environmental sampling does not necessarily restrict all other 
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bacterial growth.  A number of different organisms were able to grow on the 
CDMN agar in RODAC plates, not just C. difficile.  Diagnostic C. difficile tests 
identified that despite the media being a specific agar-based product combined 
with particular antibiotic supplements, moxalactam and norfloxacin, specifically 
developed for C. difficile growth, this was not observed.  In addition, there were a 
variety of other colony morphologies recorded following sampling and incubation 
of the plates suggesting a lack of agar selectivity. 
The API 20A strip kit was utilised on four unknown samples that had been 
recovered from the CDMN plates and purified.  Despite it being a widely used 
diagnostic method, this technique failed to identify three of the four chosen 
colonies (Kaatz et al. 1988).  Of the one positive isolate identified, Clostridium 
clostridioforme, its presence and infection is not frequently reported.  Finegold et 
al. (2005) suggest that this bacterium consists of a mixture of three different 
clostridial species: Clostridium bolteae, Clostridium clostridioforme, and Clostridium 
hathewayi due to its variability when subjected to both tests, of phenotypic and 
antimicrobial susceptibility nature.  Few studies have been conducted into 
Clostridium clostridioforme, its symptoms and effects, but a link has been shown to 
bacteraemia and Clostridium hathewayi (Woo et al. 2004).  The API strip kit was 
able to identify this particular anaerobic bacterium, but little is known about its 
potential severity in the hospital environment. 
The tests were highly time-consuming, requiring incubations of four to four 
and a half hours following addition of the sample chosen for classification.  The kit 
also proved to be less than efficient with respect to cost.  Of the large proportion of 
the colonies growing on the CDMN agar plates, about 90% were determined as not 
C. difficile based on colony morphology with the majority of these isolates failing 
characteristic tests.  It was important to conclude what organisms were capable of 
growing on this media, as well as in the anaerobic conditions.   
The classification of the anaerobes on the CDMN plates with this kit was 
inconclusive, as three out of four chosen colonies failed to yield significant colour 
changes, indicative of biochemical changes.  This inhibited profiles to be created 
using the provided identification table.  This could be due to the kit being limited 
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to eighty different anaerobic microorganisms, and as discovered using the 
bacterial 16S sequencing, the bacteria recovered from the CDMN plates were 
facultative anaerobes.  In addition, of the list of species the kit is able to detect, 
none of the bacteria classified with the bacterial 16S sequencing would have been 
identified.  Consequently, in order to determine any unidentifiable colony 
morphologies, this study has found bacterial 16S sequencing would be the most 
reliable technique.  Developments in technology over the past twenty years have 
allowed for this method to emerge as being of high importance in terms of 
identifying bacterial species (Baker et al. 2003).  
From the results obtained in this current study, it can be concluded that a 
high proportion of the recovered bacteria were Staphylococcus epidermidis, 50% of 
the tested samples (n=12).  Furthermore, these samples do not possess the same 
morphology, varying in size as well as the ability to lyse the blood surrounding the 
colony.  It can be concluded that its presence is due to it being shed continuously 
from the skin of patients, visitors, and healthcare staff members.  The same 
conclusion can be drawn with respect to Staphylococcus saprophyticus, positive in 
16.7% of the tested samples.  This too possessed a range of size and colours in 
terms of morphology.  All species identified were facultative anaerobes.  
Furthermore, the presence of antibiotics had no effect in inhibiting the growth of 
these Staphylococcus species, suggesting their resistance to the media used.  
Moxalactam has previously been shown to exhibit sensitivity to both 
Staphylococcus aureus and Staphylococcus epidermidis (Chang et al. 1988).  
Additionally, Dancer (2008) stated the resistance of staphylococci to desiccation 
was recognised, with MRSA contamination capable of surviving within a hospital 
site for over a year after initial inoculation.  Furthermore, there have been reports 
to suggest the use of 1000 ppm chlorine-based products in manual cleaning does 
not result in effective reduction of MRSA (French et al. 2004; Jeanes et al. 2005). 
Sample 56*, the first positive C. difficile colony isolated, was an important 
find as its colony morphology does not appear characteristic of C. difficile, nor did 
the colony fluoresce yellow-green when the original sample plate was exposed to 
UV light.  This isolate did fluoresce, however, when re-plated onto a BHI blood 
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plate, prior to DNA extraction and sequencing.  This result of the colony not 
fluorescing when growing on a RODAC plate has not been documented prior to 
this study; no other groups have reported the colony morphology of C. difficile 
differing depending on how the media on the plate was exposed to the bacterium, 
in particular when collected and recovered from the environment.  Based on these 
results, positive samples of C. difficile were identified from the environment, as 
classification via colony morphology became more accurate.  Furthermore, upon 
sub-culturing the chosen colony from sample 56* onto a BHI blood plate, the 
characteristic C. difficile odour was detected, though this was not found on the 
RODAC plate (Fordtran 2006).  There have been no prior publications suggesting a 
difference in the odour of C. difficile when comparing samples recovered via a 
RODAC plate and with direct culture application onto a BHI blood plate. 
Bacterial 16S sequencing therefore proved to be a robust, efficient means of 
identifying the unknown organisms growing on the plates collected from hospital 
sampling as conclusive results were obtained from all samples.  Furthermore, the 
level of confirmation for all organisms was above the accepted thresholds in terms 
of percentage identity.  It also showed the medium CDMN is capable of recovering 
facultative anaerobes, which are able to tolerate the conditions optimal for C. 
difficile growth.  The identification of the colony morphology C. difficile presents 
with when recovered from direct contact on CDMN agar prepared in RODAC plates 
had been recorded (Figure 3.4).  This was then used as the definitive description 
following subsequent sampling episodes to identify C. difficile recovery.  Strain 
analysis of the four C. difficile-positive isolates from this sampling campaign 
confirmed the samples as ribotype 027. 
Due to the lack of C. difficile isolates recovered from the first sampling 
campaign in combination with the findings from the previous chapter in this thesis 
(Chapter 2), it was decided that all five media explored would be prepared in 
RODAC plates and used for a second round of sampling.  In addition to this, the 
location of C. difficile sampling was changed to a C. difficile isolation ward.  The 
motivation for this was to increase the chances of recovering the bacterium.   
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Furthermore, literature suggested that C. difficile-infected patients inhabit 
rooms that can recover from between 9-59% C. difficile isolates (Barbut et al. 
2009).  This is in comparison up to 8% C. difficile contamination recorded from 
rooms where no C. difficile had been reported, either through infection or 
colonisation (Kim et al. 1981).  However, this could be due to aerosolisation of 
spores and subsequent settling over time, as the authors report C. difficile spores 
are capable of persisting on surfaces for up to five months. 
Patients testing positive for C. difficile following a toxin test were isolated in 
side rooms in the LRI ward.  An increased probability of picking up these spores 
from sites within the isolation ward and subsequent germination was expected.  
Two side rooms as well as a shared toilet area were selected for sampling.  The 
disposal area for patient bedpans, the sluice, was also sampled with these media 
prepared in RODAC plates.  In order to ascertain how successful ChlorClean and 
routine cleaning of these side rooms were, the isolation rooms were sampled both 
before and after a daily standard clean. 
Data previously obtained in this project with respect to the pick-up and 
germination of C. difficile spores following damage by ChlorClean identified the 
non-selective media FAA and GS-BHI as the most successful.  It is possible the 
incorporation of antibiotics in the media CCEY, CDMN, and CCAB resulted in an 
additional stress against spores damaged by exposure to the cleaning agent. 
Following incubation, it quickly became apparent that the non-selective 
media, FAA and GS-BHI agar, did not discriminate bacterial pickup, recovering 
overall bacterial counts ranging from zero to 498, many of which were not 
identified as C. difficile or C. difficile-like.  The selective C. difficile media exhibited 
perhaps more selectivity than predicted with RODAC plates prepared with CCEY 
recovering up to five colonies.  This could also be attributed to the antibiotic-
containing media affecting the selection pressure against less viable spores, 
affecting the germination into vegetative cells and colony formation.  Differences 
in susceptibility to antibiotics with species of Listeria have been observed.  
Changing the temperature at which the antibiotic-containing agars are incubated 
has been shown to affect selectivity (Curtis et al. 1989).  Although it is not 
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suggested that the incubation temperature would have affected the growth of C. 
difficile in this study, it could be inferred that the addition of antibiotics has had 
some effect on the number of colonies present on a RODAC plate following 
sampling. 
The overall recovery numbers from the RODAC plates were somewhat 
lower than expected, however.  This was based on the success rates reported in 
literature by the research groups who had previously utilised these agar media, 
which range from 12% to up to 90% C. difficile recovery (Table 1.1) (Kamiya et al. 
1989; Martirosian et al. 2005; Alfa et al. 2008; Shapey et al. 2008; Wheeldon et al. 
2008).  Electing an isolation ward was based on the prospect of a site heavily 
contaminated with C. difficile, which would be seemingly easier to recover from 
and therefore culture for strain identification.   
Prior to IMS washing, GS-BHI agar led to the recovery of the highest 
number of C. difficile-positive samples with the RODAC plates directly contacting 
the surfaces in this sampling campaign (n=3).  This was equal to CCEY, the agar 
concluded overall as the most selective following the results from Chapter 2 of this 
thesis.  The results from this chapter also demonstrated CDMN and CCAB 
recovered the same number of positive samples of C. difficile, which was also seen 
with this campaign (n=2).  Despite the ability of FAA to recover 32.7% of C. difficile 
spores in the laboratory tests following chemical damage with sub-lethal 
concentrations of ChlorClean, this success did not translate well with use in the 
hospital environment (n=1).  Nevertheless, FAA was the only agar to pick up all of 
the different ribotypes found when conducting this sampling campaign. 
Only 3/25 C. difficile isolates were identified with the use of CCFA broth.  All 
25 were found with RODAC plates and the other means of resuscitation.  This lack 
of selectivity with the enrichment broth is not concurrent with previous findings in 
literature (Riley et al. 1987; Arroyo et al. 2005; Thitaram et al. 2011).  Riley et al. 
(1987) reported that the use of an alcohol shock technique (9.6%) in the isolation 
of C. difficile was twice as efficient as attempting to directly culture following 
sampling (5.5%), whilst a selective enrichment broth was three times more 
successful (14.2%) in the resuscitation of C. difficile (n=218).  Reports of 15.9% 
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(n=345) C. difficile with an enrichment broth (cycloserine-cefoxitin fructose broth 
supplemented with 0.1% sodium taurocholate) were also stated by Thitaram et al. 
(2011).  The same broth was used by Arroyo et al. (2005), with a 94% isolation 
rate.  It is noteworthy, however, that all of these studies were based on the 
recovery of C. difficile from faecal specimens whereas the use of this technique 
within this chapter was from damaged and stressed spores isolated from the 
environment.  The use of an enrichment broth was suggested only when fewer C. 
difficile spores were expected to be present, reporting a frequent over-growth of 
other microorganisms (O’Farrell et al. 1984). 
Based on the difficulties encountered with the identification of individual C. 
difficile colonies on RODAC plates containing other bacterial growth, sometimes 
over-run with contamination, the method of C. difficile selection and recovery was 
modified.  Personal experience and literature demonstrated that with faecal 
samples it is essential to use an alcohol shock to ensure only C. difficile spores 
survive and are isolated from within the plethora of organisms (Borriello & 
Honour 1981; Riley et al. 1987; Clabots et al. 1989).  Therefore, this notion was 
applied to the environmental isolates.  Each RODAC plate was washed with IMS to 
induce an alcohol shock and, theoretically, kill any other bacterial cells that had 
grown on the surfaces of the plates.  This led to an increase in the numbers of 
samples testing positive with C. difficile and would therefore be advisable as a 
technique to be used after sampling with RODAC plates.  This practice has been 
previously reported with environmental sampling and also demonstrated as a 
necessary step in isolation in this thesis (Kaatz et al. 1988; al Saif & Brazier 1996; 
Alfa et al. 2008). 
The agar media used in the resuscitation of C. difficile after IMS washing 
were selected because of its use in laboratory culturing of C. difficile (CCEY and BHI 
blood), or its success in recovery identified in this thesis (Chapter 2 and this 
chapter) (FAA and GS-BHI).  The number of positive C. difficile cultures obtained 
from RODAC plates prepared with GS-BHI agar increased from three to nine, and 
for FAA this was one to nine.  This supports the previous findings that the non-
selective agars are more successful at the pick-up and germination of C. difficile 
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spores.  Lysozyme has been shown to significantly increase the recovery of C. 
difficile when integrated into a selective medium which contains bile salts (Wilcox 
et al. 2000).  Although not selective media, FAA and GS-BHI agar did contain 
sodium taurocholate.  It has been well documented that the incorporation of this 
bile salt into C. difficile media has the effect of increasing the proportion of C. 
difficile spores germinating into CFU up to 1.7-log10 higher (Wilson et al. 1982).  
Therefore, it could be possible to attribute the increase in recovery to the presence 
of germination agents within the agars, enabling the spores to thrive and complete 
their growth cycle.  
The additional step of IMS washing also helped increase the number of 
positive samples obtained from CDMN prepared RODAC plates from two to five.  
This result shows the effects of incorporating this alcohol shock can extend to 
selective media as well as non-selective.  It has been reported that the 
incorporation of such a shock results in the reduction of competing flora, allowing 
C. difficile to be isolated somewhat easier (Brazier 1998).  However, with the 
media CCEY and CCAB, the washing of the colonies with IMS did not induce any 
more C. difficile positive cultures, and so the numbers of samples remained 
unchanged.  These two media recovered far fewer overall bacterial counts; for 
example, a RODAC plate used to sample the floor entrance in the second side room 
with CCEY recovered only one colony, which was confirmed as C. difficile.  It could 
be inferred that the selectivity of the antibiotics was successful in that no other 
bacteria were able to proliferate on the surface of this particular RODAC plate. 
The data from this study also identified that there were differences in the 
ability of an agar to resuscitate C. difficile following the IMS wash step.  CCEY agar 
was the most successful with respect to colony formation and enabling C. difficile 
growth.  Fourteen samples grew on CCEY agar from the original 42 RODAC plates 
used for sampling.  This medium is used for the isolation of C. difficile from faecal 
specimens, specifically selective of C. difficile over other clostridial species.  This 
study has demonstrated that this selectivity extends to samples obtained 
environmentally.   
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The media FAA and BHI blood agar recovered twelve and eleven C. difficile 
samples, respectively.  The lack of selective agents in these two agars meant that 
these results were relatively unexpected.  BHI blood agar possesses no selective or 
germination agents to propagate C. difficile from the IMS shocked cultures.  The 
main use of this agar is in the identification of C. difficile in diagnostic testing and in 
the maintaining of samples through sub-culturing. 
GS-BHI agar recovered the highest number of positive samples from the 
RODAC plates; eight samples spread post-sampling onto this medium isolated C. 
difficile.  It is therefore possible that this medium is less able to resuscitate C. 
difficile spores, but more successful in initially picking-up the spores from a 
surface and germinating them, as seen in the previous chapter of this work.   
All five media used for this sampling campaign recovered ribotype 103.  
Little knowledge exists in literature on this particular strain; it does not appear to 
be clinically relevant or dominant in UK hospitals.  This makes its presence 
particularly noteworthy.  The spread of this ribotype in all sites sampled could be 
attributed to the dissemination or transfer by healthcare and/or cleaning staff 
between rooms, particularly since patients present in these side rooms are usually 
rendered immobile.  In addition to this, there were few occurrences of ribotype 
027 recovered from this sampling campaign, despite it featuring heavily in 
literature as a problematic strain (Roberts et al. 2008; Dawson et al. 2011; Health 
Protection Agency 2012).  Localised within the sluice area, this shows that either 
the media were unable to pick up and germinate the C. difficile spores of this type 
or it was not present within the side rooms or toilet at the time of sampling.  This 
could also explain the presence of ribotype 081 in the sluice alone.  
Conducting the routine cleaning procedure evidently has an effect on the 
presence of ribotype 010; found in both side rooms before cleaning, but in neither 
after.  This non-toxigenic strain has been reported in pigs, cats and dogs (Terhes et 
al. 2006; Keel et al. 2007; Koene et al. 2011).  It accounted for 0.04% of the C. 
difficile-positive samples submitted for ribotyping to the HPA during the period of 
2007/2008 (Health Protection Agency 2008).  A recent report proposes the spread 
of C. difficile cannot be accredited entirely to contact with infected patients 
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(Walker et al. 2012).  This group interestingly discovered that even with 
consenting to the persistence of ward contamination after the discharge of a C. 
difficile-positive patient, there was no increase in the infection rates. 
From this sampling campaign, there was a distinct lack of positive samples 
obtained, both before and after the enrichment stage.  Although, the incorporation 
of the enrichment aided in increasing the total number of positive samples, the 
overall number of RODAC plates that successfully recovered at least one viable C. 
difficile colony was too low for meaningful statistical analyses to be performed. 
The RODAC plates were not IMS washed immediately following the 
sampling.  Having attempted to identify the maximum potential C. difficile colonies, 
the plates were individually sealed and refrigerated to restrict further bacterial 
growth.  A common method for preservation of faecal samples before isolation of 
the bacterium is storage at 4°C (Freeman & Wilcox 2003).  It is possible, however, 
that the spores present in a faecal sample differ from those recovered 
environmentally in situations such as these, in which the spores have been 
exposed to more stresses, and storage at this temperature could be another 
potential stress.  
Little has been found as to the mechanisms of how C. difficile spores react 
when exposed to stresses, but studies have been carried out into such effects on 
Bacillus subtilis.  The effect of hypochlorite or other such agents are capable of 
rendering spores defective and incapable of successful germination because of the 
damage these agents cause to the inner membrane of the spores (Young & Setlow 
2003; Fawley et al. 2007).  Evidence has also shown that germinant receptors can 
be distressed and therefore damaged.  Comparisons are often drawn between C. 
difficile and Bacillus subtilis spores due to the homology of their genes; Bacillus 
subtilis germination has also been well studied (Paredes-Sabja et al. 2011). 
This particular method of sampling in an attempt to gauge the presence of C. 
difficile and the distribution of ribotypes was not as successful as anticipated.  This 
was based upon previous studies reporting success in the recovery of C. difficile 
spores (Kamiya et al. 1989; Martirosian et al. 2005; Alfa et al. 2008; Shapey et al. 
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2008; Wheeldon et al. 2008).  Further development into the sampling technique 
employed would be required to maximise the number of samples recovered.  
Additionally, resuscitation methods following sampling also required optimisation.  
This consequently effected the resuscitation of the damaged spores themselves.  
The findings from this section have demonstrated there may be further work in 
manipulating and modifying the media used to resuscitate C. difficile.   
From the results obtained from the previous two rounds of environmental 
sampling, and the lack of recovered C. difficile, a further third campaign was 
conducted, with a different technique.  The main restriction identified with the use 
of a RODAC plate is the maximum area that can be sampled.  The probability of 
recovering C. difficile from a site is therefore reduced with a smaller sampling area.  
Therefore, expanding this site would potentially increase the proportion of C. 
difficile-positive samples recovered, if the bacterium is indeed present.  
Subsequently, alternate methods for sampling were explored and the use of pre-
moistened sponges in the same C. difficile isolation ward was chosen.  This would 
allow for coverage of a greater surface area as well as more ‘hard to sample’ and 
rounded-edged areas with a RODAC plate (Otter et al. 2009).  It was still assumed 
that sampling in the isolation ward would recover the highest number of positive 
samples. 
Following this sampling campaign, all fifteen sponges were individually 
homogenised before being alcohol shocked and then plated onto the surfaces of 
the non-selective top layers.  Samples were spread on solid agar rather than 
immersing cultures in the non-selective agar in its molten forms and subsequently 
poured onto the antibiotic-containing media to reduce the possibility of any 
further sub-lethal damage to the spores and cells.  The alcohol shock was thought 
to illicit enough injury to the other bacterial contamination.   
Of the sponges used in the sampling campaign, C. difficile was successfully 
isolated from 66.7% (n=15).  Use of pre-moistened sponges such as those applied 
in this work, previously produced C. difficile from 27% samples collected over six 
healthcare facilities (Dubberke et al. 2007).  The recovery recorded was 28% for 
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Otter et al. (2009) following hydrogen peroxide vapour treatment of the sampling 
sites. 
The layering of two different media, an antibiotic-containing base with a 
non-selective top media, has been employed in the food industry (Wu 2008).  Wu 
(2008) suggested the presence of a thin layer of non-selective agar (5 ml) over 
antibiotic-containing media (14 ml) aids in the bacterial growth, demonstrating 
success with Escherichia coli O157:H7, Listeria monocytogenes, Salmonella 
typhimurium, Staphylococcus aureus, and Yersinia enterocolitica (Wu et al. 2001).  
Duan et al. (2006) also reported overlaying an equal volume of 10 ml non-selective 
medium over a selective medium was an effective alternative method for recovery 
of bacteria.   
The five different media (CCAB, CCEY, CDMN, FAA, and GS-BHI) which have 
been used throughout these studies, were combined to produce a range of layered 
agars (Table 3.2).  The use of a layered media tempers the stress that antibiotics 
may impose directly.  The damaged cells are able to survive and grow, germinating 
due to the presence of sodium taurocholate in the lower layer, when incubated 
(Wilson et al. 1982; Buggy et al. 1985).  The supply of nutrients and antibiotics 
from the base layer would interact with the cultured cells to resuscitate 
microorganisms, in this case, C. difficile.  The antibiotics are thought to also inhibit 
the formation of colonies not C. difficile, as suggested with findings from other 
bacteria (Kang & Fung 2000; Wu et al. 2001; Wu & Fung 2003).  This aids in the 
resuscitation of weaker spores from hostile environments, as exhibited in the 
hospitals, such as from cleaning products and an aerobic setting.  The use of this 
layering technique is expected to be significant as the combination of the two 
media acts to allow those damaged spores present on the surface of a sampling site 
to be detected.  Ordinarily, these may not have necessarily been successful in full 
germination to cells if selection pressures from antibiotic use in the media alone 
resulted in inhibition.  The presence of the non-selective media and allowing the 
samples to be exposed to this first would have theoretically permitted the cell 
growth before selection can be applied. 
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In this study, not only was a thin layer of non-selective media used over an 
antibiotic-containing preparation, but the inverse with a thicker layer, as well as 
equal volumes of both.  No conclusive evidence was produced with the samples of 
C. difficile collected in this study to indicate a particular ratio was important in 
ensuring recovery of the bacterium.  The numbers of positive samples recovered  
were also too low to warrant conducting statistical testing.  This work in isolation 
is not sufficient to conclude the success of layering media in C. difficile recovery, 
however, the scarcity of studies pertaining to the optimisation of C. difficile 
resuscitation from environmental isolates suggests this is a potential area for 
further investigation.  Nevertheless, there may be a link in the proportions of 
antibiotic concentrations required.  The positive isolates recovered indicate the 
spores can be resuscitated with this layering media technique.  However, 
experimental work in the laboratory exposing known concentrations of cultures to 
the surfaces of these agar media may provide an insight into the specifications 
required for conclusive results. 
The selection of the C. difficile isolation ward for sampling was for the same 
reason as with the second campaign: to maximise the chances of recovering the 
bacterium.  Attempting to pick up C. difficile in a ward where the patients have 
been previously tested positive for the bacterium and are under-going treatment 
for its disease would suggest that the sites themselves would be at higher risk of 
contamination (Kim et al. 1981; Barbut et al. 2009).  Exposures of the sites 
following diarrhoeal incidents results in aerosolised spores and therefore the 
presence of C. difficile (Roberts et al. 2008). 
The work in this study identified the presence of ribotype 027 within 
hospital wards, amongst other strains, albeit non-epidemic strains.  Environmental 
sampling by Shapey et al. (2008) identified the prevalence of ribotypes 001, 027 
and 106, as well as 16 other strains.  Rotimi et al. (2003) reported the isolation of C. 
difficile from Kuwaiti hospitals: ribotype 078 from one hospital site alone, while 
ribotype 097, an infrequently reported strain, was restricted to another.  Many 
authors, however, fail to report the identity of ribotypes isolated from such studies, 
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providing only the total number of successful samples collected (Barbut et al. 2009; 
Otter et al. 2009).  This hinders any comparisons that can be drawn with this work. 
The presence of ribotype 027 throughout all the sampled side rooms either 
would suggest the transfer of strains or perhaps suggests the general strain 
abundance.  Comparing the ribotypes from the patients to their individual side 
rooms could suggest that regardless of potential strain transfer by hospital, clinical 
or cleaning staff, the patients themselves were carrying this ribotype prior to 
admission.  As described above with the second sampling campaign, many of the 
patients present in the side rooms sampled were immobile and were not 
permitted to move from room to room if able enough.  The faecal samples analysed 
from the patients present in the rooms were all obtained before the admission into 
the C. difficile isolation ward.  The infection had already been contracted.  The 
contamination of ribotype 027 in the rooms could well have been from the current 
patients residing.  This is supported by a report by Hota (2004), which suggested a 
link exists between strains infecting a patient and those within the surrounding 
environment. 
Comparing the ribotype distribution obtained from the two sampling 
campaigns conducted in the C. difficile isolation ward in the LRI, only a small 
proportion of ribotype 027 was identified from the second sampling campaign.  
This contrasts with all of the samples from the third campaign, confirmed as 027.  
A method that can be used for further contextualisation of strains to a more 
discriminatory level than a ribotype is MLVA typing (van den Berg et al. 2007).  
This technique would provide information as to whether the same MLVA type of 
the ribotype 027 strain was being carried by the patient and present in their 
surroundings, as identified in the third campaign, or perhaps that the repeated 
reports of ribotype 027 and its underlying presence within healthcare facilities is 
responsible for its detection from each room investigated.   
Despite this, it is possible for more than one ribotype to reside within a 
given site; the second sampling campaign demonstrated the presence of multiple 
strains in one enclosed room, however, the sponges recovered only one type per 
room.  Although, the total number of samples collected differs between the two 
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studies, 15 samples were collected with the pre-moistened sponges and 42 from 
the RODAC plates, the proportion of positive samples identified from the sponges 
was greater.  This suggests further advantage of the sponge technique for C. 
difficile pick-up over the use of RODAC plates in addition to the aforementioned 
surface area sampled. 
The initial sampling campaign conducted within this chapter was designed 
to identify whether a difference in the recovery of C. difficile is affected with the 
use of a deep clean with hydrogen peroxide.  Issues with the identification of C. 
difficile, in addition to the disadvantage of utilising only one RODAC plate per site 
sampled proved problematic.  The results from this chapter have identified the use 
of agar media within RODAC plates may not be ideal, however, optimisation of the 
layering of media in combination with the use of pre-moistened sponges has 
suggested a potential avenue in the selection and isolation of environmental C. 
difficile. 
In the previous chapter of this thesis, RODAC plates were utilised for the 
pick-up of one strain of C. difficile from an area where the spores had been applied 
and therefore its presence was known.  In addition to this, the spores were 
stressed with only one factor, a germicide.  With environmental recovery of C. 
difficile, there are a number of stresses exerted onto the spores, such as desiccation, 
disinfectants, and more importantly, aerobic conditions.  The findings from this 
chapter have demonstrated that regardless of these additional pressures, a range 
of ribotypes were able to tolerate these stresses.  This therefore suggests that 
further work is required to investigate the different strains present within the 
healthcare facilities and methodologies into their eradication, as investigated in 
Chapters 4 and 5.  
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3.5 Conclusions 
 RODAC plates prepared with different media were placed in ‘high’ 
and ‘low’ contact sites.  Temporal patterns were observed with 
respect to bacterial contamination over time.   
 The C. difficile medium, CDMN, was not as selective as expected 
and so techniques to germinate and isolate the bacterium were 
necessary.  Bacterial 16S sequencing was identified as a key tool 
in differentiating between species recovered from environmental 
sampling. 
 Five C. difficile media were used in recovery from two isolation 
rooms before and after routine cleaning, in addition to a shared 
toilet area and sluice (47.6% C. difficile-positive sites). 
 Fewer positive cultures were identified post-clean, indicating a 
reduction in spore viability with the use of ChlorClean, as 
supported in literature. 
 Different ribotypes were found to reside within a single patient 
isolation room.   
 The importance of IMS washing and/or alcohol shocking to 
inhibit other microbial flora from environmental isolates was 
highlighted.  This increased the number of positive samples 
isolated from the sampling campaigns. 
 Sampling with sponges was the most successful in terms of C. 
difficile recovery (66.7% C. difficile-positive samples).  
Investigations into layering of non-selective media over 
antibiotic-containing agar were inconclusive, although a link in 
proportions is suspected.   
 Ribotype 027 was identified in both patient faecal samples and 
the surrounding isolation rooms, indicating potential patient-
environment contamination.  
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3.6 Appendix 
 
 
Figure 3.11: Map of a bed in the UHL Trust.  
Areas identified show where sampling occurred with Campaign 1.  Sampling Campaigns 2 and 3 were conducted in 
isolation rooms, as such, with the addition of a personal sink.  Image by Pawel Wolyniec. 
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Figure 3.12: Map of the LGH ward sampled in Campaign 1.   
Numbers indicate notation for plate identification.  Image by Pawel Wolyniec. 
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Figure 3.13: Map of the LRI ward sampled in Campaign 1. 
Numbers indicate notation for plate identification.  Image by Pawel Wolyniec. 
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Sample Genbank ID Full Species Identity 
6 FJ357583.1 
Staphylococcus epidermidis strain BBEN-01d 16S 
ribosomal RNA gene, partial sequence 1432 bp 
7 EU419922.1 
Staphylococcus epidermidis strain RW35 16S 
ribosomal RNA gene, partial sequence 
28a AP006716.1 
Staphylococcus haemolyticus JCSC1435 DNA, 
complete genome 2685015 bp 
31 EU162006.1 
Staphylococcus saprophyticus isolate PGO16 16S 
ribosomal RNA gene, partial sequence 1196 bp 
56* AM180355.1 Clostridium difficile 630 complete genome 
G2 EU162006.1 
Staphylococcus saprophyticus isolate PGO16 16S 
ribosomal RNA gene, partial sequence 1150 bp 
G8 FJ749756.1 
Enterococcus faecium strain IMAU60025 16S 
ribosomal RNA gene, partial sequence 1434 bp 
G9 FJ613561.1 
Staphylococcus epidermidis strain EIV-3 16S 
ribosomal RNA gene, partial sequence 
G22 AE015929.1 
Staphylococcus epidermidis ATCC 12228, 
complete genome 
G23 FJ844987.1 
Lactobacillus fermentum strain IMAU20081 16S 
ribosomal RNA gene, partial sequence 
G31 FJ357583.1 
Staphylococcus epidermidis strain BBEN-01d 16S 
ribosomal RNA gene, partial sequence 1440 bp 
G32 FJ613572.1 
Staphylococcus epidermidis strain EIV-14 16S 
ribosomal RNA gene, partial sequence 1190 bp 
Table 3.6: Full species information following bacterial 16S sequencing of isolates collected in Campaign 1.
 
 
Chapter 4. Distribution of C. difficile 
PCR Ribotypes in an NHS Trust 
  
Chapter 4. Distribution of C. difficile PCR Ribotypes in an NHS Trust 
 
120 
 
4.1 Introduction 
Several methods have been developed in order to contextualise and 
categorise the different sub-types of C. difficile.  These include multi-locus 
sequence typing, multi-locus variable-number tandem-repeat analysis, pulsed-
field gel electrophoresis, restriction endonuclease analysis, amplified fragment 
length polymorphism and surface layer protein A gene sequence typing (Killgore 
et al. 2008).  Of the possible approaches, PCR ribotyping is the most commonly 
used in the UK and Europe (Kuijper et al. 2007; Bauer et al. 2011).  This technique 
targets the 16S and 23S rRNA interspacer regions of the bacterial gene with 
specific primers (Brazier 2001).   A ribotype is assigned according to the number 
of copies of this gene and their sizes which range from 250 to 600 bp (Stubbs et al. 
1999).  It has been reported that there are over 430 recognised official ribotypes 
(W Fawley, 2012, pers. comm., 20 Mar). 
Different ribotypes of C. difficile exhibit different phenotypes, with respect 
to virulence factors, toxin production, and susceptibility to antibiotics, amongst 
others.  The differentiation of bacterial strains is important as it can also identify 
the prominent in a sample cohort.  Routine monitoring of strains could aid in 
identifying which particular ribotypes are currently in the environment and 
therefore can be considered responsible for causing a disease outbreak.  It has 
been reported that ribotype 027, the most commonly isolated ribotype of C. 
difficile worldwide, causes a higher level of disease severity than any other 
ribotype (McDonald et al. 2005; O’Connor et al. 2009).  Different research groups 
have debated this, but what is certain is its dominance.   
Traditionally, PCR products from ribotyping are separated on a high-
resolution agarose gel, and the sizes of the bands are estimated with gel analysis 
software, with size standards used as markers.  The separation of DNA can differ 
between gels which leads to the analysis of sizes of bands being subjective (Zaiss 
et al. 2009).  Recently, capillary gel-based PCR ribotyping electrophoresis has been 
used by research groups as well as the HPA in the UK (Indra et al. 2008; Wei et al. 
2011; Xiao et al. 2012).  This incorporates a fluorescent primer in the PCR mixture 
and a fluorescent standard marker for each sample.  Computer outputs in the form 
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of chromatograms have peaks corresponding to fragment sizes allowing greater 
precision and enabling standardisation of strains between laboratories (Indra et al. 
2008).  
Data on the PCR ribotypes identified within a Trust or a healthcare facility 
are not routinely collected in the UK.  This is due to time and costs which arise 
from the isolation and culturing of the bacterium.  However, collating such 
information would make for a discriminatory dataset, which would in turn provide 
the framework to enable further understanding of the disease epidemiology.  
Currently in the UK, the HPA has a programme in place, which requires NHS Trusts 
to disclose the number of C. difficile-positive patients.  The HPA also conduct 
mandatory surveillance of C. difficile infection rates and routinely release these 
data (Health Protection Agency 2008).  Specific subsets of samples are sent to the 
HPA following periods of increased incidences or outbreaks, for example, and are 
all ribotyped to produce an overview of strains present in the regions of the UK.  
The data have shown that since the start of the scheme, ribotypes 002, 015, and 
078 have become more abundant over the periods 2007/8.  They then gained even 
greater prominence in subsequent years (Health Protection Agency 2012). 
4.1.1 Aim of this study 
In this section of the thesis, a robust method for PCR ribotyping was 
established.  The specific aim was to investigate the ribotypes present within an 
NHS Trust over a period, to determine their abundance, and their geographical 
locations, with respect to hospital or within community sites.  The work presented 
in this chapter is from two different sampling cohorts.  In the first study, faecal 
samples tested as C. difficile-positive in the UHL Trust over a four-month period 
with a reported increased incidence were characterised by ribotype (August to 
November 2009).  The method of C. difficile detection from faecal samples changed 
in January 2011 within the UHL Trust.  Specimens were therefore obtained both 
two months prior and following this enforced change to evaluate any patterns in 
the distribution of strains. 
The optimisation of PCR ribotyping was also imperative for addressing 
aims in other chapters of this thesis, in the investigation into the diversity of 
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strains collected from environmental sampling in hospitals (Chapter 3) and 
subsequently exposure of hydrogen peroxide to a range of strains (Chapter 5).   
The findings from this chapter aim to help better understand the C. difficile 
epidemiology within our local NHS Trust.  It will also show how more 
comprehensive studies can identify trends that may not be reported with the 
current practice of submitting only a proportion of patient faecal samples for 
strain analysis. 
  
Chapter 4. Distribution of C. difficile PCR Ribotypes in an NHS Trust 
 
123 
 
4.2 Materials and Methods 
4.2.1 C. difficile culturing on solid medium 
These are the solid media used for growth of C. difficile in a laboratory. 
4.2.1.1 Selective C. difficile medium 
CCEY agar: Prepared as directed and autoclaved at 121°C for 15 min.  Once 
cooled, 5% (v/v) egg yolk emulsion and an antibiotic mix of cycloserine (250 mg/l) 
and cefoxitin (8 mg/l) were added [all BioConnections, UK].   
This agar also known as Brazier’s Medium, was used to select for C. difficile 
from faecal specimens following an alcohol shock (Brazier 1993).  The use of egg 
yolk emulsion in media preparation is to aid in the detection of lecithinase and 
lipase enzymic activity.  Indicators of positive results of the enzymes are a shiny 
surface and a halo around colonies.  It has been documented however that C. 
difficile produces neither of these characteristics; the addition of the supplement 
proves useful with respect to confirmation and identification (Wilson et al. 1982). 
4.2.1.2 Non-selective C. difficile medium 
BHI blood agar: Prepared as directed from Brain-Heart Infusion and 1% 
Agar Bacteriological (Agar No. 1), prior to autoclaving as described above.  This 
was supplemented with 7% (v/v) defibrinated horse blood [all Oxoid Ltd., UK].   
This medium was used to confirm C. difficile presence and for diagnostic 
tests, as described by George et al. (1979).   
4.2.1.3 Preparation of agar plates 
Following preparation of the media, as described above, the agar was 
poured aseptically into 55 or 90 mm Petri dishes [Fisher Scientific Ltd., UK]. 
4.2.2 C. difficile culturing in liquid medium  
There were two different broths used to grow C. difficile cultures: BHI and 
FA broth [BioConnections, UK].  37 g of BHI broth or 22.8 g FA broth was dissolved 
in 1000 ml of ultra-pure water and autoclaved at 120°C for 15 min.  All liquid 
media were pre-reduced with overnight incubation in the anaerobic chamber.  
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4.2.3 PCR ribotyping 
PCR ribotyping is a method used to differentiate between C. difficile strains 
through the individual patterns produced from the 16S to 23S bacterial 
interspacer regions, and has been utilised throughout this project.  There has been 
evidence to show the dominance of particular ribotypes in a given geographical 
location, in addition to there being consistency between the strain possessed by a 
patient and their surrounding areas (Rotimi et al. 2003; Goorhuis et al. 2008; 
Cheknis et al. 2009).  Therefore, PCR ribotyping has been used in this work to 
contextualise faecal specimens as well as samples collected from hospital 
environments in other parts of this thesis to help understand what strains are 
being found in the UHL Trust.   
4.2.3.1 Faecal specimen collection 
The samples utilised in this study were collected by hospital or healthcare 
staff directly from patients possessing symptoms associated with C. difficile 
infection.  Following confirmation of C. difficile within the UHL Microbiology 
Laboratory [Leicester Royal Infirmary] using the diagnostic methods described 
below, the specimens were kindly donated for the use in this work. 
4.2.3.2 Methods for C. difficile detection in faecal samples 
From 2008 and 2010 in the UHL Trust, the method for confirming C. difficile 
was an ELISA-based assay [Techlab Inc., USA].  This detected the production of C. 
difficile specific toxins, enterotoxin (A) and/or cytotoxin (B), from diarrhoeal 
faecal samples.   
The method of detection changed in January 2011 to a GDH antigen 
detection assay [Techlab Inc., USA], which acts to screen out C. difficile-negative 
samples.  The GDH-positive specimens are then further analysed using a toxin EIA 
to detect the presence of toxins within the faecal sample.  Molecular methods are 
also used in the form of a PCR-based test (GeneXpert C. difficile assay) which tests 
for PCR ribotype 027 specifically through a series of signals [Cepheid, USA].   
All samples were selected based on whether the patient was over the age of 
2 years and had a loose stool.  All loose faecal samples obtained from patients aged 
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65 or over were subject to testing.  For faecal specimens positive for either toxin, 
aliquots were stored in sealed vials at 4°C aerobically.  This method of storage has 
been shown to have little effect on the viability of C. difficile spores and toxins 
(Freeman & Wilcox 2003).  Strains were isolated and stored in cryopreservation 
glycerol stocks at -80°C.  All samples were obtained from the three major hospitals 
in Leicester: LRI, LGH and GGH, as well as community sites, consisting 
predominantly of GP surgeries or other smaller healthcare facilities. 
4.2.3.3 C. difficile isolation and identification 
For the purpose of C. difficile isolation from patient samples, the protocol 
was the same regardless of which of the two above methods were used to confirm 
diagnosis. 
A faecal sample (1 g) was suspended in 1 ml IMS in the ratio 1:1, mixed via 
vortex using Vortex Genie 2 Shaker [Scientific Industries, USA] and left at room 
temperature for 30 min.  This selected viable C. difficile spores and eliminated 
potential growth of non-spore forming faecal organisms.  Using an inoculation loop, 
50-75 µl was then added to CCEY agar plates before incubating overnight at 37°C 
in the anaerobic chamber.  Single colonies were selected and plated out onto BHI 
blood agar plates.  These were then incubated overnight in the anaerobic chamber 
at 37°C. 
4.2.3.4 C. difficile propagation 
To confirm C. difficile presence on the BHI blood agar plates, characteristic 
tests were carried out; positive colonies should appear about 4-6 mm irregular in 
diameter with edges slightly fanning out, raised, opaque and whitish grey in colour.  
Under long-wave UV light (365 nm), a greenish-yellow colour is fluoresced (Figure 
4.1) (Brazier 1998).  When cultured, C. difficile samples also possess a 
characteristic horse manure odour.   
C. difficile-positive cultures were grown anaerobically overnight at 37°C in 
3 ml of pre-reduced FA broth.  Cultures were then sub-cultured in 8 ml BHI broth 
and incubated under previous conditions, or until the optical density (OD550) 
reached 0.8-1.0.  This was measured using a UV-Visible Spectrophotometer Model 
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6715 [Jenway, UK] set at a wavelength of 550 nm with cuvettes [Scientific 
Laboratory Supplies Ltd., UK]. 
 
Figure 4.1: C. difficile colonies on BHI blood agar. 
Colonies fluoresce a greenish-yellow colour under UV light.  Photograph by Dr Danish Malik. 
 
4.2.3.5 Chromosomal DNA extraction 
DNA extraction was modified from a standard protocol (Sambrook & 
Russell 2001).  Briefly, cells were centrifuged at 21,000 x g for 5 min at room 
temperature.  The pellet was washed with 0.1 x saline-sodium citrate buffer and 
centrifuged as before, then re-suspended in 0.8 ml of lysis buffer (10 mM Tris.Cl 
pH 8.0, 1 mM EDTA, 1% SDS and 0.2 mg proteinase K).  Cell pellets were incubated 
for 90 min at 37°C after which an equal volume of 4°C phenol:chloroform:isoamyl 
alcohol (25:24:1) was added for 2 min prior to centrifugation at 21,000 x g for 10 
min at 4°C.  The aqueous layer was recovered and the step repeated with an equal 
volume of chloroform:isoamyl alcohol (24:1).  The aqueous layer was again 
recovered and the DNA precipitated by adding 2 volumes of 4°C propan-2-ol and 
0.4 volume of 7.5 M ammonium acetate, then centrifuged at 21,000 x g for 30 min 
at 4°C.  The pellet was washed with 1 ml of 4°C 75% ethanol, centrifuged as before 
for 15 min then air-dried and re-suspended in 50 µl of Tris.HCl pH 8.5.  DNA 
quantity and quality was analysed using a NanoDrop ND-8000 spectrophotometer 
[ThermoScientific Ltd., UK]. 
4.2.3.6 PCR amplification 
PCR reactions of each sample were prepared as follows (50 µl): 200 µM 
dNTPs, 10 x reaction buffer with NH3, 1.5 mM MgCl2, and 0.5 U Taq polymerase [all 
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Bioline, UK], 0.5 µM of the 16S rRNA gene primer, fluorescently labelled with 
carboxyfluorescein (FAM) {5’-CTG GGG TGA AGT CGT AAC AAG G-3’} and 0.5 µM of 
the 23S rRNA gene primer {5’-GCG CCC TTT GTA GCT TGA CC-3’} [Applied 
Biosystems, UK and vhbio, UK, respectively] (Stubbs et al. 1999).  Template DNA 
(100 ng) was added.  Table 4.1 shows the conditions for C. difficile PCR ribotyping, 
amplified with a SensoQuest Gradient Thermal Cycler [Geneflow Ltd., UK]. 
Process Temperature (°C) Time (sec) Cycles 
Initialisation 94 360 1 
Denaturing 94 60 35 
Annealing 57 60 35 
Extension 72 60 35 
Further extension 72 420 1 
Table 4.1: PCR protocol for PCR ribotyping. 
 
4.2.3.7 Agarose gel-based PCR ribotyping 
PCR products were visualised under UV light after 3% agarose gel 
electrophoresis using Hi-Res super agarose [AGTC Bioproducts Ltd., UK] in TAE 
buffer containing 0.5 µg/ml ethidium bromide [Sigma-Aldrich, UK], and with 
reference to HyperLadder IV 100-1000 bp molecular weight markers [Bioline, UK].   
4.2.3.8 Capillary gel-based PCR ribotyping 
PCR fragments were run using an Applied Biosystems ABI 3730 genetic 
analyser by Protein Nucleic Acid Chemistry Laboratory [University of Leicester]. 
Briefly, a 20-1200 bp fluorescent GeneScan ladder was added to each 
sample prior to denaturation at 95°C for 2 min, storing on ice and analysed with 
the sequencer prepared with a 50 cm capillary, loaded with a POP7 gel.  The 
samples were injected with 1.6 kV over 15 sec with a total running time of 103 min 
at 8 kV run voltage [all Applied Biosystems, UK].   
4.2.3.9 Statistical analyses 
The sizes of the peaks from chromatograms following capillary PCR 
ribotyping were resolved using Peak Scanner v1.0 [Applied Biosystems, UK].  
Peaks that were at least 10% of the highest peak of the sample in question and 
between 250 and 650 bp were accepted as genuine fragments.  Minitab 16 
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[Minitab Inc., USA] was used to create graphical representations of these data and 
to perform subsequent statistical analyses.  Chi-squared defective tests were used 
to compare strain presence between cohorts.  Significance was set to P<0.05. 
4.2.3.10 C. difficile reference ribotypes 
Reference strains of C. difficile ribotypes 027 and 106 were kindly donated 
by Professor Anthony Hart, Royal Liverpool University Hospital, and PCR ribotype 
012 (CD 630) from Professor Neil Fairweather, Imperial College London.  
Confirmation of officially accepted ribotypes was carried out by Dr Warren Fawley 
and Professor Mark Wilcox, University of Leeds.   
4.2.4 Ethical issues 
Ethical approval was obtained for the ribotyping distribution studies 
conducted in this chapter.  All information regarding patient data was made 
anonymous prior to use.  
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4.3 Results 
4.3.1 Capillary gel-based PCR ribotyping compared with agarose gel-based  
Three reference strains (PCR ribotypes 012, 027, and 106) and a 
representative of each of the ribotypes identified in this study were analysed using 
both agarose gel-based and capillary-based electrophoreses techniques.  The 
ribotype profiles obtained matched to known profiles with both methods; there 
were similar numbers of DNA fragments and corresponding sizes (Figure 4.2 and 
Figure 4.3).  The capillary-based system was found to detect fragments that were 
difficult to differentiate on an agarose gel.  The capillary-based technique was 
investigated for its reproducibility with five isolates and three biological replicates 
each.  The data obtained were consistent in all cases with respect to fragment size, 
in bp and number.  The variations in fragment size recorded for an individual 
fragment ranged from 0.0-0.16 bp.  Therefore, the majority of samples from this 
study were PCR ribotyped using the capillary-based system only.  Representatives 
of each ribotype were sent to the CDRN reference laboratory [HPA, Leeds, UK] to 
assign them to their official designated nomenclature. 
 
Figure 4.2: Agarose gel-based electrophoresis image of C. difficile PCR ribotype profiles.   
Lane 1: PCR ribotype 012.  Lane 2: Unknown ribotype.  Lanes 3-5: PCR ribotype 106, NC11204, PCR ribotype 027.  
Lane 6: Faecal sample from study identified using the capillary-based system as ribotype 027. 
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Figure 4.3: Capillary-based outputs of reference PCR ribotypes.   
Peaks represent DNA fragments (base pairs), corresponding to bands which are visible on an agarose gel.  Peak 
intensity is shown as fluorescence.  Chromatograms correspond to the PCR ribotypes identified in Figure 4.2.  (a): PCR 
ribotype 012 (lane 1), (b): PCR ribotype 027 (lane 5), (c): PCR ribotype 106 (lane 3). 
 
4.3.2 Ribotype distribution between August to November 2009 
The aim of this study was to describe the genetic diversity observed within 
one NHS Trust with a ‘snapshot’ of ribotype distribution over a short period of 
time.  No previous studies have concentrated on a cohort of samples continuously 
collected over a fixed episode.  This unique study was carried out in an attempt to 
recognise any emerging trends in distribution or abundance. 
Faecal samples that appeared to be C. difficile-positive following an ELISA-
based test, detecting the presence of toxins A and/or B, were collected from all 
patients who presented with symptoms and/or a positive C. difficile test in the UHL 
Trust over a four-month period (August to November 2009).  This study aimed to 
establish the number of different ribotypes present within the UHL Trust and their 
relative abundance.  Samples were acquired from the three major hospitals in 
Leicester, and from community samples that were collected from care homes, 
smaller hospitals, or predominantly GP surgeries.  
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4.3.2.1 Strain collection and characterisation 
After significant effort, C. difficile was isolated from 203 of 215 toxin A/B-
positive faecal samples.  It is possible that the remaining twelve samples from 
which C. difficile was unable to be isolated from could have been false positives 
from the initial ELISA-based assay.  Of the 203 isolated that successfully grew C. 
difficile onto the selective CCEY agar plates, 187 could be sub-cultured onto the 
non-selective BHI blood agar plates.  From these, 181 samples grew when 
inoculated in BHI broth in preparation for the extraction of chromosomal DNA, as 
described in Section 4.2.3.5.  Good quality DNA was obtained from 179 samples, all 
of which were assigned a PCR ribotype; 83% of the original 215 faecal specimens.  
This has been reported as an acceptable success rate (Health Protection Agency 
2009). 
4.3.2.2 Ribotype prevalence 
Figure 4.4 shows the 11 different PCR ribotypes identified from the samples 
in this study.  The most prevalent was ribotype 027, with 63 samples.  There were 
four other frequently identified ribotypes: 014/020 (n=24), 002 (n=23), 015 (n=16) 
and 078 (n=15).  Other ribotypes were confirmed: 107 (n=12), 013 and 087 (n=7), 
005 (n=6), 026 (n=4), and 081 (n=2).   
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Figure 4.4: PCR ribotypes by month and site from the first cohort.   
Distribution of C. difficile ribotypes from UHL Trust between August and November 2009. 
 
4.3.2.3 Ribotype temporal diversity 
The relative proportions of ribotypes varied per month over the four-
month period of study (Figure 4.5).  For example, ribotype 107 was predominantly 
identified in October and November (P=0.020), and made up 15% of all the 
November isolates but none in August.  Ribotype 078, in contrast over this four-
month period, was found eight times in August but only three times in November 
(P=0.017). 
Ribotype 027 was identified as the most prevalent strain, occurring in all of 
the sampled months.  The apparent decrease in strain abundance by month was 
not statistically significant (P=0.057).  The other ribotypes in the study were 
consistently isolated over the four-month period.  The ribotype cluster 014/020 
was the second most dominant ribotype, isolated 6, 2, 8 and 8 times respectively; 
there were no significant changes in proportion with time (P=0.235).  
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Figure 4.5: PCR ribotypes by month from the first cohort.   
Distribution of C. difficile ribotypes from UHL Trust between August and November 2009. 
 
4.3.2.4 Ribotype spatial diversity 
Multiple ribotypes were found in all three major hospitals and in the 
community sites, with most ribotypes being distributed throughout the sites.  In 
the LRI, the 66 isolates represented 8 ribotypes, the 10 isolates from the GGH 
belonged to 4 ribotypes and the 49 from the LGH 10 ribotypes.  The 54 isolates 
from the community samples also grouped as 10 different ribotypes.  Despite the 
LRI accounting for the highest number of isolates recovered, there were fewer 
ribotypes present at this site than at the LGH.  There were consistently higher 
rates of ribotype 027 in the LRI than in other hospitals (P=0.031).  
Figure 4.6 illustrates the dominance of ribotype 027 in all three main 
hospitals despite its varying proportion for each site; 60%, 20% and 35% of the 
isolates were from the GGH, LGH and LRI, respectively (P=0.024).  The proportion 
of this strain within the samples obtained from the patients in the community was 
also high (44%).  The ribotype cluster 014/020 was predominantly isolated in the 
LRI and LGH (P=0.027), but was overall the next most abundant strain.  Ribotypes 
015 (P=0.698) and 078 (P=0.597) were distributed evenly throughout the sites, 
having been identified in all four sample sets. 
NovOctSepAug
50
40
30
20
10
0
N
u
m
b
e
r 
o
f 
O
c
c
u
rr
e
n
c
e
s
087
107
002
005
013
014/020
015
026
027
078
081
Chapter 4. Distribution of C. difficile PCR Ribotypes in an NHS Trust 
 
134 
 
Localisation of ribotypes was observed with particular sites.  PCR ribotype 
087 was found only in the LRI and from community samples (P=0.048), and 
ribotype 081 only in the LGH (P=0.147).  Despite not being dominant in any 
specific site, ribotype 107 was absent from the LRI (P=0.048).  This study did not 
identify any ribotypes that were exclusively identified in the community. 
 
Figure 4.6: PCR ribotypes by site from the first cohort.   
Distribution of C. difficile ribotypes from UHL Trust between August to November 2009. 
 
4.3.3 Ribotype distribution with changes in method of C. difficile diagnosis 
The motivation for this study was to determine if a change in the faecal 
detection method from the ELISA-based assay to the GDH and EIA-based test 
affects the proportion of C. difficile-positive samples and whether this in turn 
changes the ribotype distribution. 
For the second C. difficile PCR ribotyping study in this chapter, samples 
were collected from the UHL Trust and another study of four months investigating 
the diversity of C. difficile ribotypes was conducted.   
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4.3.3.1 Strain collection and characterisation  
Faecal samples were treated in the same manner as in the first cohort, 
isolating the bacterium prior to extracting the chromosomal DNA and assigning a 
PCR ribotype. 
As before, following significant effort, C. difficile was isolated from 162 of 
174 GDH- and PCR-positive faecal samples.  Once again, this could be attributed to 
false positives.  From 162 isolates which grew onto CCEY agar plates, 157 were 
then sub-cultured onto BHI blood agar plates.  From these, 142 samples were 
propagated when inoculated in BHI broth prior to the extraction of chromosomal 
DNA (Section 4.2.3.5).  Good quality DNA was obtained from 136 samples, before 
the assigning of a PCR ribotype; 78% of the original 174 faecal specimens.   
4.3.3.2 Ribotype prevalence  
The twenty-five individual PCR ribotypes found in the samples investigated 
in this study and the relative number of occurrences is shown below (Figure 4.7).  
There were frequently identified ribotypes: 014/020 (n=24), 015 and 027 (n=20), 
106 (n=15), 078 (n=13) and 005 (n=6).  Other ribotypes were found to a lesser 
extent.  One instance of an unknown ribotype was also found; this strain did not 
match any of the known PCR ribotypes within the CDRN database at the time of 
this study.  
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Figure 4.7: PCR ribotypes by month and site from the second cohort.   
Distribution of C. difficile ribotypes from UHL Trust from November to December 2010 (ELISA-based assay) and from 
February to March 2011 (GDH-based testing). 
 
4.3.3.3 Ribotype temporal diversity  
Before the change in diagnosis was enforced, the samples obtained in 
November and December amassed 11 and 9 different ribotypes, respectively.  
Following the change in methodology, which incorporated the GDH-based test, 17 
different ribotype profiles were identified in February and 15 in March.  The 
month following this change possessed the greatest variation in strains identified; 
seven different strains were found in the community-isolated samples, 2 in the 
GGH, 7 in the LGH and 14 from the LRI.  The proportions of PCR ribotypes 
successfully assigned for the samples obtained from each of the months were as 
follows: November (37/41), December (26/27), February (40/59) and March 
(33/47).  Therefore, in addition to the relative number of samples that were C. 
difficile-positive increasing in February and March, the relative proportion of 
samples that were assigned a PCR ribotype decreased. 
With respect to strain temporal distribution, five strains were recovered in 
both February and March, but these strains were not identified in either November 
or December (ribotypes 003, 009, 026, 035, and 103). 
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Figure 4.8: PCR ribotypes by month from the second cohort.   
Distribution of C. difficile ribotypes from UHL Trust from November to December 2010 (ELISA-based assay) and from 
February to March 2011 (GDH-based testing).   
 
Some ribotypes were found in one month only, with ribotypes 054, 057, 
081 and 258 found exclusively in November and 107 in December.  February was 
the only month in which ribotypes 031, 100 and an unknown strain of C. difficile 
were identified while ribotypes 017, 021, and 056 were isolated during March.  
Therefore, 11 of the 25 different ribotypes found in this cohort were exclusive to 
their respective months. 
However, certain strains were identified in all months of the study: 
ribotypes 005, 014/020, 015, 027, 078, and 106.  With the exception of 078, which 
has a significant difference between the months November and December 
(P=0.046), the proportions of each of these ribotypes are statistically significantly 
similar between months (P>0.05).  This suggests that certain strains of C. difficile 
are recovered consistently, irrespective of time.  For example, the proportions of 
ribotype 027 found in each month are significantly similar (P=0.777) and thus 
remaining constant between months.  The temporal patterns are shown in Figure 
4.8. 
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4.3.3.4 Ribotype spatial diversity 
The composition of ribotypes found in this study varied by site.  The 
numbers of ribotypes identified from the samples were as follows: community 
(35/44), GGH (5/9), LGH (33/46), and LRI (63/75).  Of the three major hospital 
sites, the LRI was the most diverse with 18 different ribotypes identified from 63 
isolates.  The other hospitals, the LGH and GGH, found 17 and 3 different ribotypes 
from 33 and 5 isolates, respectively.  The 35 isolates from community sites were 
classified into 13 ribotypes.  The spatial breakdown of ribotypes is shown in 
Figure 4.9.   
Of the four most dominant strains identified in this study, 014/020 (n=24), 
015 and 027 (n=20) and 106 (n=15), three of these were found at all sites.  The 
only exception was that ribotype 027 was not recovered at the GGH, but this is not 
a statistically significant result (P=0.204), and is likely due to the small sample size 
of the GGH.  These dominant strains were therefore recovered evenly across all 
sites with no noted patterns of diversity, and of the less frequent ribotypes, 005, 
014/020, 015, 078 and 106 were all found to have statistically significantly similar 
counts for all sites (P>0.05). 
Of the 25 different ribotypes found in this cohort, nine were localised in one 
site only.  The LRI was the only host to ribotypes 021, 056, 100 and Unknown, 
while the LGH was the only site from which ribotypes 003, 031, 054, 087 and 107 
were recovered.  Ribotype 017 was recovered from just community sites and not 
in the three major hospitals.  All ribotypes found within the GGH were observed at 
other sites, but again, this can be attributed to its sample size.  Furthermore, of 
these 10 ribotypes that were exclusive to their respective site, 7 were found 
exclusively in either February and/or March.   
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Figure 4.9: PCR ribotypes by site from the second cohort.   
Distribution of C. difficile ribotypes from the UHL Trust from November to December 2010 (ELISA-based assay) and 
from February to March 2011 (GDH-based testing).  ‘U’ – unknown ribotype.  
 
The largest hospital, the LRI, was dominated by ribotypes 027 (n=13), 106 
(n=10) and 014/020 and 015 (n=8).  This constitutes over half of the ribotype 027 
isolates and two-thirds of the 106 isolates from the entire cohort.  Statistically, 
however, the proportions of 027 (P=0.204) and 106 (P=0.288) show that these 
strains are not significantly distributed across all sites. 
4.3.3.5 Cases involving multiple samples per patient 
The samples obtained from this second cohort were analysed further by 
means of investigating the patients.  Of all the samples tested and assigned a PCR 
ribotype, thirteen patients presented with a positive C. difficile specimen more 
than once within the four-month period.  Seven of these had the samples collected 
from the same site and were found to be the same ribotype.   
Three of these seven patients were all positive with isolates from the LRI, 
with ribotype 106.  All of the patients had moved within the site between 
collections as the wards from which the specimens were collected differed.  The 
time between the collections of samples was either one, three or four weeks. 
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One patient was identified as C. difficile-positive at two different sites 
within the community (once in November and again in February).  On both 
occasions, the isolated strain was ribotype 078. 
A separate incident occurred with a community sample collected in 
December identified as 027 and then a second from the same patient in the LRI 
also identified as carrying the same strain months later in February. 
Finally, in December, one patient possessed ribotype 107 when in the LGH.  
Upon release and months later in February, the patient tested C. difficile-positive 
again within the community setting, for ribotype 035.  These strains have not been 
noted as serious, widespread strains. 
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4.4 Discussion 
The most common method for characterising C. difficile strains in the UK 
and Europe is PCR ribotyping.  It has become increasingly common when 
ribotyping to utilise a capillary-based gel electrophoresis method as it has been 
shown to reliably assign strains unambiguously and more accurately (Indra et al. 
2008; Janezic et al. 2011).  For the purpose of this work, this technique has been 
used throughout the thesis to characterise isolates collected directly from patients 
in addition to those obtained from sampling the environment.  
Surveys on PCR ribotype distribution and prevalence have been carried out 
across Europe.  These continent-wide studies allow the identification of major 
disease-causing strains, comprising of data from a number of different countries 
and mapping which ribotypes are problematic.  Continuous monitoring like this 
would eventually permit the movements of strains to be tracked.  The ECDIS 
(European Clostridium difficile infection study) has investigated C. difficile infection 
on such a scale (Barbut et al. 2007; Bauer et al. 2011).  Barbut et al. (2007) 
collected C. difficile-positive samples from 38 hospitals in 14 European countries 
over a two-month period.  Sixty-six different ribotypes were identified; the most 
prevalent overall were 001 (13%), 014 (9%) and 027 (6.2%).  Investigations like 
this highlight differences in abundance between countries too: ribotype 027 was 
far more abundant in countries such as the Netherlands (40%) and Belgium 
(31.4%) (Barbut et al. 2007).  Bauer et al. (2011) collected samples from 34 
countries, identifying 65 individual profiles; ribotypes 014/020 (16%), 001 (10%) 
and 078 (8%) were the most prevalent in this study.  These two reports have 
shown the importance of ribotyping to identify patterns in strain diversity.  In 
addition to this, they have ascertained although specific ribotypes may be 
dominant overall, relative ribotype composition varied with both country and time 
(Barbut et al. 2007; Bauer et al. 2011; Kachrimanidou & Malisiovas 2011). 
Despite PCR ribotyping being used in this study as well as others in 
determining C. difficile strain diversity, it is not a practice routinely carried out 
within all NHS Trusts.  This is due to the extensive labour, and limitations 
associated with finances and time that would be encountered for each C. difficile-
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positive sample.  The introduction of the CDRN has meant that a proportion of 
samples that are C. difficile-positive, in addition to those collected during an 
outbreak, must be submitted for strain identification.  These results are published 
online quarterly, identifying important trends in ribotype distribution and 
prevalence within England and Northern Ireland.  It permits an overall monitoring 
of ribotypes from the start of the study in 2007, allowing in depth analyses into 
strains such as ribotypes 002, 015, and 078.  These three strains have increased in 
abundance over the period of 2007/8, and even more so in 2008/9 and 2009/10 
(Health Protection Agency 2011).  Despite the increasing emergence of these new 
C. difficile ribotypes the most prevalent ribotype in the UK, across Europe and in 
North America remains ribotype 027.  
From the first study, 83% of the samples in the cohort were assigned a PCR 
ribotype, and from the second, 78%.  It has been previously reported that with the 
failure rates of C. difficile detection tests and assays used on faecal samples to aid 
in the diagnosis of a patient, these recovery and ribotype rates are consistent and 
are acceptable values (Health Protection Agency 2009).   
Through the analysis of the data, there was a clear dominance of ribotype 
027 from August to November 2009 in the UHL Trust, accounting for 35% (n=179).  
These data show that although it is still abundant, its prominence in healthcare 
facilities is somewhat declining, making way for other ribotypes to emerge as 
dominant strains (Health Protection Agency 2009; Hensgens et al. 2009).  It has 
been suggested that the success of this strain in the hospital environment and 
environment is due to its ability to persist in these sites, despite changes in 
cleaning techniques (Best et al. 2010).  
Other ribotypes found in this cohort were the ribotype cluster 014/020, 
grouped together due to their similarity both genetically and when run with 
agarose gel-based electrophoresis (Janezic et al. 2012).  This was also abundant in 
two of the tested hospital sites (LGH and LRI), and its increasing prominence is 
also consistent with the national data available from the HPA (Health Protection 
Agency 2009).  
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Another nationally emerging strain is 078.  This strain was identified in all 
of the three hospitals, as well as the community, in this study.  Originally isolated 
from porcine and bovine sources, ribotype 078 has been since reported in 
healthcare facilities, both in the UK and internationally (Goorhuis et al. 2008; 
Health Protection Agency 2009).  From this cohort, it was predominantly found in 
August.  In contrast to this, the little known ribotype 107 was identified as more 
abundant in the later months of the study in October and November. 
Several trends were recorded within the less abundant ribotypes.  Three 
ribotypes (002, 005, and 013) were not found in the GGH, although this could be 
due to the number of isolates from this site being low.  Ribotype 087 was identified 
exclusively in the LRI and within the community, which could suggest the potential 
of strain transfer between these environments.  It could be possible that these 
patients along with those with the ribotypes 014/020, 027, 078, and 107 
contracted C. difficile whilst hospital inpatients, before being discharged into the 
community, where they were later confirmed as C. difficile-positive.  Although 
there were only two ribotype 081 samples identified, these were from the LGH and 
both in August, which suggests strain transfer between patients.  The movement of 
strains may clarify why similar ribotypes are found in the hospital sites as well as 
the isolates from GP surgeries.  All strains identified from the community samples 
were also found from patients within at least one of the three main hospitals.  This 
finding reinforces the suggestion of strain transfer to the community following 
admission within the hospitals in the UHL Trust.   
The second study described in this chapter was carried out in November 
and December 2010 and February and March 2011.  This study set out to identify 
any patterns of PCR ribotype distribution with changes in the method of C. difficile 
detection from faecal samples.   
There was a clear difference noted in the number of profiles produced 
between the two methods, the initially utilised ELISA-based technique, and the 
subsequently established GDH-based and EIA-based assays.  The change was 
implemented in the UHL Trust in January 2011, and it has since been announced 
that the Department of Health require all NHS Trusts to change their method of C. 
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difficile detection (H Patel 2011, pers. comm., 14 Jan).  No previous studies have 
investigated the diversity in PCR ribotypes identified before and after 
implementing this change, which strengthens the novel nature of this work. 
A key reason for the implementation of a new technique was to improve 
diagnosis and subsequently deliver treatment that is more efficient.  There is 
currently no gold standard for C. difficile detection from faecal samples, and it has 
been reported that the most accurate procedure for identifying its presence is 
through culturing onto selective medium (Bartlett & Gerding 2008).  This can take 
a number of days and can be costly, and since these time and financial limitations 
exist, for the purposes of rapid diagnosis for healthcare workers and clinicians, a 
quick laboratory-based test is preferable.  The combination of the high sensitivity-
low specificity GDH-based assay, which targets for C. difficile itself, and the low 
sensitivity-high specificity EIA, detecting the presence of toxins within the faecal 
samples, aims to eliminate the possibility of false positive and negative results 
(Tenover et al. 2011). 
The data presented here show the numbers of samples recorded as C. 
difficile-positive increased following the change in methodology.  However, an 
increase in the number of samples failing to grow on both the selective and non-
selective plates when culturing was also observed.  Another finding from this 
study is the increase in diversity of ribotypes identified.  More strains were 
isolated from all of the sites investigated, including those less reported, such as 
ribotypes 035 and 054.  Despite the combination of sensitivity and specificity tests 
used, it is possible that the GDH-assay methodology of detecting C. difficile is 
identifying non-toxigenic strains.  This would explain the increase in less clinically 
relevant ribotypes.   
Some strains were present in all months of this study (005, 014*/020, 015*, 
027*, 078* and 106).  An asterisk (*) identifies one of the most prevalent strains in 
England (Health Protection Agency 2012).  Ribotypes 014/020, 015 and 106 were 
also identified in all three main hospitals in the UHL Trust as well as from the 
community samples.  Data from the HPA show that these dominant strains are 
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present nationwide, as well as within the UHL Trust, demonstrating consistency 
with results from this study. 
These national reports suggest the overall decrease of strains (014/020, 
023, and 027) and increase of others (002, 005, 015, and 078) (Health Protection 
Agency 2012).  Bar 014/020, which demonstrates an increase in this ribotype 
cluster from the time between these two cohorts, the result from these studies 
agrees with these national averages.  There appears to be a shift in the proportions 
of the most prevalent strains in the UK. 
Ribotype 026 was identified in this second study, but not the first.  Not 
much is known in regard to this strain compared to the other previously described 
strains.  The strain was identified in the community as well as the LRI in this study.  
This ribotype accounted for 4% of the cohort of this study, and 1% of the total 
samples tested in the East Midlands, found exclusively between January and March 
2011 (Health Protection Agency 2012).  Accounting for 0.8% of all the samples 
tested by the CDRN in both 2009/10 and 2010/11, the proportion of the ribotype 
has not changed over the past two years with respect to its national prevalence.  
However, this was the first quarter in which it was identified in the East Midlands 
(Health Protection Agency 2012).  It could be inferred that this strain was 
therefore spreading throughout the country prior to the study, and migrated into 
the East Midlands region over this period. 
Statistical significant differences were observed with the prevalence of 
ribotype 078 between months (November and December) in this second study, as 
well as ribotype 015 between sites (GGH and LGH).  This could also be attributed 
to strain migration both temporally and spatially.   
Thirteen patients tested positive for C. difficile more than once and had PCR 
ribotypes assigned to their samples.  Of these, three patients were in separate 
wards in the LRI and had carriage of PCR ribotype 106, a strain often isolated in 
the UK; the times of specimen collections also differed (John & Brazier 2005).  A 
case was also recorded of ribotype 078 identified from a patient twice, once in 
November and again in February.  These four patients demonstrate strains can 
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repeatedly cause C. difficile-associated diarrhoea, and may persist despite 
treatment. 
Ribotype 027 was found at a statistically similar proportion overall across 
all eight months studied in this chapter.  The same was also seen with the ribotype 
cluster 014/020.  These data therefore demonstrate these strains to be 
consistently prevalent within the UHL Trust, prevailing despite the twelve-month 
gap between sample collections.  The prevalence of ribotype 078 across all of the 
sites tested was also statistically similar in both cohorts.  There were clear 
differences in the relative proportions of ribotypes 014/020 and 027 in the first 
cohort; both were more evenly distributed in the second.  The persistence of these 
strains is therefore an indication that they are established within all areas of the 
UHL Trust.   
The work completed in this chapter demonstrates how monitoring a subset 
of samples can aid in the detection of newly emerging strains.  Studies of this 
nature are not often conducted, so clinicians and healthcare practitioners are not 
aware of which strains are carried by patients in their hospital environment.  A 
further benefit of monitoring is that it could help establish the spread of particular 
C. difficile strains between multiple hospitals, and their surrounding community.  It 
would also allow the identification of persistent strains within these sites.  This in 
turn provides an insight into the distribution and diversity as a useful aid in 
strategic planning of patient management and treatment. 
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4.5 Conclusions 
 Official ribotypes were assigned to C. difficile-positive faecal samples 
using a recently developed capillary-based gel electrophoresis 
method, before analysis was conducted into where and when the 
samples had been collected.  This was deemed more discriminatory 
than the traditional agarose-based approach. 
 The first study found that although ribotype 027 was still dominant 
within the UHL Trust, other ribotypes including 002, 014/020, 015, 
and 078 were prevalent at multiple sites.  
 With the second study, there was a clear difference in the profiles 
produced between the two methods, the ELISA-based and GDH-
based tests.  There was an increase in the diversity of ribotypes, 
including less well-reported strains, found after the change in C. 
difficile detection.  However, the number of samples from which C. 
difficile could not be isolated following a positive result with the 
GDH-based assay also increased.  Furthermore, 11/25 ribotypes 
identified were month-exclusive.  The six most dominant strains 
were found in all months, four of which are recorded as the most 
prevalent in the England.   
 National data from the CDRN suggests the prevalence of ribotypes 
027 and 014/020 are decreasing and 002, 005, 015, and 078 are 
increasing.  Apart from the increase observed with 014/020 
between these two cohorts, the results from these studies agrees 
with these averages. 
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5.1 Introduction 
C. difficile forms spores which are resistant to standard cleaning protocols 
within healthcare facilities (Gerding et al. 2008).  These reside on surfaces within 
the hospitals and are able to persist for many months (Kim et al. 1981).  As C. 
difficile can be transmitted orally, a patient touching these contaminated surfaces 
and subsequently putting their hands in contact with their mouth will put them at 
risk of contracting the infection.  Results in Chapter 3 showed that the strain 
carried by a C. difficile-infected patient was also found in their surrounding 
environment.  Therefore, the monitoring of bacterial contamination in a healthcare 
facility is important so that appropriate interventions can be made if such 
environments prove to be heavily contaminated by pathogenic organisms.   
Such investigations permit the identification of problematic strains.  
Correct strain characterisation also helps in the recognition of new, emerging 
ribotypes.  In addition to this, the findings of clinically relevant strains, including 
ribotype 027, with an increased ability to sporulate with the application of 
cleaning products is worrying (Fawley et al. 2007; Akerlund et al. 2008).  The 
findings from these studies suggest there may be lapses in efficiency with manual 
cleaning, especially in areas that are hard to reach as well as with hospital 
machinery.  Cleaning may also be rendered futile due to the slow settling rates of 
aerial C. difficile spores.  This suggests that the method of cleaning with 
disinfectants and detergents in hospitals may need addressing. 
Recently, hydrogen peroxide has been investigated as an adjunct 
decontamination method to manual cleaning.  Studies have demonstrated the 
effectiveness against bacteria and bacterial spores both in clinical settings and 
with inactivation curves, as well as its benefits as an antiseptic and disinfectant, 
whilst remaining non-toxic and non-corrosive (Rogers et al. 2005; Barbut et al. 
2009).  Hydrogen peroxide vapour can be generated readily and it can be 
dispersed relatively easily thereby lending itself to decontamination of large 
enclosed spaces.  There has been increasing interest shown into its usage to 
decontaminate healthcare facilities.  It has been demonstrated to successfully 
reduce surfaces from bacteria causing HCAI, such as MRSA and C. difficile (Dryden 
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et al. 2008; Cooper et al. 2011).  There are a number of hydrogen peroxide 
decontamination systems available, which can be purchased and subsequently 
used within healthcare facilities.  These use either hydrogen peroxide in its vapour 
form or as a dry-mist with silver cations to decontaminate (Boyce et al. 2008; 
Barbut et al. 2009). 
However, an inherent problem with the use of vapour decontamination in 
hospitals is the time taken before patients can be admitted into wards again 
following hydrogen peroxide exposure.  The concentrations at which these 
machines are operated have been shown to successfully reduce the bacterial 
contamination (Hall et al. 2007; Hardy et al. 2007; Otter et al. 2007).  However, 
these concentrations also increase the time before the wards or operating rooms 
can be used again, as the concentration has to fall below 1 ppm before it is deemed 
safe for patient re-admission (Boyce et al. 2008). 
The range of concentration of vaporised hydrogen peroxide predominantly 
used is within the region of 1000 ppm, with these machines ranging from 500-
2000 ppm.  Interestingly, there is a paucity of reports in the literature using 
hydrogen peroxide vapour at concentrations below 100 ppm.  In addition, there 
are reports to suggest the use of hydrogen peroxide vapour can result in 
degradation or corrosion of particular materials due to its characteristic as an 
oxidising agent (Rogers et al. 2005; Maillard 2011).  Therefore, investigating the 
efficiency of hydrogen peroxide vapour at lower concentrations would 
demonstrate the effectiveness at reducing C. difficile contamination. 
As previously stated, there are about 430 C. difficile strains, of which only 
20% have been suggested as currently problematic in clinical facilities (W Fawley 
2012, pers. comm., 20 Mar).  It could be argued, however, that all strains have the 
potential to become ‘problematic’.  Other ribotypes are found underlying and 
present to a lesser extent in other sources, for example food, water and soil 
samples (al Saif & Brazier 1996; Rodriguez-Palacios et al. 2007).  Despite this large 
number of problematic and disease-causing strains present within healthcare 
facilities, the potential resistance of certain ribotypes to hydrogen peroxide vapour 
at the concentrations employed for decontamination has not been investigated.  In 
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addition to this, the inactivation kinetics of C. difficile with hydrogen peroxide is 
not well studied.  Only a few research groups have studied how concentrations of 
hydrogen peroxide affect the spore recovery with respect to time (Lawley et al. 
2010; Fu et al. 2012).  There have been no reports to date on the effects of 
hydrogen peroxide on multiple C. difficile strains, including the exposure times and 
concentrations required for inactivation of clinical strain. 
5.1.1 Aim of this study 
This study was designed to obtain inactivation data of C. difficile spores at 
lower levels of hydrogen peroxide decontamination.  For the basis of this work, a 
purpose-built environmental chamber was designed and commissioned to 
generate a known concentration of hydrogen peroxide and expose its vapour in a 
controlled manner.  It also monitored temperature and humidity.   
Experimental work within this chapter was devised to demonstrate how 
changing the hydrogen peroxide concentration can affect the numbers of C. difficile 
ribotype 027 spores recovered.  Three additional C. difficile strains were used in 
this chapter: ribotypes 014, 103, and 220.  Ribotype 014 was obtained from a 
faecal specimen (Chapter 4), ribotype 103 following a round of environmental 
sampling (Chapter 3), and ribotype 220 was isolated from an estuary sample.  The 
work presented here will explore how these different ribotypes respond to the 
direct liquid application of hydrogen peroxide to a lawn of bacterial growth.  A key 
aim of this chapter was to compare the fractional survivals of these ribotypes and 
identify whether different times of vaporised exposure were required.  The work 
presented here would also identify whether these strains respond differently to 
the exposure of hydrogen peroxide as a disinfectant.   
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5.2 Materials and Methods 
5.2.1 Strain selection for hydrogen peroxide exposure experiments 
Throughout this thesis, samples have been collected and characterised by 
strain using PCR ribotyping (Chapter 4).  In order to conduct the work carried out 
in this chapter and investigate how C. difficile spores respond to the exposure of 
hydrogen peroxide, it was necessary to select a range of strains representative of 
the diversity of strains, which would exist within a healthcare facility.  This was to 
ensure that data collected more accurately represents what would be found in the 
environment. 
Four strains were collected from different origins.  Ribotypes 014 and 027 
are clinically relevant strains, often reported in literature as linked to sources of 
disease (Bauer et al. 2011).  These two strains were isolated from faecal specimens 
from individuals within the UHL Trust who were infected with C. difficile (samples 
collected from work conducted in Chapter 4).  
An aim for the whole project was to identify which strains of C. difficile are 
prevalent in hospitals, demonstrating resistance to cleaning and disinfection 
treatments.  The selection of ribotype 103 was due to its isolation during 
environmental sampling (conducted in Chapter 3).  This strain was not present 
within faecal specimens collected from the patient residing in the particular side 
room.  This may suggest that this particular strain may have withstood previous 
cleaning regimes and may have arisen from a previous infected patient occupying 
the room.  Ribotype 103 is not well studied, no reports have been made with 
respect to its link with disease; there is little information regarding its isolation, 
with respect to geography, as well as its virulence.   
The final strain selected was ribotype 220.  This strain was not identified 
from either faecal samples or environmental sampling throughout this thesis; the 
sample was isolated from an estuary sediment sample by Katherine Hargreaves 
[University of Leicester].  It was selected because it is not clinically relevant and its 
site of isolation differs to the other strains, as it too is non-clinical.  Again, there is 
little known about this strain. 
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5.2.2 C. difficile spore inhibition with liquid-phase hydrogen peroxide 
This section outlines the protocol for investigating the growth of a bacterial 
lawn following exposure to filter paper discs immersed in different concentrations 
of hydrogen peroxide.  As the final part of this thesis will focus entirely on 
hydrogen peroxide vapour decontamination, this experiment was devised as a 
preliminary screening test to identify strains showing differences in peroxide 
resistance. 
BHI agar with 0.1% sodium taurocholate plates were prepared and poured 
as described in Chapter 2.  Grade 3 filter paper discs [Whatman, UK] were cut out 
with a standard desk hole-punch and autoclaved.  A 0.1% (v/v) Tween 80-C. 
difficile spore mixture (6-log10 CFU) was prepared (Chapter 2); 50 µl was spread 
onto the agar plates.  Discs were immersed into liquid hydrogen peroxide, 
concentrations of 1.5, 3, 4.5, 6, or 10% (w/v) for 5 sec, and placed in the centre of 
the agar plates.  Hydrogen peroxide in its liquid form (3-6%) has been reported to 
be an effective disinfectant (Andersen et al. 2006).  The plates were incubated in 
the anaerobic workstation overnight at 37°C.  By measuring the diameter of the 
circular area that was clear from any visible colony growth, the area (cm2) or 
zones of inhibition were calculated.  These were assumed as regions where lawns 
were unable to grow and therefore, the spores were taken to have been 
inactivated. 
5.2.3 C. difficile spore inactivation with vaporised hydrogen peroxide  
This section briefly outlines the methodology developed by Claire Shaw 
[Loughborough University] for the inactivation of spores using hydrogen peroxide 
vapour, described in the PhD thesis by the same (Shaw 2013).  The techniques 
were optimised with Bacillus subtilis, a non-pathogenic bacterium frequently used 
in disinfection studies (Gardner & Shama 1998; Meszaros et al. 2005).  The strain 
utilised was ATCC 6633, purchased from the American Type Culture Collection.  
Bacillus subtilis is easier to cultivate and therefore was ideal for preliminary 
experiments rather than using the more problematic C. difficile for method 
development.   
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A hydrogen peroxide decontamination chamber was designed and 
commissioned to permit generation of controlled concentration of hydrogen 
peroxide (in the range 0-100 ppm) to spores in a controlled manner.  These data 
could then be used to establish the inactivation kinetics of hydrogen peroxide 
exposure to C. difficile spores.  
5.2.3.1 Deposition of C. difficile spores onto membranes 
In order to prepare C. difficile spore viability bio-indicators, a method was 
devised whereby a known volume of a given concentration of spore solution was 
filtered through 0.22 µm isopore membrane filters [Millipore, UK], adapted from 
Kai et al. (1999) and Kaláb et al. (2008).  A single membrane filter was placed on 
the base of a 13 mm syringe filter holder [Sartorius, UK], moistened with 30 µl 
deionised water to ensure there was no movement or drying out when autoclaving.  
The top of the filter holder was secured tightly.  A small amount of non-absorbent 
cotton wool was used to bung the syringe hole at the top of the holder.  Once 
assembled, the holder was entirely wrapped in aluminium foil and autoclaved at 
121°C for 15 min. 
A 6-log10 CFU C. difficile spore solution was prepared, with 1 ml filtered 
through each membrane.  This was conducted by unwrapping the foil from the 
filter holder after sterilisation, and removing the cotton wool.  A disassembled 2 ml 
syringe [DB Plastipak, USA] was placed in the top of the filter holder, filled with 1 
ml of the stock solution.  The spore solution was filtered through the membrane, 
and the filtrate discarded.  To remove any residual water, the filter holder was 
placed into a bung on top of a Büchner flask and a vacuum of 0.5 bar was achieved 
in the flask using a vacuum pump.  The membrane was aseptically removed from 
the filter holder by dismantling it to its two constituent parts, placing it directly 
into a vial containing recovery liquid (as described in Section 5.2.3.6) or onto 
double-sided adhesive tape, affixed to a sheet of acetate film.  The latter could then 
be exposed to hydrogen peroxide in the environmental chamber.  The used filter 
holder was autoclaved as before and washed using deionised water prior to 
reassembly.   
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5.2.3.2 Viewing C. difficile spores under scanning electron microscope 
To capture images of the C. difficile spores, they were deposited on the 
membrane, as described above.  The membrane was then immersed in 2% (v/v) 
glutaraldehyde overnight, before removal and washing for 30 min.  Washing was 
repeated twice.  The membranes were then dried in a laminar flow cabinet and 
attached onto 13 mm aluminium stubs using double-sided carbon sticky pads 
[Agar Scientific, UK].  Membranes were then gold-coated (approximately 30 nm 
thick) in a sputter coater for 90 sec at 20 mA [Polaron SC7640].  Samples were 
then visualised [Hitachi scanning electron microscope (S3000H)]. 
5.2.3.3 Exposing C. difficile spores in a desiccator 
In order to establish whether the reduction in the number of C. difficile 
spores recovered was due entirely to the exposure of hydrogen peroxide in the 
decontamination chamber, the spores were initially subjected to a desiccator.  
These were conducted as control experiments into how the spores react to 
exposure to the membranes and the subsequent recovery.  It was important to 
ensure the humidity conditions the spores would experience within the chamber 
were mimicked.  A saturated sodium bromide solution [Fisher Scientific, UK] was 
prepared with deionised water to generate a relative humidity of 60%.  The 
solution was poured into the base of a desiccator and left at room temperature 
overnight; a humidity sensor (OM-62) [Omega, UK] was placed in the top of the 
desiccator to monitor the surrounding environment.  Membranes were prepared 
as described in Section 5.2.3.1 and exposed for 5 min, 45 min, and 7 hr.  The spores 
were recovered and enumerated as explained later in this chapter (Section 5.2.3.6). 
5.2.3.4 Hydrogen peroxide decontamination chamber 
C. difficile spores were exposed to hydrogen peroxide vapour in the 
environmental chamber (Figure 5.1 and Figure 5.2).  The chamber comprised a 
hydrogen peroxide generation unit, an exhaust unit and three exposure boxes 
connected in series.  Hydrogen peroxide solution of the required concentration 
was fed at a pre-determined flow-rate using a syringe infusion pump (WU-74900-
05) [Cole-Parmer Instrument Co., UK] fitted with a 60 ml syringe onto a hotplate 
maintained at a temperature of 130°C. 
Chapter 5. Inactivation of C. difficile Spores Using Hydrogen Peroxide 
 
156 
 
 
Figure 5.1: Flow diagram of the hydrogen peroxide vapour decontamination chamber. 
Hydrogen peroxide left the syringe pump at a controlled flow rate, entering the mixing chamber.  A heated plate flash 
evaporated the liquid into its vapour form, which was then combined in the airflow and fed into the boxes in series.  
Membranes with C. difficile spores were attached to acetate films, placed within the boxes, and subsequently exposed.  
Image by Claire Shaw. 
 
The required concentration of hydrogen peroxide was prepared and fed 
into the chamber.  Upon evaporation, the hydrogen peroxide was mixed into the 
airflow generated by a fan (ACM150) [Vent-Axia, UK].  The velocity of the gas 
phase was maintained at 7 m/sec as measured at the outlet of the exhaust unit 
using an anemometer (Model 300) [Kestrel Ltd., Canada].  From the vapour 
generation unit, the air-hydrogen peroxide mixture flowed into the first of the 
three Tecavinyl PVC exposure boxes.  These were identical in construction: height 
100 mm, width 133 mm, and length 665 mm.  At the entrance to each of the boxes 
was a 30 mm thick reticulated foam gas flow distributer to ensure mixing of the 
hydrogen peroxide vapour throughout the box with the air.   
Flow distributer 
Mixing  
chamber 
CX 
Exhaust  
unit 
CX 
Box 1 
Box 2 
Box 3 
Hot plate 
Vent to fume cupboard 
Hydrogen peroxide inlet 
from syringe pump 
Humidity sensor 
Hydrogen 
peroxide sensor 
Chapter 5. Inactivation of C. difficile Spores Using Hydrogen Peroxide 
 
157 
 
 
Figure 5.2: Hydrogen peroxide vapour decontamination chamber.   
Hydrogen peroxide leaves the syringe pump at a controlled flow rate, entering the mixing chamber.  A heat plate 
converts the liquid to its vapour form, which is then fed into the boxes in series.  Membranes with C. difficile spores 
were attached to acetate films, placed within the boxes, and subsequently exposed.  Photograph by Claire Shaw. 
 
The lids of the boxes were secured with wing nuts; the third box in series 
could be opened to remove samples without affecting the exposure and airflow in 
the two other boxes.  On exiting from the last of the three chambers, the air-
hydrogen peroxide mixture flowed into the exhaust unit.  This contained a 
hydrogen peroxide sensor (Model A11-34) [ATI Ltd., UK] and a combined humidity 
and temperature logger (Model OM-62) [Omega Ltd., UK].  The hydrogen peroxide 
data were recorded using an EasyLog USB data logger [Lascar Electronics, UK].  
The hydrogen peroxide sensors were routinely checked, and if required, the 
sensors were re-calibrated using an in-house calibration bath (this work was 
carried out by Claire Shaw). 
The establishment of steady state conditions within the environmental 
chamber took approximately 2 hr.  The entire environmental chamber was located 
inside a fume cupboard and the gases exiting the chamber were safely vented.  
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5.2.3.5 Exposure of hydrogen peroxide vapour to C. difficile spores 
To generate a hydrogen peroxide vapour concentration of 10 ppm, 6% 
(w/v) hydrogen peroxide was fed into the evaporation unit at a rate of 4 ml/hr.  
For a vapour exposure of 90 ppm, 6% hydrogen peroxide was applied at 15 ml/hr.  
For 50 ppm, 3% was pumped at 15 ml/hr.  These concentrations were monitored 
constantly as stated, the data collected and analysed following each experimental 
run. 
For each time point investigated, five replicate spore-covered membranes 
were prepared as described.  For the purpose of control tests, five further replicate 
membranes were prepared, and transferred directly into the recovery solution 
without being exposed to the environmental chamber.  The membranes for 
exposure were placed into the boxes for a specified time, before removal and 
subsequent recovery of spores.  
5.2.3.6 C. difficile spore recovery 
In order to remove the spores from the surfaces of the membranes, a spore 
recovery liquid was used.  If conducting a control sample to enumerate the spore 
recovery before exposure, membranes were transferred into 30 ml universal vials 
[Sterilin, UK] containing 10 ml PBS, 0.05% (v/v) Tween 80, and 0.2 mg bovine liver 
catalase [Sigma-Aldrich, UK], with five 2 mm glass pre-sterilised Ballotini impact 
beads.  The addition of catalase was to counteract any hydrogen peroxide which 
may have adsorbed onto the membranes, as previously outlined by Johnson et al. 
(2005).  Ballotini balls were added to aid in the recovery of C. difficile spores, 
detaching them from the membrane through impact.  Membranes were vortex-
mixed for 5 min at 3,000 rpm and serially diluted as required in PBS before 
assessment of viability.  This was conducted by pour-plating solutions into BHI 
agar with 0.1% (w/v) sodium taurocholate, mixing the molten agar and sample 
thoroughly before setting.  Agar plates were anaerobically incubated at 37°C for 48 
hr prior to enumeration.  This was used to calculate the log10 CFU reduction of 
spores based on the concentration of the initial spore solution. 
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5.2.4 Statistical analyses 
Data gathered from the hydrogen peroxide exposure experiments were 
analysed using Microsoft Excel’s statistical functions and Data Analysis Tool Pack.  
Microsoft Excel was also used to create the graphical representations of the data.  
The Series-Event models and the D-values (decimal reduction times) were 
obtained using the Goal Seek feature in Microsoft Excel.  Additional statistical 
analysis was conducted with Minitab 15.  Significance was set to P<0.05.  The F-
test was used with a one-way analysis of variance.  A two-sample t-test compared 
differences of mean CFU.  
5.2.4.1 Series-Event models 
The Series-Event models used in this chapter were calculated based on the 
equations and methodology described by Labas et al. (2008) with the use of liquid 
hydrogen peroxide, and more recently by Malik et al. (2012) in the inactivation of 
Bacillus subtilis with vaporised hydrogen peroxide. 
5.2.5 Ethical issues 
Ethical approval was obtained for the use of the strains in this chapter.  All 
information regarding patient data was made anonymous prior to use. 
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5.3 Results 
5.3.1 C. difficile spore morphology 
Following the production of spore collections, preparations of ribotype 027 
spores were submitted for visualisation under SEM.  This was to investigate the 
morphology of the spores which were to be used for the work carried out in this 
chapter, as well as those used in Chapter 2.  It was also conducted to check the 
purity of the spores and confirm the stocks consisted predominantly of spores, 
rather than cells or cell debris.  
Membranes were prepared as described in Section 5.2.3.1.  SEM images 
were taken in order to ensure C. difficile spores were adherent and evenly 
distributed on the membrane surface.  It was necessary for the spores to be 
uniformly spread on the membrane surface, as this would ensure equal exposure 
of hydrogen peroxide vapour to spores. 
The SEM images (Figure 5.3) show a membrane laden with C. difficile at 
different magnifications.  The spores were approximately 2-3 µm in length and the 
holes in the membrane were 0.22 µm in diameter, and therefore, the spores were 
successfully captured and adhered to the surface of the membrane.  
 
Figure 5.3: Scanning electron microscope images of C. difficile ribotype 027 spores following deposition onto 
membrane surfaces via filtration.   
Spore solutions were prepared at 6-log10 CFU.  Magnification: (a) 3000x; (b) 9000x.  Photographs by Claire Shaw.  
 
Increasing the concentration of spores resulted in a more even spread on 
the membrane surfaces (images not shown).  This was important as it suggests 
that with the application of ChlorClean (Chapter 2) or hydrogen peroxide (this 
chapter), the spores would be equally exposed to the decontamination agent. 
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5.3.2 Exposure of different C. difficile strains to hydrogen peroxide solution 
A study was devised to obtain information into how different strains of C. 
difficile would react to the exposure of hydrogen peroxide vapour for the 
decontamination work later in this chapter.  The experiment was based on the 
inhibition of C. difficile spores with the application of liquid hydrogen peroxide.  
The basis behind the exposure of the hydrogen peroxide to the ribotypes was to 
gain an insight into whether there was a difference in susceptibility to hydrogen 
peroxide between the strains before exposing them to the vapour form. 
There was little difference observed with the zones of inhibition 
throughout 1-6% hydrogen peroxide between ribotypes 014, 027, and 220, 
irrespective of the peroxide concentration in which the discs were immersed 
(Figure 5.4).  Analyses also showed the means for these were not statically 
significantly different.  PCR ribotype 103, however, differed; the zone of inhibition 
for this strain was consistently smaller than the other strains.   
With a hydrogen peroxide concentration of 1.5%, the range of clearing was 
between 1.4-1.7 cm2 for all strains except ribotype 103 (0.2 cm2).  The means were 
also statistically different, for example at 1.5%, for ribotypes 027 and 103 
(P=0.022); the difference between ribotypes 103 and either 014 or 220 were both 
(P=0.040).  This would therefore suggest that there is a difference in the 
susceptibility of ribotype 103 to hydrogen peroxide at these lower concentrations. 
Irrespective of the hydrogen peroxide concentration used, the area of 
inhibition was significantly similar for ribotypes 014 and 220; P-values ranged 
from 0.397 to 0.896.  This would imply these strains are alike in their 
susceptibility to the liquid form of hydrogen peroxide. 
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Figure 5.4: Area of inhibition exerted on the growth of various C. difficile strains from filter paper discs immersed in 
liquid hydrogen peroxide. 
Strains used: Ribotype 027 (blue diamond), ribotype 014 (red square), ribotype 103 (green triangle), and ribotype 220 
(purple cross).  Data points indicate the averages of a single experiment carried out in triplicate, and the error bars 
indicate the standard errors of the mean. 
 
Applying the maximum concentration of hydrogen peroxide (10%), showed 
a significant difference between the area of clearing for ribotype 027 and the other 
strains tested: ribotype 027 with ribotype 014 (P=0.018), ribotype 103 (P=0.021), 
and ribotype 220 (P=0.005).  This suggests that ribotype 027 may be less resistant 
to the application of hydrogen peroxide, exhibiting greater susceptibility than the 
other strains at the 10% peroxide concentration level.   
The results from this experiment show that when exposed to the liquid 
form of hydrogen peroxide, there is a statistical difference between how C. difficile 
spores of different ribotypes respond.  At lower concentrations, ribotype 103 
appears more resilient to the hydrogen peroxide, however for the peroxide 
concentration of 10%, the areas of inhibition are similar to that of ribotypes 014 
and 220.  The opposite was observed with ribotype 027, despite similar 
inactivation response as ribotypes 014 and 220 at lower concentrations, this strain 
was more susceptible to the presence of 10% hydrogen peroxide solution.  
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Therefore, there may be a difference expected between the strains, upon exposure 
to hydrogen peroxide vapour in the decontamination chamber. 
5.3.3 Recovery of ribotype 027 spores following exposure in a desiccator 
The basis behind exposing PCR ribotype 027 spores to a desiccator was to 
gain insight into the number of spores that survive and are recovered from the 
membranes.  The work conducted earlier in this thesis (Chapter 2) demonstrated 
that the C. difficile spore recovery from a stainless steel tile was not 100% when 
attempting to use agar media and tamping onto the tile surface.  The objective of 
this work was to identify the inactivation of spores due to hydrogen peroxide.  
Therefore, it was important to calculate the maximum possible recovery without 
hydrogen peroxide exposure.   
Spores were recovered from the membranes after 5 min in the desiccator, 
45 min and 7 hr.  These time points were selected to demonstrate the effects of 
time on the recovery of spores, with 7 hr the longest time of exposure used 
throughout these experiments.  There was a 1-log10 CFU reduction of spores 
applied onto the membranes to the spores which were recovered after all three 
time points.  There was no statistical difference in the recovery of spores from the 
membrane surfaces irrespective of the time in the desiccator, with 5 min and 45 
min (P=0.293) and 5 min and 7 hr (P=0.796).  Therefore, this suggests that with 
the addition of 6-log10 spores onto the membranes, irrespective of the time the 
spores are left on the surface of membranes in the desiccator, the proportion of 
spores that cannot be recovered remains the same; the variances between the 
times were also similar. 
The results from this experiment show that when exposed to air in a 
desiccator, with no additional stress for example hydrogen peroxide, there is a 
quantifiable reduction in the number of C. difficile spores recovered.  This 
difference was then used to correct all other spore recoveries following hydrogen 
peroxide exposure in later experiments described in this chapter. 
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5.3.4 Inactivation of ribotype 027 spores with hydrogen peroxide vapour 
This section outlines the results obtained with experimental runs where C. 
difficile spores were exposed to different concentrations of hydrogen peroxide 
vapour.  These experiments were carried out to investigate the changes in log10 
CFU observed with a range of concentrations and over time.  PCR ribotype 027 
spores were used in this work to identify the optimal time for exposure to elicit an 
efficient log10 CFU reduction with a given concentration of hydrogen peroxide.  
Once determined, these parameters were then used in the final experiments in this 
chapter.  As 50 ppm was used in the preliminary experiments, to explore an evenly 
spread range of concentrations, 10 ppm and 90 ppm were also investigated.  
Ribotype 027 spores were used throughout this section as it is frequently used in 
disinfection and decontamination studies. 
 
Figure 5.5: C. difficile PCR ribotype 027 spores reduction from exposure to 50 ppm hydrogen peroxide for thirty minutes 
in the exposure chamber. 
Boxes are numbered in series.  Bars indicate the averages of five repeats and the error bars indicate the standard 
errors of the means. 
 
Preliminary experiments conducted at 50 ppm investigated the flow rate of 
the hydrogen peroxide through the three boxes in series.  This was to ensure that 
the exposure was equal throughout all three boxes (Figure 5.5).  Each of the three 
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boxes exposed five membranes with ribotype 027 spores to 50 ppm hydrogen 
peroxide vapour for 30 min.  Statistical analyses show there was no statistical 
significant difference in the log10 CFU recovery obtained from the boxes; boxes 1 
and 2 (P=0.107); boxes 1 and 3 (P=0.089); boxes 2 and 3 (P=0.641).  This finding 
ensures there would be no significant difference in the recovery of the spores 
between the boxes selected for exposure.  
Exposing the ribotype 027 spores to 10 ppm, 50 ppm, and 90 ppm 
hydrogen peroxide vapour was important to identify the rates of C. difficile spore 
inactivation for a concentration less than 100 ppm.  For the purpose of the Series-
Event models, an ‘event’ is determined by a degree of damage imposed onto a 
given cell.  An accumulation of these in series results in death of the cell.  The 
experimental data generated in this chapter has identified, for all concentrations of 
hydrogen peroxide, the total number of hits for the inactivation of C. difficile spores 
determined was four.   
The data generated for 10 ppm hydrogen peroxide exposure shows there 
are three distinct regions of inactivation over a 7 hr period where efficient log10 
CFU reduction was observed (Figure 5.6).  A Series-Event model has also been 
determined to help predict the time frame in which spores may inactivate.  There 
is a period of initial decline in spore survival before inactivation begins as seen in 
the first hr of the experiment.  This is followed by an exponential decrease in the 
log10 CFU recovered (t=1 to t=4), where a 2-log10 CFU reduction is observed.  
Finally, the few remaining hardy spores resist the effects of hydrogen peroxide 
towards the end of the exposure period.  This is represented by the slight decline 
of less than 0.5-log10 CFU between the latter 3 hr of the experiment (t=4 to t=7).  
Therefore, this suggests that after 4 hr of exposure to 10 ppm hydrogen peroxide, 
there is no difference in the spores killed.  To inactivate all of the spores, according 
to the Series-Event model, it may be required for the exposure time to be 
lengthened much past 8 hr.  Nevertheless, the application of 10 ppm hydrogen 
peroxide does appear to have an overall effect on the presence of ribotype 027 
spores.  Comparing the counts between t=0 and t=7 identifies a highly significant 
difference (P=0.000). 
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Figure 5.6: Semi-logarithmic scale representation of C. difficile ribotype 027 spore inactivation as a function of time.  
Comparison of a modified Series-Event model prediction (solid line) with experimental data at 10 ppm hydrogen 
peroxide. 
Four experiments were conducted with different times of exposure.  Data points indicate the averages of ten to twenty-
five replicates. 
 
Figure 5.7 shows the fractional survival curves and respective Series-Event 
models obtained with 50 ppm and 90 ppm hydrogen peroxide exposure.  As with 
the 10 ppm data, these results also show the viability of spores decreases with 
increased times of exposure.  There is the initial decline in log10 CFU counts where 
the weaker spores are affected by the concentration of peroxide used.   
With respect to 50 ppm, the increased concentration shows there is a 
statistically significant difference when comparing 10 ppm and 50 ppm after 60 
min (P=0.008).  After exposure for 2 hr, there is a further 1.3-log10 CFU reduction 
when compared to the end of the 10 ppm experiment (at t=7).  The counts 
between t=0 and t=120 identifies significant difference (P=0.000), with a total 
reduction of 3.9-log10 CFU.   
The final experiment carried out in this series was the exposure of spores to 
90 ppm over a period of 80 min, which elicited a 5.9-log10 CFU reduction.  The rate 
at which the spores were inactivated with this concentration was much faster than 
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observed with the previous two concentrations; the exponential decline occurred 
in less time than with 10 ppm or 50 ppm and resulted in fewer spores remaining 
by 60 min.  Most of the remaining resistant spores appear to be inactivated by 80 
min.  Extending the Series-Event model past the data points shown with 90 ppm in 
Figure 5.7 suggests complete inactivation of spores may be observed by 90 min.  
Comparing the recovery at 60 min, there was a significant difference between the 
CFU at 10 ppm and 90 ppm (P=0.007).   
 
Figure 5.7: Semi-logarithmic scale representation of C. difficile ribotype 027 spore inactivation as a function of time.  
Comparison of modified Series-Event model predictions (solid lines) with experimental data at 50 ppm and 90 ppm 
hydrogen peroxide. 
Seven experiments were conducted with different times of exposure.  Data points indicate the averages of ten to 
twenty-five replicates. 
 
Calculating the D-values, identifies the average time required for a 1-log10 
CFU reduction of C. difficile spores.  This value is frequently determined in food 
microbiology, as shown by Meszaros et al. (2005).  Using the Series-Event models 
devised in this work and the derivation of an equation in Malik et al. (2012), the 
application of 10 ppm was calculated to require 3.5 hr of exposure, 50 ppm needed 
50 min, and with 90 ppm, 21.8 min was necessary.   
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The results from these experiments show that time of hydrogen peroxide 
exposure is linked to a reduction in spore recovery.  There is an early stage where 
the weaker spores are inactivated followed by an exponential decline in a large 
proportion of the spores used.  Finally, the persistence of the more resistant 
spores can be observed towards to end of the experiments, and these are the 
spores which require the most attention with respect to disinfection.  In order to 
prevent re-colonisation, these spores need to be eradicated.  Therefore, the longer 
the spores were exposed to the hydrogen peroxide, the larger the log10 CFU 
reduction was observed, as the hardier spores were beginning to be inactivated.   
In addition to this, increasing the concentration of hydrogen peroxide 
vapour also has an effect on the log10 CFU counts.  There was a greater reduction of 
spores recovered at the same time points as the concentration increased, for 
example, there were a greater number of inactivated spores at 60 min with 90 
ppm than with 10 ppm.  These data suggest the greatest and fastest log10 CFU 
reduction of spores was with 90 ppm, where a significant 5.9-log10 CFU reduction 
was observed over the course of 80 min. 
5.3.5 Inactivation of C. difficile strains with hydrogen peroxide vapour 
The purpose of this final experiment was to inactivate C. difficile spores 
obtained from different PCR ribotypes with hydrogen peroxide vapour in the 
decontamination chamber.  This experiment also aimed to identify whether there 
were differences in the responses to counts obtained between the C. difficile 
strains, with respect to the rates at which the spores were killed.   
As conducted in Section 5.3.4, this study used a concentration of 90 ppm 
hydrogen peroxide to elicit a reduction in the number of spores recovered.  The 
protocol remained unchanged as 90 ppm invoked the greatest log10 CFU reduction 
in ribotype 027 spores, resulting in the inactivation of the hardier spores in less 
time.  In order to establish whether a difference could be observed between liquid 
hydrogen peroxide and its vapour form, the same strains from Section 5.3.2 were 
used. 
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C. difficile spores for ribotypes 014, 027, 103, and 220 were exposed for 40 
min in the decontamination chamber (Figure 5.8).  There was more killing of the 
non-clinically relevant ribotypes 103 and 220, than the problematic strains 
(ribotypes 014 and 027).  Modified Series-Event models were created for all 
strains used in the experiment; ribotypes 014 and 027 mapped better than the 
non-clinical strains.  In Section 5.3.4, the ribotype 027 inactivation data appears to 
follow a somewhat sigmoidal curve which deviates from the model during the 
experiment, mapping better initially and towards the end of the inactivation.  
However, over this shorter time period, the model appears to map better with the 
data.    
 
Figure 5.8: Semi-logarithmic scale representation of C. difficile strains and spore inactivation as a function of time.  
Comparison of modified Series-Event model predictions (solid lines) with experimental data at 90 ppm hydrogen 
peroxide. 
Strains used: Ribotype 027 (blue diamond), ribotype 014 (red square), ribotype 103 (green triangle), and ribotype 220 
(purple cross).  Data points indicate the averages of five to ten replicates. 
 
The three distinct inactivation stages observed with the previous 
experiments were also noted with these data.  All ribotypes appeared to have an 
initial inactivation of the weaker spores by 10 min, with ribotype 220 resulting in 
0.9-log10 CFU reduction.  At 20 min, there was a significant difference in the 
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recovery of ribotypes 014 and 027 compared to the non-clinically relevant strains, 
as observed when comparing ribotypes 104 and 103 (P=0.001).   
Further to this, at the end of the experiment, with 90 ppm hydrogen 
peroxide for 40 min, ribotypes 014 and 027 had 2.5- and 2.4-log10 CFU reductions, 
respectively.  This significantly contrasts with the recovery observed with the 
other strains tested, ribotype 220 (3.3-log10) and ribotype 103 (4.2-log10 CFU 
reduction).  These data show that there was a large difference in the spores 
recovered following inactivation compared to the recovery of ribotypes 014 and 
027, with this strain exhibiting more resistance to the vapour decontamination.  
This decrease in spore recovery demonstrates that the susceptibility of these 
strains to hydrogen peroxide is greater than with the clinical strains.   
In addition, it could be predicted using the Series-Event models that 
between 50-60 min, ribotype 103 would be completely inactivated and ribotype 
220 could have a 4-log10 CFU reduction at this concentration, should the 
experiment be extended.  The D-values were determined for these strains: 22.1 
min (ribotype 014), 21.8 min (ribotype 027), 15.4 min (ribotype 103) and 17.6 
min (ribotype 220).  These showed that the more susceptible the strain, the 
quicker the spore recovery was reduced by 1-log10 CFU. 
The results from this experiment show that when exposed to 90 ppm 
hydrogen peroxide, there is a significant reduction in CFU counts for all as the time 
of exposure is increased.  These data also demonstrate there is a statistical 
difference in susceptibility observed between the four strains investigated, with 
the clinically relevant strains more resistant to the exposure of hydrogen peroxide 
vapour.  
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5.4 Discussion 
Various procedures have been put into place to control the spread of 
infection in healthcare facilities such as isolating infected patients, ensuring hands 
are washed thoroughly after contact with infected patients, minimising the 
administration of high-risk antibiotics, as well as daily cleaning (Boyce et al. 2008).  
Routine cleaning with a sodium hypochlorite solution has been successful in the 
control of CDAD (Kaatz et al. 1988; Mayfield et al. 2000; McMullen et al. 2007).  
Despite this, there is evidence to suggest routine cleaning is not entirely effective, 
with surfaces in hospitals still contaminated with bacteria irrespective of cleaning 
(Oie et al. 2007; Otter et al. 2010).  These surfaces and medical equipment can act 
as bacterial reservoirs, increasing the probability of cross-contamination by 
healthcare workers, and subsequently contributing to the spread rather than 
eliminating it.  There are also areas such as keyboards, monitors, electrical beds 
and handsets where it may be difficult to clean (Andersen et al. 2006).  It must be 
noted that this is a daunting and extremely challenging task, with certain 
disinfectants and detergents being rendered useless due to difficulties in accessing 
smaller components within machinery, or being incompatible with materials 
(Davies et al. 2011).   
The use of coupons infected with bacterial spores for use in 
decontamination studies is common (Meszaros et al. 2005; Pottage et al. 2010; 
Davies et al. 2011).  However, a recent report into Listeria cells and the application 
of a bacterial load identified a more uniform technique for infecting materials in 
such a manner with the filtration onto membranes; this was confirmed with SEM 
(Bayliss et al. 2012).  This group concluded that spores were layered more 
homogenously; use of this method in this chapter ascertained this, as shown in 
Figure 5.3 of this thesis. 
Before conducting experimental runs exposing C. difficile spores to the 
decontamination chamber, it was important to run control tests to test the natural 
loss in spore recovery and the decontamination chamber to ensure the flow of 
hydrogen peroxide interspersed within the air was constant, and at a steady state 
from the initial box to the third.  Using a desiccator, C. difficile ribotype 027 spores 
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were exposed to the relative humidity at which the environmental chamber would 
be during an experimental run.  A decrease was observed when comparing the 
number of spores applied to the surface of the membrane and the number which 
could then subsequently be recovered.  Although this was found with Bacillus 
subtilis spores by Shaw (2013), the proportion of loss has not been widely 
reported.  The 1-log10 CFU reduction identified in this study was then applied to all 
subsequent recoveries from the decontamination chamber to correct accordingly. 
Preliminary work was conducted whereby the decontamination chamber 
exposed membranes to 50 ppm hydrogen peroxide vapour for 30 min.  These 
findings showed the counts obtained from the boxes were statistically similar 
(P>0.05).  This confirmed the distribution of air and hydrogen peroxide vapour 
mixture was equal throughout all three boxes within the chamber.  Shaw (2013) 
demonstrated the same with Bacillus subtilis spores, and established there was no 
more than a 5% drift in the hydrogen peroxide concentration when exposing for 
longer periods of operation.   
There are two different hydrogen peroxide systems commonly used in 
cleaning: vapour decontamination and in the form of a dry-mist.  Boyce et al. (2008) 
reported 25.6% (n=43) of samples collected from surfaces in a hospital in 
Connecticut were positive for C. difficile; recovery after exposure of vapour from 
30% liquid hydrogen peroxide [Bioquell, UK] fell to 0%.  This group also reported 
a fall in the reports of C. difficile associated disease (1.89 to 0.88 cases per 1,000 
patient-days, corresponding to the pre-intervention and intervention periods, 
respectively).  The entire process of decontamination took 3-4 hr for an individual 
room and about 12 hr for an entire ward.   
Utilising a 5% hydrogen peroxide dry-mist disinfection system (Sterinis) 
[Gloster Sante Europe, France], and a single cycle of decontamination, Barbut et al. 
(2009) reported a 4.2-log10 CFU reduction on C. difficile spore-infected coupons.  
Furthermore, Andersen et al. (2006) reported a 6-log10 CFU reduction of Bacillus 
spores with a dry-mist hydrogen peroxide system (Sterinis).  The group conceded 
that this complete inactivation only occurred with three 3 hr decontamination 
cycles. 
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Fu et al. (2012) were the first group to conduct a comparative study into 
the effects of using these two techniques.  This group used a variety of microbes, 
including an undisclosed C. difficile strain, to demonstrate the inactivation of 
spores.  The authors conceded the dry-mist technique resulted in an uneven 
distribution of hydrogen peroxide, concluding cycle times required further 
investigation. 
The experiments in this thesis have not used such cycle times in 
disinfection.  The use of a constant concentration of hydrogen peroxide over a 
distinct time period identified how long was required in order to elicit an efficient 
log10 CFU reduction in the applied spores.  The need for these long cycle times 
reported in literature ensures the inactivation of bacterial spores, in particular, 
those that are more resistant.  The persistence of these spores was observed in the 
third stage of inactivation and towards the latter time points of the vapour 
decontamination experiments in this chapter. 
Rodriguez-Palacios & Lejeune (2011) investigated the D-values of three 
strains of C. difficile spores following heat treatment, however, to date, no studies 
have identified the D-values for the C. difficile spores from different ribotypes for a 
range of hydrogen peroxide concentrations.  The benefit of obtaining this value is 
that it aids in the design of hydrogen peroxide decontamination processes.  The 
results in this chapter have identified increasing the concentration of hydrogen 
peroxide decreases the time required to elicit a 1-log10 CFU reduction.   
The findings from this work have also demonstrated that increasing the 
time of exposure leads to a greater decline in C. difficile spore inactivation.  This 
work used 10, 50, and 90 ppm, and the results were supported with the faster D-
values with increasing the hydrogen peroxide concentration.  With the application 
of 10 ppm hydrogen peroxide vapour, a 2.6-log10 CFU reduction was observed with 
spores of ribotype 027 over the course of 7 hr.  Increasing this concentration to 50 
ppm with the same strain resulted in a 3.9-log10 CFU reduction within a shorter 
time period of 2 hr.  A slightly greater reduction was obtained with 90 ppm (5.9-
log10 CFU) after exposure for 80 min.  This demonstrates that although, as 
expected, increasing the concentration of hydrogen peroxide increases the rate of 
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killing and decreases the time required for exposure, lower concentrations are 
able to elicit significant kill efficiencies. 
For all of these fractional survival curves, there were three sections of 
inactivation observed, as described with UV inactivation of Bacillus spores by 
Mamane-Gravetz & Linden (2005).  Initially, there was a stage of spore reduction, 
an exponential stage where most of the spores were inactivated, and a final region, 
which consisted of the eradication of the most resistant spores.  It was found that 
the longer the time of hydrogen peroxide exposure, the increased possibility of 
inactivating these resistant spores. 
A study by Otter & French (2009) investigating the effects of inactivation of 
a number of nosocomial bacteria with hydrogen peroxide vapour identified results 
similar to those in this chapter: longer exposure times result in an eventual greater 
number of inactivated spores.  This work demonstrated inactivation of C. difficile 
ribotype 106 spores with 30 min of 30% (w/w) liquid hydrogen peroxide (6.4-
log10 CFU).  These data also correlate with the findings of Pottage et al. (2010) and 
the inactivation of MS2 bacteriophages with hydrogen peroxide. 
Lawley et al. (2010) identified that with 400 ppm hydrogen peroxide 
vapour, 5-20 min of exposure was required to reduce the viability of C. difficile 
spores, stating prolonged exposure resulted in complete inactivation of the 6-log10 
spores applied.  The work in this thesis showed that more than 80 min of 90 ppm 
hydrogen peroxide would be able to exhibit the same.   
However, the method used by Lawley et al. (2010) made use of a peak 
concentration of exposure, whereas the concentration of hydrogen peroxide 
vapour administered in this work was continuous.  Many studies in which spore 
inactivation is reported, utilised an exposure concentration that has fluctuated 
over the time, reaching a peak concentration for a short time (Johnston et al. 2005; 
Hall et al. 2008; Fu et al. 2012).   
Furthermore, irrespective of the range of bacterial inactivation studies 
conducted, not exclusive to those investigating C. difficile alone, there are many 
studies where the authors have neglected to disclose all of the parameters for the 
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hydrogen peroxide vapour exposure.  The lack of details with respect to 
concentrations used and the corresponding times of exposure therefore prevent 
in-depth comparisons being drawn between the findings presented in this chapter 
with those in the literature. 
Despite utilising different C. difficile strains within their reports, neither 
Shapey et al. (2008) nor Barbut et al. (2009) concluded how the application of 
hydrogen peroxide had had an effect on these subtypes.  Shapey et al. (2008) 
referred to how, with the environmental sampling prior to the dry-mist 
application, ribotypes 001, 027 and 106 were collected; these are all clinically 
relevant strains.  However, the group did not report which strains of C. difficile 
were responsible for the contamination they identified when sampling post-
exposure.  This was also observed when analysing a study by Barbut et al. (2009), 
who did not conclude the effect hydrogen peroxide bore on the different ribotypes.  
Of the strains identified for the recovery experiments, two were variants of 
ribotype 027 (one historical and the other epidemic), and the third a reference 
strain (VPI 10463), sub-typed as toxinotype 0.  This strain has not been assigned a 
ribotype and therefore it is not known if this is a clinically relevant strain; 
toxinotype 0 could be ribotype 001, 003, 012, or 014/020, amongst many others 
(Rupnik et al. 2001; Mukherjee et al. 2002; Janezic et al. 2012).  It is not clear 
whether the application of hydrogen peroxide induced inactivation at the same 
rate between strains.  Furthermore, the individual log10 CFU reductions obtained 
for these strains by Barbut et al. (2009) following the use of hydrogen peroxide 
was not provided.  Therefore, it is not known whether a statistical difference was 
observed in spore inactivation between strains.  Conversely, the work presented in 
this thesis outlines the concentration and times of exposure for the strains used, as 
well as identifying differences in responses to hydrogen peroxide. 
Exposing C. difficile strains to different concentrations of liquid hydrogen 
peroxide through a simple zone of inhibition assay identified differences exist 
between ribotypes and their responses to the agent.  At lower concentrations of 
hydrogen peroxide (1-6%), ribotypes 014, 027, and 220 were statistically similar 
with respect to susceptibility; ribotype 103 was significantly more resistant.  This 
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was observed with the smaller zone of clearing around the filter paper disc in the 
centre of the bacterial lawn.  Increasing the concentration to 10% revealed 
ribotype 027 as highly susceptible to the application, despite its reputation as a 
problematic and difficult to eradicate strain. 
Interestingly, however, these preliminary data were not indicative of the 
responses of the strains when exposed to vaporised hydrogen peroxide.  The 
striking variation observed was the difference in susceptibility of ribotype 103; 
with liquid contact, this strain was the most resistant.  This strain was isolated 
following environmental sampling (Chapter 3), with its spores having resisted 
desiccation and decontamination in the hospital.  However, following exposure in 
the hydrogen peroxide chamber, ribotype 103 was recognised as the most 
susceptible of those tested.  The results from this strain suggested a reduction of 
4.2-log10 CFU after 40 min at 90 ppm.  It could be predicted using the Series-Event 
model that within a further 20 min exposure, complete inactivation of the 6-log10 
spore solution would be observed.   
Lawley et al. (2010) used 6-log10 spores obtained from a ribotype 017 
sample, an epidemic strain in Poland (Pituch et al. 2006).  This group 
demonstrated complete inactivation of these spores with 10% hydrogen peroxide 
solution, with >99% inactivation within 1 min exposure.  This research group also 
reported a 75% reduction in spore viability with the use of 1% hydrogen peroxide 
over 20 min.  These findings concur somewhat with the results identified from the 
work in this thesis, which shows that increasing the concentration of hydrogen 
peroxide solution exposed to C. difficile spores increases the rate of inactivation. 
Furthermore, there has been an investigation into the effects of liquid 
hydrogen peroxide and sporulation rates of different strains of C. difficile (Fawley 
et al. 2007).  The results from this study suggest the application of a hydrogen 
peroxide product, G-Force [JohnsonDiversey, UK], increased sporulation of 
ribotypes 001, 010, and 027.  This product bore no evident effect on the C. difficile 
spores, which is inconsistent with the findings in this study as well as an in vitro 
study by Perez et al. (2005).  This group obtained a complete inactivation of 6-
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log10 CFU reduction with 70,000 mg/l hydrogen peroxide with the Virox system 
within 13 min [Virox Technologies Inc., USA].   
Johnston et al. (2005) used C. botulinum spores to identify linear 
inactivation kinetics, comparing the log10 CFU surviving after exposure for a 
specified time, as conducted in this thesis.  This group were able to demonstrate 
exposure with less than 10 min was sufficient to induce inactivation, using a 
maximum hydrogen peroxide concentration of 355 ppm, which is significantly 
greater than the vapour concentrations used in this work.   
In addition, the findings from the liquid hydrogen peroxide experiments 
identified ribotypes 014 and 027 as susceptible to its exposure.  The vapour 
decontamination did not concur with this.  Ribotypes 014 (2.5-log10 CFU reduction) 
and 027 (2.4-log10) were the most resistant strains after 40 min at 90 ppm.  The 
calculated D-values for these strains emphasise the rate at which the recovery 
decreases by 1-log10 CFU.  Unfortunately, the lack of derivation of these values by 
other research groups hinders the comparison of these data. 
As these were the two clinically relevant strains investigated, it is vital to 
note that with respect to the vapour decontamination studies, they were resistant.  
This would be important to bear in mind when deciding on which concentration of 
hydrogen peroxide and for what time period, as these are two of the most 
problematic strains, clinically (Chapter 4).  No other studies have compared 
clinical strains in such a manner to identify the times and concentrations required 
to elicit spore inactivation. 
Based on the findings from this work, it could be suggested that the current 
treatment times used with hydrogen peroxide systems may not be adequate for 
the reduction of a range of clinical C. difficile strains.  The paucity of reports 
investigating the effects of different ribotypes suggests this is an area requiring 
further research.  The results from this chapter have identified significant 
differences exist in the responses of ribotypes to hydrogen peroxide 
decontamination, whether in liquid form or vaporised.   
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Furthermore, despite a vast number of reports demonstrating complete 
inactivation of C. difficile spores, the lack of control of hydrogen peroxide vapour at 
a fixed level could result in only the peak concentration affecting the spores for a 
limited time.  This means higher concentrations of exposure are required to elicit 
this reduction.  The identification of three regions of spore inactivation in this 
work suggests that constant application of hydrogen peroxide could be vital in the 
reduction of viable spores, targeting both the susceptible and resistant spores, 
whilst maintaining a lower exposure concentration.   
An important aspect in the work carried out in this chapter was to provide 
an insight into whether there is a link between different C. difficile strains and the 
responses elicited following hydrogen peroxide exposure.  The experiments were 
also designed to identify whether inactivation of C. difficile spores can be carried 
out with lower hydrogen peroxide concentrations.  This work suggests that a 
difference does exist between strains, with the clinically relevant strains more 
challenging to eradicate with hydrogen peroxide vapour.  However, susceptibility 
was demonstrated even with lower concentrations.  Further work into responses 
of clinical strains to vapour decontamination, with an extension into the time of 
exposure would be beneficial in accurately determining the parameters for 
complete inactivation. 
There has been a call in the literature for adequate cleaning prior to 
hydrogen peroxide decontamination.  Otter et al. (2007) and Boyce et al. (2008) 
have shown the application of pre-cleaning of contaminated surfaces with cleaning 
agents and disinfectants before the application of hydrogen peroxide vapour 
disinfection is necessary.  Although in this work there was no biological soiling 
added to the spores to simulate this contamination, previous findings have created 
such a simulation, stating hydrogen peroxide decontamination should not be 
applied in isolation and must be used in conjunction with an established cleaning 
procedure with regards to disinfection.  This is due to the spores being protected 
by various types of organic matter, affecting the inactivation.   
Hospital decontamination is an important albeit difficult problem to tackle.  
The resistant nature of C. difficile spores makes it even more challenging to reduce 
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the probability of cross-contamination and infection.  The reported success of 
hydrogen peroxide vapour decontamination with the range of HCAI researched to 
date indicates its incorporation into cleaning practice may aid in the reduction of 
problematic pathogens as well as inducing inactivation of C. difficile spores.  The 
work in this chapter also demonstrated that with lower concentrations of 
hydrogen peroxide, significant log10 CFU reduction could still be obtained, and 
affect the most clinically relevant strains.  This is the first study to identify how a 
low controlled concentration of hydrogen peroxide vapour can inactivate spores of 
a range of C. difficile strains to date.  There is a need for data of this kind to be 
collected to provide an insight into the application of hydrogen peroxide in 
hospital cleaning.  Awareness into the responses of different ribotypes increases 
the probability of eradicating all problematic clinically relevant strains. 
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5.5 Conclusions 
 A protocol was optimised to assess the inactivation of C. difficile 
strains after liquid hydrogen peroxide exposure.  Measurements 
were taken at multiple time-points to analyse the rate of kill on BHI 
agar with sodium taurocholate.  Ribotypes (014, 027, 103, and 220) 
were found to respond differently; ribotype 103 was the least 
susceptible.  Clinically relevant and problematic strains 014 and 027 
were highly susceptible. 
 Following the application of spores onto membranes prior to vapour 
exposure, a 1-log10 CFU loss of ribotype 027 spores was observed. 
 An environmental decontamination chamber was used to expose a 
specific concentration of hydrogen peroxide vapour in a controlled 
environment.  With ribotype 027 spores, it was demonstrated that 
even at 10 ppm, significant inactivation of spores occurs.  Increasing 
the concentration of exposure also increases the number of spores 
inactivated. 
 Use of the environmental chamber at 90 ppm with the above named 
strains identified a marked difference in susceptibility.  Ribotypes 
014 and 027 were the most resistant, followed by 220.  Inversely to 
the liquid peroxide results, ribotype 103 was the most susceptible. 
 There have not been studies of this kind conducted previously; this 
is the only study to demonstrate spore inactivation differs between 
C. difficile strains. 
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6.1 Key findings of this work 
The studies presented in this thesis were designed to identify the strains of 
C. difficile prevalent within UK healthcare facilities and to try to determine why 
they are so prevalent.  Using the UHL Trust as a case study, this work required 
several optimisation steps.  In order to investigate the ribotypes present in both 
patients and their surroundings, methodologies were optimised for the 
environmental recovery of C. difficile spores as well as PCR ribotyping for 
characterisation of strains.  A further aspect of the work was to use hydrogen 
peroxide in both its liquid and vapour form to investigate the kinetics in C. difficile 
spore inactivation.  It is unknown as to whether there is a reason for the 
prevalence of particular strains that persistently were recovered in the 
environment.  Could it be that their survival was due to resistance to disinfection 
agents typically deployed in these sites?   
In this section, the main conclusions from the work presented in this thesis 
are summarised: 
An aim of this work was to optimise a range of different C. difficile agar 
media and analyse the recovery efficiencies in subsequent environmental 
sampling.  Most of the medium comparative studies have been conducted with 
reference to the recovery of C. difficile from faeces, and therefore the media and 
conditions identified as ideal for these particular circumstances should not be 
regarded as necessarily optimal in environmental recovery.  Work in this thesis 
described the development of such a comparison, which was used in the 
resuscitation of environmental C. difficile.  This comparative study involved five 
different media and spore recovery following exposure to a germicide; 
investigations of this kind are infrequently conducted.  A methodology for the 
media optimisation in the environmental isolation of C. difficile spores is presented, 
in which three antibiotic-containing agar media (CCAB, CCEY, and CDMN) and two 
non-selective (FAA and GS-BHI) were compared.  The work within Chapter 2 
explored the stressing of spores with a germicide in liquid suspension and on 
stainless steel tiles.  It was also explored whether any of the media could recover C. 
difficile despite these stresses.  
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This study was designed to identify which media would be the most capable 
in the recovery of spores from the hospital environment, and whether a particular 
combination of selective and germination agents was more successful.  The 
recovery of ribotype 027 spores was analysed with different C. difficile agar media, 
which have been reported as successful in the environment as well as in the 
laboratory culturing of C. difficile.  The media displayed differences in both 
recovery and selectivity to ChlorClean.  It was shown that with direct contact of 
stainless steel tiles contaminated with C. difficile, GS-BHI and FAA recovered the 
highest proportion of C. difficile spores.  These two media possessed only the base 
agar media and supplements to aid in spore germination.   
This work has also strengthened reports in literature that allude to the 
importance of sodium taurocholate with a base agar media.  With sub-lethal 
concentrations (100 ppm) of the germicide, high recoveries of C. difficile spores 
were obtained using all five media.  Of the selective media, CCEY agar recovered C. 
difficile spores significantly more proficiently than CDMN and CCAB.  These results 
have also shown that CCEY and GS-BHI agars were able to recover C. difficile 
spores from environments where the spores had been exposed to 1000 ppm 
ChlorClean. 
With direct liquid exposure of ChlorClean at 10, 50 and 100 ppm to C. 
difficile ribotype 027 spores, it was found that fewer CFU were recovered with an 
increase in the concentration.  In addition, the longer the exposure time, the fewer 
spores recovered.  The effect of 10 ppm appeared to have very little effect overall 
on the spore reduction, however, with 50 and 100 ppm a marked inactivation was 
identified within 1 hr.  In addition, the link between the contact times of germicide 
and spores in order to effectively induce inactivation was demonstrated, as 
supported throughout literature. 
Despite the results of the laboratory-based experiments, it was 
hypothesised the use of an agar media with no selectivity properties in the form of 
antibiotics would recover a plethora of microorganisms when applied to surfaces 
in a hospital ward.  A further aim of this work was to identify techniques that could 
be used in the resuscitation of C. difficile from hospital environments.  The use of 
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CDMN agar in direct contact sampling did not yield high recovery of C. difficile-
positive isolates, despite preliminary environmental sampling (not presented) 
demonstrating this media recovered the highest number of colonies.  On the 
contrary, analysis of a sub-set of the colonies present on the surface of the agar 
plates were identified as constituting a variety of microbial species, including 
Staphylococcus haemolyticus and Staphylococcus epidermidis.  This finding suggests 
that agents widely held to be selective for C. difficile have been found to lack 
selectivity when applied in the environment.  Four positive isolates were 
confirmed from this first sampling campaign as ribotype 027, suggesting the 
presence of this strain environmentally (Chapter 3). 
Routine cleaning with germicides is effective in reducing the number of C. 
difficile-positive samples isolated, as demonstrated in this thesis.  A sampling 
campaign using the five agar media in two C. difficile isolation rooms (before and 
after a standard cleaning episode), toilet area, and sluice was conducted; 47.6% 
sites were C. difficile-positive.  The results demonstrated that within an isolation 
room, multiple ribotypes could be identified; ribotypes 010 and 103 were present 
in both isolation rooms.  Despite an overall decrease in numbers of putative C. 
difficile isolated after cleaning, there was clear evidence to suggest that routine 
cleaning fails to completely eradicate C. difficile spores from the environment, with 
ribotype 103 remaining after cleaning.  Little is known about this strain, however 
its predominance at the time of the study indicates its resistance to the cleaning 
regimes implemented in the ward.  These outcomes emphasise the need to ensure 
cleaning techniques and methodologies are tested against a range of strains and 
are capable of inactivating and eradicating multiple ribotypes of C. difficile. 
More commonly used in the isolation of C. difficile from faecal specimens to 
inhibit other microbial flora, the practice of alcohol shocking was also used to aid 
in C. difficile isolation following environmental sampling from RODAC plates.  
Samples were then evenly dispersed onto four agar media (CCEY, BHI blood, FAA, 
and GS-BHI); CCEY agar recovered the most positive isolates.  This agar medium is 
predominantly used in C. difficile isolation from faecal samples.  However, this 
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work has also demonstrated its success in the enrichment and subsequent 
resuscitation of environmentally isolated spores. 
Through this work, it was found that selective agents within media that are 
successful in certain circumstances, for example in the isolation of C. difficile from 
faeces, appear to act in an inhibitory manner in the recovery of stressed spores, as 
demonstrated from the experiments conducted with the stainless steel tiles.  
Nevertheless, without the presence of these antibiotics, one would isolate a 
number of microorganisms from the environment.  Therefore, the incorporation of 
selective and non-selective agars was a potential method for isolation and 
recovery of C. difficile, as explored within Chapter 3. 
An area of interest is whether C. difficile infection contracted by patients is 
due to its presence in the vicinity, or whether environments are contaminated 
with C. difficile because of the patients residing within them.  In the final sampling 
campaign (Chapter 3), faecal specimens from patients were collected and 
ribotyped before their admission to the ward; all patients were infected with 
ribotype 027.  Upon sampling in their individual side rooms with pre-moistened 
sponges, the same strain was detected for all sites.  This strongly suggests a 
potential for strain correlation and contamination between patient and 
environment.   
Double-layered agar media has been used in the food industry to recover 
bacteria, but has not been reported prior to this work in the resuscitation of C. 
difficile.  This work demonstrated environmental sampling with pre-moistened 
sponges and subsequent resuscitation of C. difficile on a double-layered agar media 
results in a higher rate of recovery than direct sampling with the agar media in 
RODAC plates.  The findings in this work have also identified that the combination 
of two distinctive media may act in conjunction, with the non-selective medium 
resuscitating damaged spores before the presence of the selective antibiotics in 
the lower layer diffuses onto the surface of the medium.  This would then 
theoretically inhibit the microbial growth of other bacteria, isolating C. difficile 
alone. 
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Through conducting two of the three sampling campaigns with RODAC 
plates prepared with C. difficile agar, the results from this thesis suggest that 
perhaps this method is not ideal in the recovery of environmental C. difficile (12.4% 
of the RODAC plates used recovered C. difficile).  An increased recovery was 
observed with the use of pre-moistened sponges (10/15 sponges were positive) 
and subsequent resuscitation onto these media prepared in a layered manner.  
Although there were no conclusive results into the optimum concentrations of 
antibiotics or volumes of agar required, a link may have been established. 
The third aspect of this thesis was to determine the strains of all C. difficile 
isolates collected.  This was conducted using capillary gel-based PCR ribotyping, a 
technique explained in Chapter 4.  This modern system outperformed the 
traditional agarose gel-based method by producing more accurate and precise 
ribotyping profiles.  The generation of a data file and chromatogram with the 
banding patterns that would be observed with an agarose gel image permits 
comparisons of isolates between laboratories.  Differences of ±4 bp could be 
detected, which enhanced and aided in the assignment of strains.  The findings 
from this thesis correlate with current literature suggesting this method of 
ribotyping should be employed by all typing laboratories. 
Two sampling cohorts were investigated, identifying ribotype distributions, 
both spatially and temporally, within the UHL Trust.  As expected due to its 
national presence at the time, there was a prevalence of ribotype 027 throughout 
all the sites sampled within the first cohort.  Many other dominant ribotypes were 
also identified as common throughout the three major hospitals and community-
based practices: ribotypes 002, 014/020, 015 and 078.  These outcomes correlate 
with the national statistics by the HPA, suggesting the presence of particular 
strains occurs on a wider geographical basis than within one region alone. 
The second epidemiological study conducted was designed to investigate 
any changes in ribotype distribution due to the implementation in C. difficile 
detection from faecal specimens.  Screening of isolates was modified from ELISA-
based tests to GDH-based assays, a method which has since been enforced in all 
NHS Trusts.  These changes were implemented to improve the accuracy and 
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efficiency in diagnostics.  Based on the findings, the number of samples from which 
C. difficile could not be isolated increased with the use of the GDH-based assay.  
Nevertheless, the presence of ribotypes 005, 014/020, 015, 027, 078, and 106 in 
all months of the study was noted, correlating with the predominant national 
strains.  Interestingly, despite reports of ribotype 027 declining, the data from this 
thesis suggests a similar proportion of the strain was identified throughout the 
time sampled.  This persistence would suggest ribotype 027 is well established in 
the UHL Trust.  This was also observed with ribotypes 014/020 and 078, 
correlating with literature.  The outcomes from this study emphasise the 
importance of designing studies of this nature to investigate the effect in ribotype 
proportion and diversity.   
There was also an increase in the number of ribotypes identified after 
implementing the change in diagnosis in January 2011, perhaps most curiously, in 
strains that are less well reported.  These less clinically dominant strains were not 
detected in the first sampling study, and few reports refer to them in literature.  
For example, the aforementioned strain, ribotype 103, was infrequently isolated 
from faecal specimens collected through the epidemiological studies described, 
obtained only following the modification in the method of detection.  The presence 
of many of these strains has not been reported on a national scale.  This may be 
attributed to the detection of non-toxigenic strains with the GDH-based assay, 
which would have not been identified using the ELISA-based assay. 
Determining which strains were present within areas of the UHL Trust 
aided in the decision of the ribotypes to target in the fourth and final aspect of this 
thesis: to investigate whether exposure to hydrogen peroxide has an effect on the 
recovery with respect ribotype.  As demonstrated in Chapter 5, an environmental 
decontamination chamber was designed for the application of hydrogen peroxide 
vapour in an enclosed space.  The concentration of hydrogen peroxide vapour 
administered was monitored throughout and remained constant.  Current studies 
often only specify the peak concentration of hydrogen peroxide reached during 
environmental release, with incomplete information regarding the time of peak 
concentration exposure, or of details on cycle times and total length of exposure.  
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The hydrogen peroxide vapour concentrations utilised (10, 50, and 90 ppm) 
showed the rate of inactivation of ribotype 027 spores was dependent on the 
hydrogen peroxide concentration employed.  The findings from this thesis 
demonstrated that even at 10 ppm, there is significant reduction in spores 
recovered.  Longer exposure times were also found to result in greater inactivation, 
increasing the time in which to eliminate the population of spores that were 
particularly hardy.  Series-Event modelling for these three hydrogen peroxide 
concentrations represented the experimental data reasonably well.   
An assay to identify differences in ribotype susceptibilities to liquid 
hydrogen peroxide was devised, using ribotypes 014, 027, 103, and 220.  Results 
showed statistical differences exist between strain susceptibilities, with the 
clinically relevant strains 014 and 027 the least resistant to liquid hydrogen 
peroxide, with ribotype 103 the most resistant.   
Inversely, exposure of vaporised hydrogen peroxide at 90 ppm identified a 
marked difference in susceptibility.  Ribotype 014 was the most resistant, followed 
by 027, with 103 demonstrating the fastest inactivation.  This susceptibility of 
ribotype 103 was interesting to observe due to the resistance demonstrated to the 
liquid-phase hydrogen peroxide and its predominance in the C. difficile isolation 
ward in the second sampling campaign irrespective of routine cleaning.  This is the 
only study to demonstrate spore inactivation and kinetics differ between C. difficile 
strains, in particular prevalent and lesser-known isolates.  Initiatives like those 
presented in this thesis would aid in the development of a system to reduce 
contamination of HCAI from healthcare facilities, whilst using lower, safer 
concentrations of hydrogen peroxide. 
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6.2 Proposed future work 
The following section includes several recommendations for future work 
based on the results presented in this thesis: 
Arguably, the most important aspect of C. difficile environmental sampling 
is the method by which the spores can be resuscitated and germinate.  In order to 
develop the work conducted in this thesis, it may be useful to cultivate spore 
solutions of various strains and repeating the described recovery experiments.  
This would help identify if there are any differences, with respect to which 
ribotypes can be resuscitated onto the double-layered agars, or whether ribotype 
027 grows preferentially on these media combinations. 
This thesis has provided evidence to suggest the application of antibiotics 
in an agar medium could inhibit the growth of damaged C. difficile spores.  Studies 
have identified the optimal concentrations of cycloserine and cefoxitin for C. 
difficile from faecal specimens, although whether these are the ideal 
concentrations for resuscitation of environmental isolates have yet to be studied.  
Additional work into modifying the concentrations of antibiotics in the layered 
media may provide information into the requirements of damaged C. difficile 
spores following recovery.  Comparative studies in resuscitation could be 
conducted with different proportions of the recommended concentrations of 
antibiotics. 
General protocols used to track the presence and spread of C. difficile 
infection within a ward could be adapted to gain more epidemiological data.  This 
would be vital in extending the studies conducted in Chapter 4.  Investigating the 
strains present in a healthcare facility following an outbreak or case of C. difficile, 
and specimen analysis from surrounding patients could help control the spread of 
C. difficile infection.  Sampling around the infected patients could answer the 
question: is there an association with the strains found from a patient and their 
surrounding areas? 
Studies into the diversity of strains through the monitoring of patients 
following the initial diagnosis of C. difficile could also be conducted.  The 
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characterisation of strains following the confirmation of C. difficile infection and 
tracking of patient movement between wards, as well as in and out of hospitals, 
could provide a unique viewpoint into whether the strains residing within the gut 
remain the same throughout infection, and potentially re-infection.  The data 
collected could provide interesting information into the prevalence of strains 
within infected patients. 
Based on the findings in this thesis, and as supported with current 
literature, the dominance of ribotype 027 in UK is declining, with previously 
infrequent strains increasingly identified.  Conducting epidemiological studies to 
investigate shifts in ribotype distribution provides information on a localised 
geographical basis.  In conjunction with the regional and national data provided by 
the HPA, this would provide the framework for further investigative 
epidemiological findings into strain proportions. 
The second epidemiology study was designed to investigate the effects of a 
change in the C. difficile detection from faecal specimens.  Utilising a small sample 
of the faecal isolate, retrospective analysis of strains could be carried out.  It may 
be that non-toxigenic C. difficile strains identified with the GDH-based assay would 
not have been identified with an ELISA-based assay.  A PCR test specifically 
detecting the toxin genes would clarify this.  Conducting the alternate detection 
test would permit a comparison between these diagnostic techniques.  This could 
answer the important question: was the increase in detection and diversity of 
lesser-known ribotypes entirely due to changes method of detection increasing the 
number of non-toxigenic strains? 
A conclusion from Chapter 4 suggested there was an increase in non-
cultured isolates was observed with the GDH-based assay; the samples were 
positive with the diagnostic tests, however, C. difficile could not be cultured onto 
selective agar in the laboratory.  Therefore, building on this knowledge would 
enable more understanding into whether the tests might be creating a bias and 
increasing the number of false positives.  Corroborating the findings of the ELISA-
based assays may demonstrate the differences in proportions of false positive 
isolates.  No comparative study of this nature has been reported, and therefore the 
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outcome would be of interest.  An insight into the effect these changes can have on 
the diversity of strains identified from such epidemiological studies would be 
gained.   
Further investigation into the strains used in the hydrogen peroxide studies 
at a genetic level may identify genes affecting resistance, or susceptibility, to 
exposure of decontamination agents.  Do particular strains possess genetic 
mutations enabling the resistance to standard cleaning methods?  An interesting 
strain with which to commence investigations would be ribotype 103.  This strain 
was collected from the environment, persisting in isolation rooms despite routine 
cleaning.  Upon exposure to liquid hydrogen peroxide in the laboratory, this strain 
exhibited the greatest resistance to inactivation, even more so than ribotypes 014 
and 027.  Do these lesser-known, but very much present, strains carry virulence 
factors that allow them to reside on environmental surfaces irrespective of routine 
cleaning with disinfectants? 
Exposure of hydrogen peroxide vapour to different strains could also 
identify whether the resistance with the clinical ribotypes is observed with other 
dominant isolates, for example, ribotypes 015 and 078 that were found throughout 
the epidemiology studies.  Investigations into the inactivation kinetics of a range of 
strains could help shape the optimal conditions needed for a reduction in C. 
difficile prevalence. 
Another area for potential development of this project is through the 
collection of field data with large-scale environmental decontamination.  The use 
of biosensor plates exposed to strains of C. difficile and hydrogen peroxide vapour, 
allows the comparison between the spatial and temporal distribution data with 
those obtained from the laboratory-based experiments. 
Finally, hydrogen peroxide vapour decontamination systems in current 
literature do not account for room sizes.  The work conducted in this thesis 
provides informative kinetic data.  Used in conjunction with computational 
modelling, these data could accurately calculate the required concentration and 
time of exposure to result in decontamination.  
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6.3 Concluding remarks 
Healthcare facilities possess many sites where pathogenic bacteria are 
capable of persisting irrespective of the use of disinfectants in routine cleaning, 
with findings from this work have shown the persistence of C. difficile spores.  This 
thesis has outlined the importance of identifying the strains present on these 
surfaces.  It is evident that the literature and knowledge of selective media in 
sampling and resuscitation of C. difficile spores is fundamental.  Comparative 
studies are rare and therefore the ideal selective media has yet to be identified.  
This work has identified the use of pre-moistened sponges in recovery and 
subsequent application onto a double-layered agar media for isolation is a 
potential method to be explored in environmental recovery of C. difficile.  In 
addition, it has also been shown how monitoring of strains within a single NHS 
Trust over a number of months and with a change in C. difficile diagnostics can 
identify differences in ribotype prevalence.   
With the application of hydrogen peroxide, this thesis has demonstrated 
the possibility in reducing C. difficile from both healthcare equipment and 
surrounding environments in a controlled, safer manner with lower exposure 
concentrations.  Identification of the disease-causing and persistent strains 
uncovers the importance of local surveillance into which types require attention to 
control spreading of epidemic C. difficile infections.  This work has uncovered 
evidence to suggest there are differences in the responses of clinical and non-
clinical isolates to hydrogen peroxide exposure. 
Reports conducted so far have yet to thoroughly investigate the C. difficile 
spore inactivation kinetics with controlled hydrogen peroxide vapour 
decontamination.  However, with the development and implementation of such a 
system, it is possible to gain more understanding into this important aspect of C. 
difficile contamination, spread and infection, and thereby aid in the development 
of more effective strategic techniques. 
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